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Summary 
Prenylated natural products are widely distributed in nature and demonstrate an 
amazing variety of structures and promising biological activities, which are usually 
distinct from their non-prenylated precursors. Therefore, they are intensively studied 
by researchers from different disciplines. These include investigations on their 
biosynthesis as well as on the involved key enzymes such as prenyltransferases, which 
contribute significantly to the structural diversity and biological activity. 
Prenyltransferases catalyze the transfer reactions of prenyl moieties from different 
prenyl donors to various aliphatic or aromatic acceptors. This thesis focuses on the 
prenyltransferases from the dimethylallyltryptophan synthase (DMATS) superfamily. 
A new member of this superfamily TyrPT was characterized biochemically in vitro. 
The responsible gene An13g01840 had been identified in the genome sequence of A. 
niger and cloned into pET28a. In this thesis, TyrPT was found to catalyze the O-
prenylation of tyrosine as well as C7-prenylation of tryptophan. It was further compared 
with the known tyrosine O-prenyltransferase SirD and tryptophan C7-prenyltransferase 
7-DMATS toward a series of tyrosine and tryptophan derivatives. TyrPT exhibited a 
broader substrate spectrum and significantly higher catalytic activity for several 
substrates than the other two enzymes. Kinetic parameters of TyrPT reactions with ten 
substrates were determined. This study not only provides a new enzyme, but also 
enhances the relationships between tyrosine O- and tryptophan C-prenyltransferases. 
Further studies demonstrated that tryptophan prenyltransferases FgaPT2 and 7-
DMATS also accepted tyrosine and its derivatives as substrates and catalyzed a unique 
C3- and O-prenylation, respectively. A mechanism of the FgaPT2 reaction with 
tyrosine was proposed based on the molecular modeling results with the available 
crystal structure of FgaPT2. Based on this hypothesis, sixteen mutated FgaPT2 
derivatives were tested with tryptophan and tyrosine as substrates. The mutant K174F 
demonstrated much higher catalytic ability toward tyrosine than FgaPT2 and showed 
almost no activity toward tryptophan. Therefore, tryptophan C4-prenyltransferase was 
switched to a specific tyrosine C3-prenyltransferase by site-directed mutagenesis. This 
strategy was also used for enhancing the catalytic activity of FgaPT2 as a C4-
prenylating enzyme of cyclic dipeptides. Thirteen mutated FgaPT2 with much higher 
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catalytic activities and different substrate preferences toward cyclic dipeptides were 
obtained as new biocatalysts. 
Inspired by the results above, the L-tyrosine analogs, L-o- and L-m-tyrosine, were tested 
with the tryptophan prenyltransferases FgaPT2, 5-DMATS, 6-DMATSSv and 
7-DMATS as well as the tyrosine prenyltransferases SirD and TyrPT. Surprisingly, 
SirD hardly accepted these tyrosine analogs. In contrast, tryptophan prenyltransferases 
generally demonstrated higher catalytic activities toward these two substrates. Product 
isolation and structure elucidation proved C5-prenylated o-tyrosine as unique product 
of these enzymes, and both C4- and C6-prenylated derivatives were identified as the 
products of the FgaPT2 reaction with L-m-tyrosine. These results revealed that chemical 
category of the aromatic nucleus was not the essential feature for the acceptance of a 
substrate by tryptophan or tyrosine prenyltransferases. It strongly depends on the 
substitution positions of the functional groups on the aromatic nucleus, which directly 
interact with the enzyme active sites. 
Aforementioned results exhibit fairly the broad substrate spectra of DMATS enzymes. 
However, the tryptophan prenyltransferases usually accepted cyclic dipeptides only at 
high protein concentrations. Consequently, tryptophan was a very poor substrate for 
cyclic dipeptide prenyltransferases. In this thesis, the substrate promiscuity of indole 
prenyltransferases including tryptophan and tryptophan-containing cyclic dipeptide 
prenyltransferases was further expanded by their acceptance of the synthesized 
unnatural cyclo-L-homotryptophan-D-valine with one additional C-atom between the 
indole and the diketopiperazine rings. This compound was well accepted by all the 
tested prenyltransferases including three tryptophan and five cyclic dipeptide 
prenyltransferases. Seven prenylated products with one prenyl moiety at each position 
of the indole nucleus were isolated from the enzyme assays. This was the first report on 
the production of seven monoprenylated products from one substrate by one-step 
reactions. 
The results presented in this thesis demonstrate that prenyltransferases of the DMATS 
superfamily are a rich source of biocatalysts, which could play an important role for 
production of prenylated compounds.
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Zusammenfassung 
Prenylierte Substanzen sind in der Natur weitverbreitet und weisen eine erstaunliche 
strukturelle Diversität auf. Sie besitzen häufig eine vielversprechende biologische 
Aktivität, was sie von ihren unprenylierten Vorstufen unterscheidet. Daher werden sie 
von Wissenschaftlern aus verschiedenen Disziplinen umfangreich untersucht. Die 
Forschung beinhaltet deren Biosynthese und die daran beteiligten Schlüsselenzyme, 
wie z. B. Prenyltransferasen, die maßgeblich an der strukturellen Vielfalt und 
biologischen Aktivität beteiligt sind. Prenyltransferasen katalysieren die Übertragung 
einer Prenyleinheit von unterschiedlichen Prenyldonoren auf verschiedene aliphatische 
oder aromatische Akzeptoren. Diese Dissertation beschäftigt sich mit den 
Prenyltransferasen der Dimethylallyltryptophan synthase (DMATS) Superfamilie. 
Die Prenyltransferase TyrPT, ein neues Mitglied dieser Superfamilie, wurde 
biochemisch in vitro charakterisiert. Das verantwortliche Gen An13g01840 wurde 
zuvor in der Genomsequenz von A. niger identifiziert und in pET28a kloniert. In der 
vorliegenden Arbeit wurde festgestellt, dass TyrPT sowohl die O-Prenylierung von 
Tyrosin als auch die C7-Prenylierung von Tryptophan katalysiert. Weiterhin wurde 
dieses Enzym mit der bekannten Tyrosin-O-Prenyltransferase SirD und der 
Tryptophan-C7-Prenyltransferase 7-DMATS gegenüber einer Reihe von Tyrosin- und 
Tryptophan-Derivate als Substrate verglichen. TyrPT wies ein breiteres 
Substratspektrum sowie eine deutlich höhere katalytische Aktivität für verschiedene 
Substrate auf, als die zwei anderen Enzyme. Ebenso wurden die kinetischen Parameter 
der TyrPT-Reaktionen mit zehn Substraten bestimmt. Diese Arbeit liefert nicht nur ein 
neues Enzym, sondern vergröβert auch unser Wissen über die Beziehungen der 
Tyrosin-O- und Tryptophan-C-Prenyltransferasen. 
Weitere Untersuchungen ergaben, dass die Tryptophan-Prenyltransferasen FgaPT2 und 
7-DMATS auch Tyrosin und dessen Derivate als Substrate akzeptieren und jeweils eine 
C3- und O-Prenylierung katalysieren. Ein Mechanismus der FgaPT2-Reaktion mit 
Tyrosin wurde durch molekulares modellieren („molecular modeling“) basierend auf 
der verfügbaren Kristallstruktur postuliert. Ausgehend von dieser Hypothese wurden 
16 FgaPT2-Mutanten mit Tryptophan und Tyrosine als Substrate getestet. Die Mutante 
K174F zeigte eine viel höhere katalytische Aktivität gegenüber Tyrosin als FgaPT2, 
jedoch kaum Aktivität mit Tryptophan. Somit wurde die Tryptophan-C4-
Prenyltransferase durch zielgerichtete Mutagenese zu einer spezifische Tyrosin-C3-
Prenyltransferase umgewandelt. Diese Strategie wurde auch eingesetzt um die 
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katalytische Aktivität von FgaPT2 als C4-prenylierendes Enzym von zyklischen 
Dipeptiden zu erhöhen. 13 FgaPT2-Mutanten mit deutlich höherer katalytischer 
Aktivität und unterschiedlichen Substratspräferenzen gegenüber Dipeptiden konnten 
als neue Biokatalysatoren erhalten werden. 
Motiviert durch die zuvor genannten Ergebnisse wurden zwei Analoga von L-Tyrosin, 
L-o- und L-m-Tyrosin, mit den Tryptophan-Prenyltransferasen FgaPT2, 5-DMATS, 6-
DMATSSv und 7-DMATS sowie den Tyrosin-Prenyltransferases SirD und TyrPT 
getestet. Interessanterweise akzeptierte SirD die zwei Tyrosin Analoga nur gering. Im 
Gegensatz dazu, wiesen die Tryptophan-Prenyltransferasen eine höhere katalytische 
Aktivität gegenüber diesen Substraten auf. Durch Produkt-Isolierung und 
Strukturaufklärung konnte bezüglich TyrPT und den Tryptophan-Prenyltransferasen 
C5-prenyliertes o-Tyrosin als einziges Produkt nachgewiesen werden. Für die FgaPT2-
Reaktion wurden C4- und C6-prenyliertes m-Tyrosin identifiziert. Diese Ergebnisse 
lassen erkennen, dass die Grund Struktur der Substrate keine essentielle Rolle für die 
Akzeptanz von Tryptophan- oder Tyrosin-Prenyltransferasen spielt, sondern von der 
Substitutionsposition der funktionellen Gruppe am aromatischen Kern abhängt, welche 
in direkte Wechselwirkung mit dem aktiven Zentrum des Enzyms tritt. 
Die zuvor beschriebenen Ergebnisse verdeutlichen die breite Substratspezifität der 
DMATS-Enzyme. Die Tryptophan-Prenyltransferasen akzeptieren jedoch die 
zyklischen Dipeptide nur bei hohen Proteinkonzentrationen. Im Gegenzug stellt 
Tryptophan ein sehr schlechtes Substrat für zyklische Dipeptid-Prenyltransferasen dar. 
Die Substratpromiskuität der Indol-Prenyltransferasen, einschließlich der Tryptophan- 
und tryptophanhaltigen zyklischen Dipeptid-Prenyltransferasen wurde durch das 
unnatürliche Substrat cyclo-L-homotryptophan-D-valin, welches ein zusätzliches C-
Atom zwischen den Indol- und Diketopiperazinringen besitzt, erweitert. Alle drei 
getesteten Tryptophan-Prenyltransferasen sowie die fünf zyklischen Dipeptid-
Prenyltransferasen akzeptierten das Substrat sehr gut. Sieben prenylierte Produkte mit 
jeweils einer Prenylgruppe an jeder Position des Indolkerns wurden aus den 
Enzymreaktionen isoliert. Damit wurden erstmals sieben monoprenylierte Produkte aus 
einem Substrat in einstufigen Reaktionen produziert. 
Die aus dieser Dissertation hervorgegangenen Ergebnisse demonstrieren, dass die 
Prenyltransferasen der DMATS-Superfamilie eine wertvolle Quelle für 
Biokatalysatoren darstellen und damit eine wichtige Rolle in der Produktion 
prenylierter Verbindungen spielen könnten. 
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1. Introduction 
1.1. Prenylated aromatic compounds in nature 
Natural products and their derivatives are of high significance for drug discovery and 
development process (1). These include prenylated natural compounds, which contain 
aromatic scaffolds and one or more prenyl moieties, e.g. prenylated indole alkaloids, 
tyrosines, xanthones, flavonoids, hydroxynaphthalenes and so on (Figure 1-1A) (2-5). 
Such compounds are abundant in terrestrial and marine organisms (6-9) and 
demonstrate a wide range of promising biological and pharmacological activities (3, 
10-12), which are often distinct from their non-prenylated precursors. The distinctive 
prenyl moieties play an important role in the structural diversity of these natural 
products, due to various prenylation positions on the aromatic nucleus and different 
patterns (regular or reverse) and lengths of the prenyl chain (Figure 1-1B). In addition, 
the prenylated compounds can be further modified by rearrangement, cyclization, 
oxidation and hydroxylation (Figure 1-1C) (11, 13, 14). The prenylated aromatic 
metabolites are classified, summarized and described below according to their aromatic 
nucleus. 
 
Figure 1-1. (A) Numbering of common aromatic scaffold; (B) Examples of regular and 
reverse prenyl pattern and different lengths of prenyl moieties; (C) Examples of 
bioactive prenylated natural products. 
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1.1.1. Prenylated indole alkaloids 
Prenylated indole alkaloids comprising of indole nucleus and prenyl moiety are widely 
distributed in microorganisms, especially in filamentous fungi, e.g. the genera 
Penicillium and Aspergillus of Ascomycota (9). They demonstrate various chemical 
structures and biological activities, which even have great influence in human history, 
e.g. ergot alkaloids (15-17). Therefore, prenylated indole alkaloids are of great interest 
for scientists from different disciplines and significant progress has been achieved 
concerning their isolation, structure elucidation, biological and pharmacological 
activities as well as their biosynthetic pathways. Based on the structure of aromatic core, 
prenylated indole alkaloids can be further classified into different subgroups, such as 
prenylated tryptophan and simple indole derivatives like α-cyclopiazonic acid, 
prenylated tryptophan-containing cyclic peptide derivatives (tryprostatins A and B), 
indole terpenes (paxilline) (18) and prenylated isoindolinone (aspernidines A and B) 
(19, 20), etc (Figure 1-2). This thesis focuses on the prenyltransferases catalyzing the 
formation of the former two main subgroups, which are further depicted below. 
 
Figure 1-2. Examples of prenylated indole alkaloids. 
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1.1.1.1. Prenylated tryptophan and simple indole derivatives 
The most famous representatives of prenylated tryptophan are the ergot alkaloids, 
which were first identified in ergot fungus Claviceps purpurea (C. purpurea) and 
further isolated from different fungi of the phylum Ascomycota, including Claviceps, 
Aspergillus and Penicillium as well as some plant families (17). Ergot alkaloids are 
featured with a tetracyclic ergoline ring, derived from 4-dimethylallyltryptophan and 
display numerous biological activities. Ergot alkaloids and their semi-synthetic 
derivatives are applied in the clinic for treatment of different diseases, e.g. ergometrine 
for postpartum hemorrhage, ergotamine for migraine (Figure 1-1C) and cabergoline for 
parkinsonism (16). More regular C4-prenylated indole derivatives have been identified, 
such as the mycotoxin α-cyclopiazonic acid (Figure 1-2) from Penicillium cyclopium 
(21) and rugulovasines A and B as well as 8-chloro-rugulovasines A and B from 
Penicillium islandicum (22). Furthermore, reversely N1-prenylated tryptophan was 
found in the biosynthetic pathway of the anti-inflammatory cyclomarin A and 
antibacterial cyclomarazine A in the actinobacterium Salinispora arenicola CNS-205 
(23). Regularly or reversely prenylated simple indole alkaloids containing 
hexahydropyrrolo[2,3-b]indole (HPI) unit, such as flustramines or flustraminols are 
widely distributed and isolated from plant Selaginella moellendorfii and even animal 
like the marine organism Flustra foliacea and Australian frog Pseudophryne coriacea 
(24). 5-Dimethylallylindole-3-acetonitrile (5-DMAIAN, Figure 1-2) represents a novel 
tryptophan metabolite of Streptomyces coelicolor A3 (25). Simple indole alkaloids 
including 5- and 7-dimethylallylindole, 3,7-diprenylated indole and hexalobines 
(Figure 1-2) were also isolated from plants (26, 27). Semicochliodinols A and B (Figure 
1-2) as well as isocochliodinol (C6-diprenylated indolylbenzoquinones) were produced 
by Chrysosporium merdarium as inhibitors of HIV-1 protease (28). Penipaline B 
(Figure 1-2) and penipaline C isolated from the deep-sea-sediment derived fungus 
Penicillium paneum SD-44 showed potent cytotoxic activities against A-549 and HCT-
116 cell lines (29). 
 
1.1.1.2. Prenylated tryptophan-containing peptide derivatives 
A major group of prenylated indole alkaloids belong to prenylated cyclic dipeptides, 
which consist of a 2,5-diketopiperazine or benzodiazepindine unit derived from 
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tryptophan and tryptophan/another amino acid biosynthesized by non-ribosomal 
peptide synthetase (NRPS). They are ubiquitous in nature and mainly in the phylum 
Ascomycota, notably in Aspergillus and Penicillium sp. A plurality of prenylated cyclic 
dipeptides are cyclo-tryptophanyl-prolinyl (cyclo-Trp-Pro) derivatives, e.g. 
brevianamides, mostly with a distinctive C2-reverse prenylation, i.e. 
deoxybrevianamide E, which can be further modified or rearranged to more 
complicated natural products, e.g. brevianamide A and stephacidin A (Figure 1-2) (30, 
31), brevianamide S-U (32), notoamides (30, 31, 33), mangrovamides A-C (34) and 
versicamides A-H (35). Another group of C2-prenylated cyclo-Trp-Pro derivatives are 
the bioactive tryprostatins (36), e.g. the microtube inhibitor tryprostatins A and B 
(Figure 1-2) and fumitremorgins as well as verruculogen (36), which usually have a 
regular dimethylallyl substitution at C-2 of the indole ring (Figure 1-2). Furthermore, 
mainly multiple prenylated cyclo-tryptophanyl-alaninyl derivatives also contribute 
greatly to the diversity of prenylated cyclic dipeptide, e.g. echinulins (37, 38), 
rubrumlines A-O (38) and variecolorins (39). The third type of prenylated cyclic 
dipeptides is represented by the roquefortine C (Figure 1-2) and comprises of 
roquefortines (40-42) and meleagrin (43), which are the reversely syn-cis C3-prenylated 
cyclo-tryptophanyl-histidinyl derivatives. More members of prenylated cyclic 
dipeptides might contain cyclo-tryptophanyl-tryptophanyl, such as gypsetin (44) or 
cylco-tryptophanyl-anthranilate, like (acetyl)aszonalenin (9, 45). Further examples are 
dipeptides of tryptophan with leucine, isoleucine, valine or serine in the core, which 
demonstrate activities to regulate plant growth (46-48) or anti-inflammatory (49). 
In addition, prenylated linear peptides and other cyclic peptides enrich the diversity of 
prenylated tryptophan-containing peptide derivatives as well (50, 51). 
Since the prenylated tryptophan-containing peptide derivatives display the bulk 
structural diversity and promising biological activities, they are substantially 
investigated on their occurrence, biological activity, biosynthesis (9, 50, 52, 53), total 
synthesis (24, 54, 55) and even structure-activity relationship (SAR) (56, 57). 
 
1.1.2. Prenylated tyrosine derivatives 
Tyrosine is an important proteinogenic amino acid, which is synthesized from the 
essential amino acid phenylalanine in human being and via the shikimate pathway in 
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plants, fungi, bacteria and algae (58). By the virtue of its 4-hydroxyl group, tyrosine 
contributes significantly to post-translational modifications, biosynthetic 
transformations and molecular interactions, which resulted from phosphorylation, 
sulfation, nitration, oxidation, halogenation, glycosylation, AMPylation or cross-
linking, etc (58). Prenylated tyrosine derivatives are not as common as indole 
derivatives in the secondary metabolism in nature. The O- or C-prenylated tyrosyl exists 
mostly in peptides or cyclic peptides (59) such as aestuaramides from Lyngbya aestuarii 
(60), pullularins from Bionectria ochroleuca (61) as well as prenylagaramides A and B 
from Oscillatoria agardhii (NIES-205) and Oscillatoria agardhii (NIES-596), 
respectively (62). It was proven that some regularly C-prenylated products were the 
results of Claisen rearrangement of reversely O-prenylated precursors (Figure 1-3A) 
(63, 64). Several simple O- or C3-prenylated tyrosine derivatives, e.g. stachylines were 
also found in Stachylidium sp., Pithomyces sp. and Streptomyces sp. IFM 10937 (65-
67). For example, stachyline A (Figure 1-3B) was identified as a O-prenylated tyrosine 
derivative with a unique terminal oxime group (65) and a C3-prenylated tyrosine 
(Figure 1-3C) was isolated during a screening program for TRAIL-resistance-
overcoming activity (66). Furthermore, O-prenylated tyrosine is the precursor of the 
phytotoxin sirodesmin PL (Figure 1-1C) in Leptosphaeria maculans (L. maculans) (68). 
 
 
Figure 1-3. (A) O-prenylation and Claisen rearrangement to C-prenylated derivative; 
(B) An example of simple prenylated tyrosine derivative; (C) C3-prenylated tyrosine; 
(D) Examples of prenylated xanthones; (E) Examples of prenylated flavonoids, 
naphthalenes and quinones. 
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1.1.3. Prenylated xanthones 
Prenylated xanthones are a widespread and structurally diverse group of natural 
products frequently found in plants, fungi and lichens (69). The prenyl moieties usually 
attach to hydroxyl groups or the ortho-positions of hydroxyl group and contribute 
greatly to the bioactivity of prenylated xanthones (70, 71). For example, garcinone C 
(Figure 1-3D) and γ-mangostin from Garcinia mangostana show cytotoxic activity (72) 
and AChE inhibitory activity (70), respectively. Macluraxanthone B from Maclura 
tinctoria was proven to have HIV-inhibitory activity (73), cudracuspixanthone A 
(Figure 1-3D) from Cudrania tricuspidata antiproliferative activity (4) and 
garciniacowone A (Figure 1-3D) from Garcinia cowa antimicrobial activity (74). 
Furthermore, there are structurally more complicated prenylated xanthone dimers in 
nature (69) such as bigarcinenone A (Figure 1-3D) with one geranyl and four 
dimethylallyl groups exhibiting a strong antioxidant activity (75). 
 
1.1.4. Prenylated flavonoids, naphthalenes and quinones 
Flavonoids are a huge group of structurally diverse and bioactive secondary metabolites 
with a distinctive C6-C3-C6 carbon framework mainly distributed in plant kingdom. 
Prenylation, frequently regular C-prenylation, represents one of the most important step 
in structural elaboration of flavonoids. So far, about 1000 prenylated flavonoids are 
characterized structurally and well investigated in their occurrence, biological activities 
chem- and biosynthesis (76-80). Dimethylallyl and geranyl substituted flavonoids and 
isoflavonoids have been substantially isolated, while farnesylated flavonoids are 
extremely rare. They have been reported to possess various biological activities and 
widely utilized in pharmaceutical, food and cosmetic industries. For example, 
xanthohumol (Figure 1-3E) from hops exhibits multiple pharmacological activities 
including anticancer (81, 82), antihyperglycemia (83) and antiviral activities (84). Other 
biologically active prenylated flavonoids include pannokin D (Figure 1-3E) with 
TRAIL-resistance-overcoming activity (85), quercetin-3-O-α-L-rhamnoside with 
strong antioxidant activity (86) and lespecrytin E3 with potent melanin biosynthesis 
inhibitory activity (87). 
Prenylated naphthalenes are not as common as flavonoids in nature. Cytotoxic 
adenaflorins A-D and vismiones B (Figure 1-3E), E and F were isolated from Adenaria 
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floribunda and Cratoxylum sp., respectively (88, 89). Vismione B also demonstrates 
potent anti-malarial activity (89). 
Prenylated quinones often referred as meroterpenoids from mixed polyketide and 
isoprenoid biosynthetic origins, have been substantially isolated from marine organisms 
(3, 90) and terrestrial plants and animals (91-93). They exhibit a wide variety of 
structural diversity and biological activities, especially for anti-inflammatory and 
anticancer activity (3). In addition to the versatile lapachol (92), dimeric prenylated 
quinone scabellone B (Figure 1-3E) from Aplidium scabellum demonstrates selective 
anti-malarial activity without detectable apoptosis toward human neutrophils, which 
could be a novel lead for the development of new drugs for treatment of malaria (94). 
 
1.2. Biosynthesis of prenylated aromatic secondary 
metabolites 
In recent years, investigations on the biosynthesis of secondary metabolites grew 
vigorously and significant progress has been achieved due to the development of 
various biotechnologies and the availability of genome sequences. With the help of 
genome mining, feeding experiment, gene deletion and overexpression as well as 
heterologous expression, more and more biosynthetic pathways have been identified in 
microorganisms and plants. Meanwhile, bioinformatic analysis (95) has greatly 
accelerated this process. Owing to the importance of prenylated indole alkaloids, the 
gene clusters responsible for their biosynthesis are intensively studied and reviewed (53, 
96-98). Moreover, achievements were made in biosynthetic pathways of prenylated 
xanthones (99, 100) and epipolythiodioxopiperazine as well. Some prenyltransferases 
used in this thesis are involved in several biosynthetic pathways, which are described 
in the following paragraphs. Furthermore, the interests of scientists have expanded to 
activate numerous silent secondary metabolite gene clusters to identify the 
unprecedented biosynthetic pathways and to regulate the production of natural products 
(2, 101). 
 
1.2.1. Biosynthetic pathway of fumigaclavine C in Aspergillus 
fumigatus 
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Fumigaclavine C belongs to the bioactive ergot alkaloids, some of which are clinically 
used as mentioned before (17). Its biosynthesis in Aspergillus fumigatus (A. fumigatus) 
(Scheme 1-1A) started with the C4-prenylation of L-tryptophan (102) followed with 
methylation by FgaMT (103), oxidation by FgaOx1 and dehydrogenation by FgaDH to 
form the key intermediate chanoclavine-1-aldehyde, which was the ancestor of 
festuclavine in A. fumigatus, pyroclavine in Penicillium commune or agrocavine in C. 
purpurea (17, 104, 105). 
Up to chanoclavine-1-aldehyde, the biosynthesis of ergot alkaloids in these three 
species shares the common steps. Chanoclavine-1-aldehyde was converted to 
festuclavine in A. fumigatus by FgaOx3 and FgaFS (106), which was further 
hydroxylated and acetylated to produce (8S,9S)-fumigaclavine A (15, 107). Another 
prenyltransferase FgaPT1 catalyzed the C2-reverse prenylation of (8S,9S)-
fumigaclavine A for the final step in the biosynthesis of (8S,9S)-fumigaclavine C (108). 
 
1.2.2. Biosynthetic pathway of prenylated brevianamide F derivatives 
Brevianamide F, i.e. cyclo-L-Trp-L-Pro, assembled by bimodular NRPS, is a common 
precursor in the biosynthesis of a wide range of prenylated compounds, e.g. 
tryprostatins, fumitremorgins, spirotryprostatins, stephacidins and notoamides (Scheme 
1-1B) (9, 97, 98, 109-111). Regular C2-prenylation of brevianamide F by FtmPT1 leads 
to the formation of tryprostatin B, which can be converted to tryprostatins, 
spirotryprostatins or fumitremorgins (112) by further modifications, e.g. oxidation, 
methylation, prenylation and rearrangement. Alternatively, reverse C2-prenylation by 
BrePT or NotF leads to deoxybrevianamide E, which is the precursor of stephacidins 
and notoamides (Scheme 1-1B) (30, 113).  
 
1.2.3. Biosynthetic pathway of acetylaszonalenin 
Acetylaszonalenin is a N1-acetylated and reversely C3-prenylated derivative of R-
benzodiazepinedione, isolated from N. fischeri NRRL181. Its biosynthetic pathway 
begins with the formation of R-benzodiazepinedione, which is assembled by a NRPS 
AnaPS and followed by prenylation with AnaPT and acetylation with AnaAT (Scheme 
1-1C) (9, 114). 
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Scheme 1-1. (A) Biosynthetic pathway of fumigaclavine C in A. fumigatus; (B) 
Biosynthetic pathways of brevianamide F derivatives; (C) Biosynthetic pathway of 
acetylaszonalenin; (D) Proposed biosynthetic pathway of sirodesmin PL. 
 
1.2.4. Biosynthetic pathway of sirodesmin PL 
20
INTRODUCTION 
 
Sirodesmin PL is an epidithiodioxopiperazine derived from tyrosine and serine. It was 
isolated from the L. maculans and is responsible for the blackleg disease (115, 116). 
The biosynthesis of sirodesmin PL has been extensively studied and its biosynthetic 
pathway is proposed (Scheme 1-1D) (68, 117-120). Our group reported the biochemical 
characterization of SirD, which catalyzed the regular O-prenylation of L-tyrosine as the 
first step in its biosynthesis (68). Welch et al proposed a biosynthetic pathway for 
sirodesmin PL as depicted in Scheme 1-1D (117). 
 
1.3. Prenyltransferases 
Prenyltransferases (PTs) are a large family of enzymes that catalyze the attachment of 
prenyl moieties (n × C5) derived from the terpenoid biosynthetic pathways, e.g. 
dimethylallyl (C5), geranyl (2 × C5), farnesyl (3 × C5) or geranylgeranyl (4 × C5), to 
various aliphatic or aromatic acceptors including small-molecule natural products, 
peptides and proteins (13) and even a few t-RNAs (121). They play an important role 
in both primary and secondary metabolism in nature. According to their sequences, 
structures, biochemical properties and functions, PTs can be classified into different 
subgroups, like protein PTs, cis- and trans-PTs and aromatic PTs. Our group focuses 
on the aromatic PTs of DMATS superfamily, therefore it will be described in details. 
 
1.3.1. Protein prenyltransferases 
Protein PTs attach a farnesyl or geranylgeranyl moiety to a conserved cysteine residue 
in a “CaaX box” at the C-terminus of several proteins and peptide substrates. 
Prenylation of protein is a ubiquitous post-translational modification found in all 
eukaryotic cells, which is required for the proper cellular activity of many proteins, e.g. 
Ras family GTPases and heterotrimeric G-proteins. Therefore, protein prenylation has 
been extensively investigated as drug targets for treatment of cancers, progeria, aging, 
parasitic diseases and bacterial as well as viral infections (122). 
 
1.3.2. Prenyl diphosphate synthases: trans- and cis-prenyltransferases  
Prenyl diphosphate synthases catalyze the transfer of prenyl moiety to a specific 
acceptor, isopentenyl diphosphate (IPP) and are responsible for the biosynthesis of the 
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carbon skeleton of over 55 000 isoprenoids, which are high value components of 
pharmaceutical products, cosmetics, fragrances, flavors and foods (123-125). Based on 
the trans- or cis-configuration of formed prenyl units, prenyl diphosphate synthases are 
classified into two major groups, trans-PTs, e.g. GGPP synthases (126) and cis-PTs, 
e.g. undecaprenyl diphosphate synthase (UPPs) (127, 128). Although these two groups 
of PTs utilize the same substrates and both are Mg2+-dependent, they have different 
amino acid sequences and three-dimensional structures (123, 124). Trans-PTs consist 
of α-helices with two conserved aspartate-rich DDxxD motifs which allowed the 
binding of prenyl diphosphate in complex with Mg2+ (129-131), while cis-PTs are 
featured with an Asp in the conserved P-loop involved in the chelating of Mg2+  (132-
134). 
 
1.3.3. Aromatic prenyltransferases 
Aromatic PTs catalyze the formation of prenylated natural products by attaching prenyl 
moieties to a wide variety of aromatic substrates and contribute significantly to their 
structural diversity and biological activities (9, 11, 13, 14). Therefore, aromatic PTs are 
intensively investigated during the past decades. Based on their differences on 
sequences, structures and biochemical properties, such as distinctive substrate binding 
motifs or metal ion dependency, aromatic PTs could be classified into membrane-
bounded PTs, i.e. PTs of the UbiA family and soluble PTs, e.g. CloQ/NphB group and 
DMATS superfamily including LtxC group (13). 
 
1.3.3.1. Prenyltransferases of the UbiA superfamily 
PTs of the UbiA superfamily are involved in the biosynthesis of ubiquinones, 
menaquinones (135) and membrane lipids in archaea (136) as well as in plant secondary 
metabolites (137). UbiA or UbiA-like enzymes catalyze mainly the C-prenylations of 
benzoic and naphthoic acids and flavonoids. So far, all of them are membrane-bound 
proteins (138) and divalent ion-dependent (139). The structure of UbiA from 
Aeropyrum pernix was solved recently (140). In addition to the representative C-
prenylation of most UbiA enzymes, a membrane-bound PT CnqPT1 from Streptomyces 
sp. CNQ-509 was identified to catalyze O-prenylation of 1,6-dihydroxyphenazine (141). 
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1.3.3.2. Prenyltransferases of the CloQ/NphB group 
PTs of the CloQ/NphB group catalyze mainly prenylations of naphthalenes, quinones 
as well as phenolic compounds. These soluble proteins from bacteria and fungi display 
a novel and distinctive structure with five repeating “αββα” barrel fold, named PT-
barrel (13, 142-144). In contrast to the aforementioned UbiA enzymes, most of them 
have no conserved aspartate-rich motif, thus independent of divalent metal ions. 
Furthermore, they also demonstrate higher substrate flexibility than UbiA enzymes. 
The CloQ/NphB group is named after the first identified enzymes CloQ from 
Streptomyces roseochromogenes catalyzing the prenylation of 4-
hydroxyphenylpyruvic acid (142) and the NphB from Streptomyces sp. attaching a 
geranyl group to a 1,3,6,8-tetrahydroxynaphthalene (143). More and more PTs are 
identified from this family (145-150) and used for chemoenzymatic synthesis of 
prenylated compounds (151). 
 
1.3.3.3. Prenyltransferases of the DMATS superfamily 
Our group focuses on the study of PTs from the DMATS superfamily, which is one of 
the most investigated subgroup of aromatic PTs. Until now, more than forty such 
enzymes from fungi and bacteria have been identified by genome mining and 
characterized biochemically by using recombinant proteins. Due to the conflict of 
numerous PTs and limited space, only PTs used in this thesis were summarized in Table 
1-1. According to their major function, the DMATS enzymes could be further classified 
into subgroups, such as tryptophan, cyclic peptide and tyrosine PTs, etc. They exhibit 
common characteristics, such as solubility, divalent metal ions independency as well as 
broad aromatic substrate promiscuity. Furthermore, they usually display high 
specificity toward prenyl donor (152-154). Dimethylallyl diphosphate (DMAPP) serves 
as the most common prenyl donor, while GPP and FPP are only accepted by a few 
members of the DMATS superfamily. 
The first isolated and characterized DMATS enzyme was the C4-tryptophan PT, 
DmaW, which is involved in the biosynthesis of ergot alkaloids in Claviceps (155, 156). 
As mentioned above, the orthologue FgaPT2 is involved in the biosynthesis of 
fumigaclavine C in A. fumigatus (Scheme 1-1A) (15, 102, 157). So far, N1-reverse, C4-, 
C5-, C6- and C7-regular prenylations of tryptophan were found to be catalyzed by 
23
INTRODUCTION 
 
CymD, FgaPT2, 5-DMATS, 6-DMATSSa or 6-DMATSSv and 7-DMATS as well as 
their homologues DamW-Cs (158, 159), 5-DMATSSc (160), IptA (161) and 7-
DMATSNeo (162), respectively (Table 1-1). CymD, DmaW-Cs, 5-DMATSSc, IptA and 
7-DMATS are involved in the biosynthesis of cyclomarin/cyclomarazine, ergot 
alkaloids, 5-DMAI-3-acetonitrile, 6-DMAI-3-carbaldehyde and asteochrome, 
respectively (23, 158, 160, 161, 163). CymD and IptA along with LtxC (164) and TleC 
(165), which catalyze the C7-geranylation of (-)-indolactam V, are bacterial origin and 
were cataloged to an individual LtxC group. They share common features with DMATS 
enzymes from fungi and are therefore integrated into DMATS superfamily. 
Table 1-1. PTs of the DMATS superfamily used in this thesis. 
Enzyme Organism Prenylated substrate, position and pattern Reference 
Tryptophan PTs 
 
FgaPT2 A. fumigatus L-Trp, C-4, regular (102) 
5-DMATS A. clavatus  L-Trp, C-5, regular (166) 
6-DMATSSa S. ambofaciens L-Trp, C-6, regular (167) 
6-DMATSSv S. violaceusniger L-Trp, C-6, regular (167) 
7-DMATS A. fumigatus L-Trp, C-7, regular (163) 
Tryptophan-containing cyclic peptides PTs Products 
 
FtmPT1 A. fumigatus 
brevianamide F, 
C-2, regular 
 
(168) 
BrePT A. versicolor  
brevianamide F, 
C-2, reverse 
 
(30) 
CdpC3PT N. fischeri  cyclo-L-Trp-L-Leu, 
syn-cis C3-reverse 
 
(169) 
AnaPT N. fischeri cyclo-D-Trp-Ant, 
anti-cis C3-reverse 
(114) 
CdpNPT A. fumigatus cyclo-L-Trp-Ant 
syn/anti-cis C3-reverse 
(170) 
Tyrosine and xanthone PTs                                 
 
SirD L. maculans L-Tyr O-regular (68) 
XptB A. nidulans  xanthone O-regular (100) 
A.: Aspergillus; N.: Neosartorya; S.: Streptomyces; L.: Leptosphaeria. 
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Compared to the most tryptophan PTs, tryptophan-containing cyclic peptide PTs are 
usually responsible for the biosynthesis of structurally more complicated natural 
products (Table 1-1). As aforementioned, FtmPT1, FtmPT2 and FtmPT3 from A. 
fumigatus/N. fischeri catalyze the sequential, regular C2-, N1- and O-prenylations in 
the biosynthesis of fumitremorgins and verruculogen, respectively (Scheme 1-1B) (109, 
168, 171), while NotF and NotC from Aspergillus species prenylate sequentially on the 
C-2 (reversely) and C-7 (reguarly) of the indole ring in the biosynthesis of notoamides 
(Scheme 1-1B). The C2-prenylation was also observed with BrePT from Aspergillus 
versicolor (30) and CdpC2PT from N. fischeri with different substrate preferences. 
CdpC2PT is proposed to be involved in the biosynthesis of fellutanine (172). Two C3-
PTs CdpC3PT and AnaPT are characterized from N. fischeri and found to produce syn-
cis and anti-cis configured reverse C3-prenylated pyrroloindolines with high 
stereoselectivity (114, 169). In contrast, the third reverse C3-PT CdpNPT from A. 
fumigatus exhibited low stereoselectivity and catalyzed both syn-cis and anti-cis 
configured prenylations (170, 173). CTrpPT from Aspergillus oryzae catalyzed the 
simultaneous regular C7- (major) and reverse N1-prenylation (minor) of cyclo-L-Trp-
L-Trp with high substrate specificity (174), while a new member of the DMATS family, 
CdpC7PT from Aspergillus terreus (175) demonstrated much higher substrate 
flexibility and converted six cyclic dipeptides to ten prenylated products, including the 
first O-prenylated cyclo-L-Tyr-L-Tyr (175). 
PTs of other indole derivatives were also identified, such as didemethylasterriquinone 
D PT TdiB (176), asterriquinone D PT AstPT (177) and indole diterpene PT AtmD 
(178) and PaxD (179).  
Compared to the numerous indole PTs, a few DMATS enzymes catalyze prenylations 
of non-indole derivatives, such as tyrosine O-PT SirD (68) and xanthone PT XptB as 
well as the distinctive reverse O-PT of glucose moiety in fusicoccin P PAPT (180). 
Despite of their low to moderate similarities on the amino acid level, similar crystal 
structures with five repeating “αββα”(ABBA) barrel fold were found for FgaPT2 
(Figure 1-4) (181), FtmPT1 (182), CdpNPT (183) and AnaPT (173), which were used 
as basis for understanding the prenyl transfer reactions (181, 182, 184). Their active 
sites are located in the center of the barrel and no metal ions were detected in the 
structures. The amino acid residues in the DMAPP binding sites seem to be fairly 
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conserved in these four structures, whereas the binding sites of the aromatic substrates 
differ from each other. Further experiments showed that the enzyme reactions catalyzed 
by the DMATS superfamily might contain three common steps: it firstly started with 
ionization of DMAPP to form the dimethylallyl carbocation, which was confirmed by 
a positional isotope exchange in isotopically-labeled DMAPP (184); then nucleophilic 
attack of the aromatic ring to the primary center (regular prenylation) or the tertiary 
center (reverse prenylation) of the dimethylallyl carbocation; at last rearomatization of 
the aromatic ring to produce the final product (Figure 1-4, FgaPT2 as example) (181). 
Most controversy over the mechanism focused on the second step: whether it went 
under a directly nucleophilic attack by the prenylated position to the dimethylallyl 
carbocation or the nucleophilic attack first happened at other position and followed by 
different rearrangements (cope rearrangement or aza-cope rearrangement or 1,2 shift) 
to obtain the final products (185). All these results illuminate the route of function study 
and rational modification of DMATS to improve their catalytic ability.  
The distinct common structure, “ABBA” fold, of CloQ/NphB group and DMATS 
superfamily provides evidence for a common ancestry of these enzymes (186). 
Therefore, they also termed ABBA-PTs. 
Figure 1-4. Structure of FgaPT2 and proposed mechanism of its prenyl transfer reaction 
(modified from (181)). 
 
1.3.4. Potential uses of DMATS enzymes for production of prenylated 
compounds 
As mentioned above, prenylated natural products display a wide array of biological 
activities (3, 9-12, 64). Thus, synthesis of such compounds is of great interest and 
different strategies have been developed consequently. There are two most commonly 
used synthetic strategies: addition of a prenyl moiety from prenyl bromide to a substrate, 
which was activated by strong base before; or by coupling reactions catalyzed by metal 
salts (55, 57, 187). Reactions of both types are usually carried out under anhydrous or 
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anaerobic conditions with special temperature control using dangerous and 
environment hazardous chemicals and organic solvent (55, 57, 187). Even so, only 
electron-rich positions, e.g. N-1, C-2 and C-3 of the indole ring, are preferred by 
chemical prenylation. Meanwhile, additional steps are usually necessary for protection 
and deprotection of functional groups (55, 188). 
Due to the availability of an increasing number of PTs, chemoenzymatic synthesis of 
prenylated compounds are now considered as a promising alternative of classic 
chemical synthesis, because it is more efficient, environment-friendly and easier to 
handle than the traditional synthesis in organic solvent. The reactions catalyzed by PTs 
are mostly regio- and stereoselective and carried out in aqueous solutions at low 
temperature, e.g. 37 ℃, without any involvement of protection groups (154, 189).  
Before my PhD study, regularly C4- and C7-monoprenylated tryptophan and 
derivatives as well as C4- and C7-diprenylated tryptophan were synthesized by using 
the DMATS enzymes (163, 190, 191). For cyclic dipeptides, regiospecific reverse C2- 
and C3-prenylated derivatives were able to be produced (114, 168-170, 192). During 
the recent four years, characterization of DMATS enzymes as well as their substrate 
promiscuity developed rapidly. More than ten DMATS enzymes were newly 
characterized and used for the prenylations of indole, tyrosine, xanthone and flavonoid 
derivatives. They accept not only natural substrate analogues with similar structures, 
but also compounds with quite different aromatic nucleus. Thus, a large number of 
simple indole derivatives, cyclic dipeptides as well as tyrosine and xanthone derivatives 
were converted by these enzymes to their prenylated derivatives (100, 193, 194). Until 
now, reversely N1-, regularly C4-, C5-, C6- and C7-prenylated tryptophan and 
derivatives were synthesized by the DMATS enzymes (Figure 1-5A) (23, 163, 166, 167, 
190, 191). Regiospecific synthesis of N1-, C2-, C3- and C7-prenylated tryptophan-
containing cyclic dipeptides by cyclic dipeptide PTs were also reported (Figure 1-5B) 
(168-170, 172-175, 192). Remarkably, the bacterial metabolites such as prenylated 
hydroxynaphthalenes and indolocarbazoles as well as plant metabolites, e.g. prenylated 
flavonoids and acylphloroglucinols can also be produced from their non-prenylated 
precursors by DMATS enzymes, which are generally more convenient and efficient 
than membrane-bound  PTs (Figure 1-5C) (195-198). Until 2012, prenyl transfer 
reactions mentioned above all took place on the aromatic nucleus. Chen et al reported 
that cyclic dipeptide PT FtmPT1 was able to catalyze the formation of the unnatural α-
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prenylindolylbutenone, demonstrating the prenylation of a nonaromatic carbon by an 
indole PT (199). This example indicated that further investigations on the substrate 
promiscuity and catalytic ability of PTs could lead to production of novel unnatural 
products. 
However, one barrier for the use of DMATS enzymes as biocatalysts is their high 
specificity toward prenyl donors. They usually stick to their natural donor, e.g. DMAPP, 
GPP or FPP and do not accept other prenyl diphosphates. During the past four years, 
efforts and progresses have been made to expand their acceptance for other natural 
prenyl donors (200, 201) as well as some unnatural alkyl, even benzyl donors, which 
can be used to produce novel unnatural prenylated indole or tyrosine derivatives (202-
206). For instance, AstPT from A. terreus, catalyzed N1- and C2-prenylation of 
bisindolyl benzoquinone with extremely high substrate specificity, (177) could even 
use DMAPP, GPP and FPP for O-prenylation of hydroxyxanthones (Figure 1-5D) (201).  
 
Figure 1-5. (A) – (C) Examples of prenylated compounds synthesized by DMATS 
enzymes; (D) and (E) Examples of unnatural alkylated or benzylated compounds 
synthesized by DMATS enzymes. 
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Furthermore, several unnatural DMAPP analogues were synthesized and tested as 
prenyl donors for indole and tyrosine PTs (202-206). It has shown that the double bond 
at the ß-position to pyrophosphate is essential for an acceptance by these enzymes. One 
methyl group can be deleted as in the case of monomethylallyl (MAPP) or shifted to 
the δ-position as in the case of 2-pentenyl-PP (2-pen-PP) (Figure 1-5E) (205). Even 
more space-demanding benzyl-PP can be accepted by some DMATS (Figure 1-5E) 
(202, 204). Additionally, the alkylation position of the products can differ from those 
with DMAPP, depending on the used prenyl donors. As an example, the tryptophan C4-
PT FgaPT2 used these unnatural donors and the prenyl positions were partially (MAPP) 
or total shifted (2-pen-PP and benzyl-PP) to C-5 (Figure 1-5E) (204). 
Unfortunately, biocatalyst application is often hampered by its long-term stability under 
process conditions and by difficulties in recovery and recycling. To overcome this 
problem, enzyme immobilization was proposed (207). Furthermore, coexpression of 
PT genes with NRPS genes in fungi resulted in high product yields of prenylated 
derivatives and did not need addition of expensive DMAPP (208, 209). Additionally, 
the whole cell biocatalyst by Autodisplay FgaPT2 on the surface of E. coli demonstrates 
high catalytic efficiency and stability, which can be easily separated from reaction 
system by centrifugation for reuse (210). 
Investigation on the substrate and catalytic promiscuity of the DMATS enzymes 
demonstrated their potential application in the chemoenzymatic synthesis and synthetic 
biology. So far, more than 250 prenylated compounds have been produced by using 
DMATS enzymes as biocatalysts (211). 
Enzyme promiscuity is latent skills of enzymes during evolution and widely considered 
and investigated for developing biocatalysts (212, 213). Mechanism of enzyme 
promiscuity might involve the variation in the mode of substrate binding interactions 
or conformational diversity. In a few cases, changes on other parts of the catalytic 
machinery occurred (214). If a natural enzyme cannot fulfill task, protein engineering 
can be used to improve its properties, such as regio-/stereoselectivity, desired substrate 
scope or stability to heat or organic solvents. Random mutagenesis/directed evolution 
combined with high throughput screening (HTS) as well as rational protein design 
methods are considered as useful tools (215-217). As refer to PTs, crystal structures of 
DMATS enzymes provide not only detailed insights into the reaction mechanism of the 
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prenyl transfer reactions, but also basic information for protein engineering to create 
new biocatalysts with desirable features (182). Due to the difficulty of HTS for PT 
mutants, rational design based on the available crystal structure is more efficient and 
preferred. Structure-based engineering of EpzP resulted in a novel phenazine PT with 
conformational changes at C-termini and increased its catalytic turnover rate (218). 
In addition to biochemical investigation on a new PT, substrate promiscuity of DMATS 
enzymes and attempt to construct mutants with desired property are studied in this 
thesis. 
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2. Aims of this thesis 
The following issues have been addressed in this thesis: 
 
Prenylation of unnatural cyclo-L-homotryptophan-D-valine by both 
tryptophan and tryptophan-containing cyclic dipeptide 
prenyltransferases 
Tryptophan and tryptophan-containing cyclic dipeptide PTs comprise the majority of 
DMATS enzymes. Usually, the former enzymes accepted cyclic dipeptides only at high 
protein concentrations. Likewise, tryptophan was a very poor substrate for cyclic 
dipeptide PTs. Furthermore, each cyclic dipeptide PT has its own preference for 
substrates. The aim of this project was to elucidate the behavior of these two enzyme 
groups toward unnatural cyclo-L-homotryptophan-D-valine, which bears one additional 
C-atom between the indole and diketopiperazine rings. The following experiments were 
planed: 
 Synthesis of cyclo-L-homotryptophan-D-valine 
 Overproduction and purification of cyclic dipeptide PTs BrePT, FtmPT1, 
CdpC3PT, CdpNPT, AnaPT as well as tryptophan PTs FgaPT2, 5-DMATS and 
7-DMATS  
 Enzyme assays and HPLC analysis 
 Enzyme product isolation on HPLC and structure elucidation by nuclear 
magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) 
 Determination of kinetic parameters of the enzyme reactions 
 
Functional proof of a putative prenyltransferase gene An13g01840 
from Aspergillus niger FGSC A1180 
One putative PT CAK41583 (latter named TyrPT), deduced from the gene An13g01840 
in A. niger, shares sequence identities of 36 and 30 % with SirD and 7-DMATS on the 
amino acid level, respectively. In order to characterize this enzyme biochemically, the 
following experiments were planed: 
 Sequence analysis of neighboring genes of tyrPT from A. niger CBS513.88 for 
secondary metabolite information and mRNA isolation from A. niger FGSC 
A1180 and RT-PCR to verify the tyrPT expression 
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 Overproduction and purification of TyrPT  
 Enzyme assays of TyrPT with various substances and HPLC analysis 
 Enzyme product isolation on HPLC and structure elucidation by NMR and MS 
 Determination of ion dependency of TyrPT reactions 
 Overproduction and purification of SirD and 7-DMATS 
 Comparison the enzyme activities of TyrPT with SirD and 7-DMATS toward 
tryptophan and tyrosine as well as their derivatives 
 Determination of kinetic parameters of TyrPT and 7-DMATS reactions 
 
Prenylation of tyrosine and its derivatives by tryptophan 
prenyltransferase 7-DMATS 
7-DMATS from A. fumigatus and SirD from L. maculans catalyze a C7-prenylation of 
L-tryptophan and an O-prenylation of L-tyrosine in nature, respectively. SirD was 
reported also to catalyze the C7-prenylation of L-tryptophan in vitro. The aim of this 
project was to elucidate the behavior of 7-DMATS toward L-tyrosine and its derivatives.  
The following experiments were planed: 
 Overproduction and purification of 7-DMATS 
 Enzyme assays and HPLC analysis 
 Enzyme product isolation on HPLC and structure elucidation by NMR and MS 
 Determination of kinetic parameters of the enzyme reactions 
 
Creation a specific tyrosine C3-prenylating enzyme from tryptophan 
prenyltransferase FgaPT2 
The tryptophan PTs FgaPT2 and 7-DMATS from A. fumigatus catalyze C4- and C7-
prenylations at the indole ring, respectively. 7-DMATS was found to accept L-tyrosine 
as substrate as well and converted it to an O-prenylated derivative. The original aim of 
this project was to elucidate the behavior of other available tryptophan PTs including 
FgaPT2, 5-DMATS and 6-DMATSSa toward tyrosine. Further study demonstrated a 
C3-prenylation of tyrosine and 4-amino-L-phenylalanine by FgaPT2. The second aim 
of this project was to improve the catalytic efficiency of FgaPT2 toward tyrosine. The 
following experiments were planed: 
 Overproduction and purification of used PTs  
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 Enzyme assays of the tryptophan prenyltransferases with L-tyrosine 
 Enzyme product isolation on HPLC and structure elucidation by NMR and MS. 
 Determination of kinetic parameters of the enzyme reactions 
 Molecular modeling-guided site-directed mutagenesis experiments to obtain 
FgaPT2 mutants 
 Enzyme assays of mutated enzymes and FgaPT2 with L-tryptophan and L-
tyrosine 
 Analysis and comparison of the enzyme activities on HPLC 
 Enzyme product isolation on HPLC and structure elucidation by NMR and MS 
 
Regular C-prenylation of o-tyrosine and m-tyrosine by tryptophan and 
tyrosine prenyltransferases 
Previous study found that tyrosine O-PTs SirD and TyrPT catalyzed the same C7-
prenylation of tryptophan as 7-DMATS. Meanwhile, the tryptophan C4- and C7-PT 
FgaPT2 and 7-DMATS catalyzed the C3- and O-prenylations of tyrosine, respectively, 
which indicated the close relationship between tryptophan and tyrosine PTs. This 
project focuses on the behavior of these two enzyme groups toward isomers of tyrosine, 
i.e. o-tyrosine and m-tyrosine. The following experiments were planed: 
 Overproduction and purification of used PTs  
 Enzyme assays with tryptophan, tyrosine, o-tyrosine and m-tyrosine and HPLC 
analysis 
 Enzyme product isolation on HPLC and structure elucidation by NMR and MS 
 Determination of kinetic parameters of the enzyme reactions 
 
Creaction of FgaPT2 mutants for production of C4-prenylated cyclic 
dipeptides with high efficiency by saturation mutagenesis 
Until now, N1-, C2-, C3- and C7-prenylated cyclic dipeptides can be synthesized with 
cyclic dipeptide PTs. Tryptophan C4-PT FgaPT2 was reported to accept a few cyclic 
dipeptides using high amount of protein. The aim of this project was to enhance the 
catalytic ability of FgaPT2 toward cyclic dipeptides by site-directed mutagenesis and 
to create new biocatalysts for C4-prenylation of cyclic dipeptides with high efficiency. 
The following experiments were planed: 
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 Overproduction and purification of FgaPT2 and available mutants  
 Enzyme assays with cyclic dipeptides and HPLC analysis 
 Enzyme product isolation on HPLC and structure elucidation by NMR and MS 
 Saturation mutagenesis of R244 to obtain FgaPT2 mutants 
 Attempt for optimization screening process of mutants by enzyme assays with 
mixtures of cyclic dipeptides and crude mutated proteins 
 Overproduction and purification of selected mutants 
 Characterization of the selected mutants by enzyme assays and HPLC analysis 
as well as isolation and structure elucidation of the enzyme products by NMR 
and MS 
 Determination of kinetic parameters of enzyme reactions 
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3. Results and discussion 
3.1. Prenylation of cyclo-L-homotryptophan-D-valine by both 
tryptophan and tryptophan-containing cyclic dipeptide 
prenyltransferases 
 
The enzymes of the DMATS superfamily are known for their broad substrate spectra. 
However, the tryptophan PTs accepted cyclic dipeptides only at high protein 
concentrations. Consequently, tryptophan was a very poor substrate for cyclic dipeptide 
PTs. In this project, we used eight DMATS enzymes, including tryptophan and 
tryptophan-containing cyclic dipeptide PTs to catalyze the prenylations of an unnatural 
cyclic dipeptide cyclo-L-homotryptophan-D-valine. 
To fulfill this aim, cyclo-L-homotryptophan-D-valine with one additional C-atom 
between the indole and diketopiperazine rings was synthesized. It was then tested as 
substrate with five cyclic dipeptide PTs including BrePT, FtmPT1, CdpC3PT, CdpNPT, 
and AnaPT as well as three tryptophan PTs FgaPT2, 5-DMATS and 7-DMATS. HPLC 
analysis of the reaction mixtures revealed that cyclo-L-homotryptophan-D-valine was 
well accepted by all the tested PTs. This could be explained by the increased similarity 
of this substance with L-tryptophan and reduced steric hindrance of the diketoperazine 
ring after insertion of one CH2 between the indole and diketoperazine rings. Seven 
products with one prenyl moiety at each position of the indole nucleus and one 
diprenylated derivative were isolated from enzyme assays (Figure 3-1). Along with the 
enhanced product yields, the regioselectivity decreased in the presence of this unnatural 
aromatic substrate. This phenomenon was also observed for PTs with unnatural alkyl 
donors (205). To solve this problem, molecular modeling-guided mutagenesis 
experiments might be a useful tool. 
To the best of our knowledge, this was the first report for production of seven 
monoprenylated products from one substrate by one-step reactions. 
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Figure 3-1. Enzyme products of cyclo-L-homotryptophan-D-valine (modified from 
(219)). 
 
For detailed information about this work, please see the publication (section 4.1) 
Fan, A. and Li, S.-M. (2013). One substrate - seven products with different prenylation 
positions in one-step reactions: Prenyltransferases make it possible. Adv. Synth. Catal. 
355, 2659-2666. 
 
3.2. Prenylation of both tyrosine and tryptophan derivatives 
by TyrPT from Aspergillus niger FGSC A1180 
 
A putative PT gene An13g01840 of the DMATS family was identified in the genome 
sequence of A. niger CBS513.88. The deducted protein CAK41583 shares sequence 
identities of 36 and 30 % with SirD and 7-DMATS on the amino acid level, respectively. 
Therefore, it could be a tyrosine or indole PT. 
To evaluate the gene function, the entire DNA sequence of An13g01840 was PCR 
amplified from genomic DNA of A. niger FGSC A1180 and the intron sequence was 
eliminated by QuickChange Site-Directed Mutagenesis. The obtained coding sequence 
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was cloned into pET28a and resulted in the plasmid pHC16. The works described above 
were carried out by Huizhi Chen within the PPP program between DAAD and CSC. 
In this thesis, the plasmid pHC16 was transformed into various E. coli strains to find a 
best condition for protein overproduction. The soluble His6-tagged protein from E. coli 
SoluBL21 was purified to near homogeneity and used for enzyme assays with diverse 
aromatic substrates in the presence of DMAPP. 
Lacking the information about its possible natural substrate, tyrosine, tryptophan and 
their derivatives as well as peptides were tested as potential substrates for this enzyme. 
HPLC analysis revealed that tyrosine and its derivatives were well accepted and product 
formations were detected in the incubation mixtures of L-tyrosine and five derivatives 
thereof. L-Tryptophan and two derivatives were also used by this enzyme as substrates. 
Structure elucidation of the enzyme products by NMR and MS analyses confirmed O- 
or N-prenylations of tyrosine and derivatives (Figure 3-2), which proved the 
identification of a tyrosine O-PT, named TyrPT. It was further compared with SirD 
toward tyrosine and its derivatives. 
Similar to SirD from L. maculans, TyrPT also accepted L-tryptophan for a C7-
prenylation (Figure 3-2). Therefore, it was further compared with SirD and 7-DMATS 
toward tryptophan and derivatives. The KM values of TyrPT for L-tyrosine, L-
tryptophan and DMAPP were determined to be 0.24, 0.19, and 0.71 mM, respectively. 
The kcat of tyrosine and tryptophan reactions were determined at 0.58 and 0.0053 s
−1, 
respectively. 
The results presented in this study enhance the relationship of tyrosine O- and 
tryptophan C7-PTs and provide meanwhile a new enzyme for production of prenylated 
compounds. In comparison to the known tyrosine PT SirD, TyrPT exhibited broader 
substrate spectrum and significantly higher catalytic activity for several substrates, e.g. 
4-amino-L-phenylalanine as well as 4- and 5-methyl-DL-tryptophan. 
 
For detailed information about this work, please see the publication (section 4.2) 
Fan, A., Chen, H., Wu, R., Xu, H. and Li, S.-M. (2014). A new member of the DMATS 
superfamily from Aspergillus niger catalyzes prenylations of both tyrosine and 
tryptophan derivatives. Appl. Microbiol. Biotechnol. 98, 10119-10129. 
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Figure 3-2. Prenylated products of TyrPT, SirD and 7-DMATS. Nucleus in red for 
SirD, blue for 7-DMATS and all for TyrPT. 
 
3.3. Prenylation of tyrosine and its derivatives by tryptophan 
prenyltransferase 7-DMATS 
 
7-DMATS from A. fumigatus and SirD from L. maculans catalyze C7-prenylation of 
tryptophan and O-prenylation of tyrosine in vivo, respectively. SirD was reported to 
catalyze mainly C7-prenylation of tryptophan and some derivatives thereof in vitro. 
This inspired us to investigate the acceptance of tyrosine and its derivatives by 7-
DMATS. 
Therefore, tyrosine and nine derivatives were incubated with 7-DMATS in the presence 
of DMAPP. HPLC analysis of the incubation mixtures revealed clear product formation 
in several enzyme reactions. Product yields of 36, 70 and 97 % were calculated for 
tyrosine, 4-amino-L-phenylalanine and 3-iodo-L-tyrosine, respectively and the same O- 
or N-prenylated products as SirD were obtained and characterized by NMR and MS 
38
RESULTS AND DISCUSSION 
 
analyses (Figure 3-3). Determination of kinetic parameters revealed that high KM and 
low turnover number were obtained for 7-DMATS with tyrosine, whereby comparable 
KM value was calculated for 7-DMATS with 3-iodo-L-tyrosine to that of SirD with 
tyrosine or 7-DMATS with tryptophan. 
These results demonstrated the similar substrate and catalytic promiscuity of SirD and 
7-DMATS and indicated their close relationship in the evolution. Comparable studies 
on their structures and identification of their active sites could provide detailed insights 
into their difference and similarity, which would help us to understand these intriguing 
DMATS enzymes. At the same time, it could even provide information for enzyme 
modification to create new biocatalysts with higher substrate flexibility and 
regioselectivity. 
 
 
Figure 3-3. Enzyme reactions catalyzed by 7-DMATS toward tyrosine and its 
derivatives.  
 
For detailed information about this work, please see the publication (section 4.3) 
Fan, A. and Li, S.-M. (2014). Prenylation of tyrosine and derivatives by a tryptophan 
C7-prenyltransferase. Tetrahedron Lett. 55, 5199-5202. 
 
3.4. Creation a specific tyrosine C3-prenylating enzyme from 
tryptophan prenyltransferase FgaPT2 by molecular 
modeling-guided site-directed mutagenesis 
 
As mentioned above, tryptophan PT 7-DMATS catalyzes in vitro O-prenylation of 
tyrosine and its derivatives. Meanwhile, tyrosine O-PTs SirD and TyrPT can also 
catalyze the same C7-prenylation of tryptophan as 7-DMATS, which indicated close 
relationship between tryptophan and tyrosine PTs and encouraged us to investigate the 
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acceptance of tyrosine by other tryptophan PTs including FgaPT2, 5-DMATS and 6-
DMATSSa. 
For this purpose, FgaPT2, 5-DMATS, 6-DMATSSa and 7-DMATS were purified and 
incubated with tyrosine in the presence of DMAPP. A unique product peak was 
observed in the HPLC chromatogram of FgaPT2 reaction mixture, whose retention time 
was 2 min shorter than that of 7-DMATS with tyrosine. After isolation and structure 
elucidation, the enzyme product was proven to be a unique C3-prenylated tyrosine, 
which was also a natural product isolated from Streptomyces sp. IFM 10937 in 2008 
during a screening program for TRAIL-resistance-overcoming activity. So far, there is 
neither report about its biosynthesis nor an enzyme for tyrosine C3-prenylation. 
Therefore, this was the first report on an enzymatic C-prenylation of tyrosine as free 
amino acid. 
In order to figure out the catalytic mechanism of this reaction, molecular modeling 
experiment was carried out by Dr. Zocher from Universität Tübingen based on the 
available crystal structure of FgaPT2.  According to this model, Thr-102 was proposed 
to interact with the hydroxyl group of tyrosine, while Arg-244, Tyr-191, Leu-81, and 
Ile-80 to stabilize the side chain. Tyr-413, Lys-187, Arg-100, Tyr-409, Arg-404, Arg-
257, Gln-343 and Lys-259 are involved in the diphosphate binding sites. The carboxyl 
entity of Glu-89, which has an interaction with N-1 of tryptophan, is oriented toward 
the C-3 of tyrosine and therefore suitable to function as a base to abstract the proton 
from the σ-complex, which was carried out by Lys-174 in the FgaPT2 reaction with 
tryptophan. To prove the proposed mechanism, eleven FgaPT2 mutants were newly 
constructed by site-directed mutagenesis. Together with six available mutants, these 
proteins were purified and tested for their enzyme activities toward tryptophan and 
tyrosine. HPLC analysis of the reaction mixtures led to identify an enzyme derivative 
FgaPT2_K174F, which showed practically no activity toward L-tryptophan, whereas 
the acceptance of L-tyrosine by this enzyme was improved significantly (Figure 3-4). 
Therefore, we created a specific tyrosine C3-prenylating enzyme from FgaPT2 by 
molecular modeling-guided mutagenesis. Based on the modeling and mutagenesis 
results, a mechanism for FgaPT2 reaction toward tyrosine was also proposed. 
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Figure 3-4. Switching a tryptophan prenyltransferase to a tyrosine C3-prenylating 
enzyme by molecular modeling-guided site-directed mutagenesis (graphical abstract of 
(220)). 
 
For detailed information about this work, please see the publication (section 4.4) 
Fan, A., Zocher, G., Stec, E., Stehle, T. and Li, S.-M. (2015). Site-directed mutagenesis 
switching a dimethylallyl tryptophan synthase to a specific tyrosine C3-prenylating 
enzyme. J. Biol. Chem. 290, 1364-1373. 
 
3.5. Regular C-prenylation of o-tyrosine and m-tyrosine by 
tryptophan and tyrosine prenyltransferases 
 
As aforementioned, tryptophan C4- and C7-PTs FgaPT2 and 7-DMATS catalyze C3- 
and O-prenylation of tyrosine in vitro, respectively. In return, tyrosine O-PTs TyrPT 
and SirD prenylate tryptophan at C-7 of the indole ring. These results demonstrated 
complementary substrate promiscuity of these four enzymes, indicated close 
relationship between tryptophan and tyrosine PTs and prompted investigation on the 
acceptance of tyrosine isomers, i.e. L-o-tyrosine and L-m-tyrosine by these two PT 
groups. 
For this purpose, FgaPT2, 5-DMATS, 6-DMATSSv and 7-DMATS were purified and 
incubated with L-o-tyrosine and L-m-tyrosine as well as tryptophan and tyrosine under 
the same condition in the presence of DMAPP. HPLC chromatograms showed 
interesting results: both L-o-tyrosine and L-m-tyrosine are hardly accepted by the 
tyrosine PT SirD. Meanwhile, tryptophan PTs FgaPT2, 6-DMATSSv and 7-DMATS 
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exhibited higher catalytic ability toward o-tyrosine than another tyrosine PT TyrPT. In 
addition, m-tyrosine was better converted by FgaPT2 than TyrPT. After product 
isolation and structure elucidation, C5-prenylated L-o-tyrosine was identified as a 
unique product of FgaPT2, 5-DMATS, 6-DMATSSv, 7-DMATS and TyrPT. C4- and 
C6-prenylated L-m-tyrosine were obtained from FgaPT2 reaction (Figure 3-5). 
These results suggest that the acceptance of a substrate by tryptophan or tyrosine PTs 
would not strictly depend on the chemical category of the aromatic nucleus, but strongly 
rely on the positions of the functional groups on the aromatic nucleus, which perform 
the direct interactions with the enzyme active sites. Furthermore, these results revealed 
that tryptophan and tyrosine PTs possess very likely similar active sites and strengthen 
their close relationship in the evolution. 
 
 
Figure 3-5. Enzyme reactions catalyzed by tryptophan and tyrosine PTs toward L-o-
tyrosine and L-m-tyrosine. 
 
For detailed information about this work, please see the publication (section 4.5) 
Fan, A., Xie, X. and Li, S.-M. (2015). Tryptophan PTs showing higher catalytic 
activities for Friedel-Crafts alkylation of o- and m-tyrosine than tyrosine 
prenyltransferases. Org. & Biomol. Chem. (online published). 
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3.6. Creation of FgaPT2 mutants for production of C4-
prenylated cyclic dipeptides with high efficiency by 
saturation mutagenesis 
Tryptophan C4-PT FgaPT2 was reported to catalyze the C4-prenylations of cyclic 
dipeptides with high concentration of protein as well. To improve the catalytic ability 
of FgaPT2 toward cyclic dipeptides, saturation mutagenesis experiments were carried 
out on the key amino acid R244, which is involved in the binding of tryptophan side 
chain. Fifteen additional mutants of FgaPT2 were obtained. Thirteen mutated FgaPT2 
were found to demonstrate much higher catalytic efficiency toward eight tryptophan-
containing cyclic dipeptides with up to 155-fold catalytic efficiency of that of FgaPT2 
and catalyze the same C4-prenylation as non-mutated FgaPT2. Among these mutants, 
R244L showed the highest activity toward most of the tested cyclic dipeptides. The 
highest product yield of 49.9 % toward cyclo-L-Trp-D-Pro was obtained with 0.08 
µg/µL R244L and 1.5 h incubation time. In addition, cyclo-L-Trp-L-Pro, cyclo-L-Trp-
L-Leu were also well accepted substrates by these mutants, with product yields of 32.8 
and 37.8 %, respectively. More importantly, these mutants showed different substrate 
preferences toward these eight cyclic dipeptides. Product yields of 10.5 – 49.9 % were 
achieved for the eight cyclic dipeptides by using the respective best mutants. 
These results provide not only new biocatalysts for production of C4-prenylated cyclic 
dipeptides, but also abundant data for further investigations on the catalytic mechanism 
of FgaPT2 and its mutants toward cyclic dipeptides. 
 
For detailed information about this work, please see the submitted manuscript 
(section 4.6) 
Fan, A. and Li, S.-M. (2015) Creation of FgaPT2 mutants with enhanced catalytic 
ability and different preferences toward cyclic dipeptides by saturation mutagenesis. 
ChemCatChem (submitted). 
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3.7. Impacts and perspectives of prenyltransferases of the 
DMATS superfamily for use in biotechnology 
 
In the past decade, significant achievement has been obtained on the PTs of the DMATS 
superfamily. More than forty members of this family have been characterized 
biochemically by genome mining and four crystal structures of them were solved, 
which served us not only with more biocatalysts for production of prenylated products, 
but also valuable information to understand these prenyl transfer reactions. Compared 
to their high substrate specificity on prenyl donors, DMATS enzymes are well-known 
for their broad substrate promiscuity on the aromatic substrates. Numerous 
investigations on substrate and catalytic promiscuity of these enzymes have been 
published and demonstrated their potential application in the chemoenzymatic 
synthesis and synthetic biology, which are summarized in this review. 
Additionally, efforts and progresses have been achieved to expand their acceptance for 
other prenyl donors, e.g. GPP and FPP as well as some unnatural alkyl, even benzyl 
donors, which can be used to produce novel unnatural prenylated products (202-205). 
Furthermore, the potential usage of these enzymes was expanded by coexpression the 
PT genes with other genes like NRPS and by development of whole cell biocatalyst. 
More than 250 prenylated compounds produced by using DMATS enzymes as 
biocatalysts are summarized in this review. Availability of more crystal structures of 
these enzymes will provide bases for creation of new desirable biocatalysts with broad 
substrate specificity, high catalytic efficiency and regio- as well as stereoselectivity for 
unnatural substrates by site-directed mutagenesis. 
 
For detailed information about this review, please see the submitted manuscript 
(section 4.7) 
Fan, A., Winkelblech, J. and Li, S.-M. (2015). Impacts and perspectives of 
prenyltransferases of the DMATS superfamily for use in biotechnology. Appl. 
Microbiol. Biotechnol. (Invited review, submitted). 
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Abstract: Prenylated indole alkaloids derived from
l-tryptophan are widely distributed in nature and
show diverse biological and pharmacological activi-
ties, usually distinct from their non-prenylated pre-
cursors. Prenyltransferases catalyze the transfer reac-
tions of prenyl moieties onto the indole nucleus and
contribute largely to the structural diversity of these
compounds. In this study, we demonstrate the ac-
ceptance of cyclo-l-homotryptophan-d-valine, an un-
natural cyclic dipeptide, by eight prenyltransferases
of the dimethylallyltryptophan synthase superfamily.
Seven products with one prenyl moiety at each posi-
tion of the indole nucleus and one diprenylated de-
rivative were isolated from enzyme assays of cyclo-l-
homotryptophan-d-valine with dimethylallyl diphos-
phate. To the best of our knowledge, this is the first
report for production of seven monoprenylated prod-
ucts from one substrate by one-step reactions.
Keywords: dimethylallyltryptophan synthase;
enzyme catalysis; Friedel–Crafts alkylation; prenyl-
transferase
Introduction
Natural products and their derivatives contribute sig-
nificantly to drug discovery and development.[1,2]
From 1981 to 2012, they comprised 26% of all new
approved drugs, meanwhile 20% of new drugs are
natural product mimics.[2] Prenylated indole alkaloids
including prenylated indole diketopiperazines consti-
tute a natural product class that is widely distributed
in both terrestrial and marine organisms.[3,4] These
compounds show potent biological and pharmacologi-
cal activities,[3,4] for example, anti-cancer[5–7] and anti-
fungal activities,[8] which are usually distinct from
those of their non-prenylated precursors.[3,9] There-
fore, different approaches and agents were developed
for synthesis of the prenylated indole derivatives.
Prenyl bromide, isoprenyl bromide or prenyl acetate
with NaH,[10] lithium salt[9] or other metal catalysts[11]
are often used in the prenylation reactions. However,
chemical prenylation usually has some limitations
such as different reactivities of C-atoms on the indole
nucleus, low selectivity of the prenylation for several
positions, side products, toxicity and danger of the re-
agents and solvents for products and environment. In
addition, protection and deprotection of functional
groups are usually necessary in the synthetic route,
which decreases the efficiency of desired products.[10]
In contrast, prenylation catalyzed by enzymes, i.e. ,
prenyltransferases, provides a more selective, effi-
cient, environment-friendly and safer alternative. The
majority of the known indole prenyltransferases be-
longs to the dimethylallyltryptophan synthase
(DMATS) superfamily.[12,13] In the past 10 years, tre-
mendous progress has been achieved on the molecu-
lar biological, biochemical and structural biological
investigations on this enzyme group.[13] They mainly
catalyze transfer reactions of a dimethylallyl moiety
from dimethylallyl diphosphate (DMAPP) onto dif-
ferent positions of the indole ring of diverse sub-
strates. One important subgroup of the DMATS su-
perfamily is the dimethylallyltryptophan synthases (=
tryptophan prenyltransferases) such as FgaPT2,[14,15] 5-
DMATS[16] and 7-DMATS,[17] which use l-tryptophan
as natural substrate and catalyze prenylation reactions
at C-4, C-5 and C-7 of the indole ring, respectively.
The second important subgroup comprises cyclic di-
peptide prenyltransferases, which accept tryptophan-
containing cyclic dipeptides as natural (BrePT,[18]
FtmPT1[19] and AnaPT[20]) or best substrates
(CdpNPT[21,22] and CdpC3PT[23]). These enzymes
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mainly catalyze prenylations at C-2 or C-3 of the
indole nucleus.[13] Usually, tryptophan prenyltransfer-
ases accepted cyclic dipeptides only at high protein
concentrations.[24] Conversely, tryptophan was a very
poor substrate for cyclic dipeptide prenyltransferas-
es.[25] Furthermore, each cyclic dipeptide prenyltrans-
ferase has its own preference for dipeptides. In this
paper, we report the clear acceptance of cyclo-l-ho-
motryptophan-d-valine (1) by both tryptophan and
cyclic dipeptide prenyltransferases. Products 2–8 with
the prenyl moiety at all positions of the indole nu-
cleus were identified in the enzyme assays.
Results and Discussion
Synthesis of Compound 1
The synthesis of compound 1 started with lithium–hal-
ogen exchange of N-TBDMS-substituted 3-bromoin-
dole by tert-butyllithium, followed by nucleophilic
attack on the ethylene oxide, the anion of which was
caught by p-toluenesulfonyl chloride to generate the
tosylate. Alkylation of the anion of the Schçllkopf
chiral auxiliary with the tosylate produced the inter-
mediate 10.[26] Intermediate 10 was partly hydrolyzed
and deprotected to compound 1 by iodotrimethylsi-
lane (TMSI) (Scheme 1).[27]
Acceptance of 1 by All of the Tested Enzymes
Compound 1 was assayed with eight overproduced
and purified enzymes of the DMATS superfamily in-
cluding five cyclic dipeptide prenyltransferases
BrePT,[18] FtmPT1,[19] CdpC3PT,[23] CdpNPT[21] and
AnaPT[20] as well as three tryptophan prenyltransfer-
ases FgaPT2,[14] 5-DMATS[16] and 7-DMATS.[17] It can
be expected that 1 should be a good substrate for
cyclic dipeptide prenyltransferases, because it bears
just one additional C-atom between the indole and
the diketopiperazine rings of naturally occurring tryp-
tophan-containing cyclic dipeptides. HPLC analysis of
the reaction mixtures revealed indeed that compound
1 was well accepted by all of the five cyclic dipeptide
prenyltransferases (Figure 1A–E). Substrate consump-
tions (Table 1) were calculated from HPLC peak
areas of products to substrate in combination with the
ratio of signals in 1H NMR spectra and were found
for BrePT, FtmPT1, CdpC3PT, CdpNPT and AnaPT
to be 87, 57, 92, 73, and 55%, respectively (Table 1).
Interestingly, 1 was also well accepted by the three
tryptophan prenyltransferases (Figure 1F–H). Incuba-
tion of 1 with 20 mg of FgaPT2 for 16 h at 37 8C result-
ed in a nearly complete conversion (Figure 1F). The
very good acceptance of 1 by three tryptophan pre-
nyltransferases could be explained by the fact that the
structure similarity of 1 with tryptophan has been in-
creased by insertion of one CH2 between the indole
and the diketoperazine rings, which reduces the steric
hinderance of the diketoperazine ring.
Inspection of the HPLC chromatograms of the re-
action mixtures (Figure 1) revealed, with exceptions
for 5-DMATS and 7-DMATS, the presence of two or
more product peaks. One dominant peak was detect-
ed in most assays. It seems that the high regioselectiv-
ity of the prenyltransferases observed for their natural
or best substrate[13] was broken in the presence of the
unnatural aromatic substrate 1. This phenomenon was
also observed for two tryptophan prenyltransferases
with unnatural alkyl donors.[28]
Identification of Enzyme Products with a Prenyl
Moiety at Each Position of the Indole Ring
For structure elucidation, enzyme assays in 15–25 mL
scales were carried out. Enzyme products were isolat-
ed subsequently from the reaction mixtures by repeat-
ed chromatography on HPLC. One product was ob-
tained from the reaction mixture of 5-DMATS (Fig-
ure 1G) and two from those of BrePT, FtmPT1
CdpNPT, FgaPT2 and 7-DMATS (Figure 1A, B, D, F
and H). Three and five products were isolated from
assays of AnaPT and CdpC3PT, respectively. 1H NMR
and MS analyses of the isolated compounds revealed
that same products have been isolated from different
enzyme assays, e.g., 2 and 3 in those of BrePT and
FtmPT1 (Figure 1A and B), or 6 and 7 in those of
CdpC3PT, AnaPT and 7-DMATS (Figure 1C, E and
H). In total, eight products 2, 3, 4, 5, 6, 7, 8, and 9
(Figure 2) were identified as prenylated products of 1.
MS analysis showed 2–8 are monoprenylated and 9
a diprenylated product(s) of 1. In the 1H NMR spec-
trum of 2, signals at 5.18 ppm (dd, 10.5, 1.0 Hz, 1H),Scheme 1. Synthetic route for 1.
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Figure 1. HPLC chromatograms of the reaction mixtures.
Adv. Synth. Catal. 2013, 355, 2659 – 2666  2013 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim asc.wiley-vch.de 2661
One Substrate – Seven Products with Different Prenylation Positions in One-Step Reactions
48
5.19 ppm (dd, 17.5, 1.0 Hz, 1H) and 6.12 ppm (dd,
17.5, 10.5 Hz, 1H) indicate the attachment of the 3,3-
dimethylallyl moiety in a reverse pattern. Considering
the chemical shift and coupling pattern of the four ar-
omatic protons, the prenylation position is determined
as C-2. This is in consistence with the reverse C-2 pre-
nylation of BrePT for its natural substrate breviana-
mide F.[18] Interestingly, 2 was also identified in the
enzyme assay of FtmPT1, which prenylated breviana-
mide F at C-2 in a regular pattern.[19]
Signals for a reverse prenyl moiety were also de-
tected in the 1H NMR spectrum of 3 (5.06 ppm, dd,
17.5, 1.5 Hz, 1H; 5.07 ppm, dd, 11.0, 1.5 Hz, 1H; and
5.84 ppm, dd, 17.5. 11.0 Hz). The chemical shifts and
coupling pattern of the four aromatic protons suggest-
ed a prenylation at C-3, which is in agreement with
the presence of the signal for H-2 at 6.41 ppm. NOE
effects between H-2 and H-1’, H-2’, H-4 and H-5’ in-
dicated that H-2 and the prenyl moiety have a cis-
configuration. The NOE effect between H-2 and H-18
suggested a C-3a prenylation as shown in Figure 2.
The C-3 prenyled product 3 from enzyme assays of
two C-2 prenyltransferases, BrePT and FtmPT1, indi-
cates a reduction of regioselectivity in the presence of
an unnatural substrate which was also observed with
FtmPT1 in the presence of some cyclic dipeptides
with low conversion yields.[29] In that study, regularly
C-3 prenylated products were detected.
In the 1H NMR spectra of 4, 5, 6 and 7, signals of
dimethylallyl moieties at 3.44–3.73 ppm (d, 7.0 Hz,
2H), 5.35–5.40 ppm (tsept, 7.5, 1.5, 1H), 1,75–1,77 (s,
23H) or 1.77 (s, 3H) and 1.75 (d, 1.0, 3H) suggested
regular prenylations. Interpretation and comparison
of the signals for three aromatic protons each on the
benzene ring with data from the literature[15,16,24,28]
proved prenylation of 4, 5, 6 and 7 at C-4, C-5, C-6
and C-7, respectively. Identification of 4 and 5 in the
FgaPT2 assay and 6 and 7 in the 7-DMAT assay is not
surprising and indicates just a slight change of an
attack position of the indole moiety. A similar phe-
nomenon was also observed for unnatural alkyl
donor.[28] However, prenylation on position C-6 and
C-7 by cyclic dipeptide prenyltransferases, as in the
cases of the two C-3 prenyltransferases CdpC3PT
(Figure 1C) and AnaPT (Figure 1E) have not been re-
ported before. This provides evidence of a more flexi-
bility and higher capability of these enzymes for che-
moenzymatic synthesis.
In comparison to those of 4–7 at 3.44-3.73 ppm, the
signal of H-1’ of 8 isolated from reaction mixtures of
CdpC3PT and CdpNPT (Figure 1C and D) is strongly
down-field shifted to 4.63 ppm, which is typical for
regularly N-prenylated products.[21] This is also sup-
ported by the presence of signals for five aromatic
protons. Compound 9 from the AnaPT assay was
identified as a C-5 and C-6 diprenylated derivative
(Figure 2). In summary, derivatives with prenyl
moiety at N-1, C-2, C-3, C-4, C-5, C-6 and C-7 have
been produced from a common substrate by one-step
reactions using different prenyltransferases of the
DMATS superfamily.
Kinetic Parameters
To learn more about the behaviour of the eight pre-
nyltransferases in the presence of 1, kinetic parame-
ters were determined and calculated from Hanes–
Woolf, Eadie–Hofstee and Lineweaver transforma-
tions (Table 1, Supporting Information). The observed
Table 1. The yields and kinetic parameters of enzyme reactions.
Enzyme Substrate Consumption [%] Product Yield [%] KM [mM] kcat [s
1]
BrePT 87 2 55 0.25 0.010
3 24
FtmPT1 57 2 14 0.13 0.0040
3 35
CdpC3PT 92 2 11 0.23 0.011
3 2
6 11
7 43
8 23
CdpNPT 73 3 51 0.37 0.042
8 16
AnaPT 55 6 23 0.27 0.009
7 11
9 9
FgaPT2 97 4 49 0.54 0.20
5 49
5-DMATS 21 5 22 0.34 0.005
7-DMATS 50 6 17 0.42 0.020
7 34
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reactions apparently followed Michaelis–Menten ki-
netics. As given in Table 1, KM values of the eight en-
zymes differ slightly from each other, from 0.13 for
FtmPT1 to 0.54 mM for FgaPT2, clearly distinct from
the significant difference of these enzymes towards
their natural substrates, e.g., 0.004 mM for l-trypto-
phan with FgaPT2,[14] 0.032 mM for brevianamide F
with BrePT,[18] 0.055 mM for brevianamide F with
FtmPT1,[19] or 0.23 mM for (R)-benzodiazepindinone
with AnaPT.[20]
FgaPT2 showed a lower affinity, but higher turn-
over number of the tested eight enzymes towards 1.
The kcat value of 0.2 s
1 is approximately 54% of that
of l-tryptophan with FgaPT2 at 0.37 s1.[14]
Conclusions
In this study, we demonstrated the prenylation of a di-
ketopiperazine derivative 1 at each position of the
indole ring by eight prenyltransferases, expanding the
potential usage of the enzymes. Prenylated derivatives
with prenyl moieties at each position have been pro-
duced by chemoenzymatic synthesis by using re-
combinant prenyltransferases.[13] However, production
of all of the mentioned products from one substrate
has not been reported until now. Given the advantag-
es of chemoenzymatic synthesis mentioned in the in-
troduction, this work has increased significantly the
substrate and catalytic promiscuity of the prenyltrans-
ferases and therefore also the structure diversity of
the possible candidates for drug discovery and devel-
opment.
Experimental Section
General Remarks
Indole, n-BuLi, NBS, t-BuLi, Schçllkopf chiral [(R)-2,5-dihy-
dro-3,6-dimethoxy-2-isopropylpyrazine], TMSI, THF were
purchased from Aldrich. TBDMSCl and TsCl were from
Figure 2. Enzyme products 2–9 of compound 1.
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Acros. Ethylene oxide was obtained from Fluka. THF was
dried by distillation from sodium benzophenone ketyl. Ana-
lytical TLC plates (silica gel 60 F254) were from Merck
KGaA, Germany; preparative TLC, pre-coated TLC-plates
SILG-200 V254 (2.0 mm silica gel with fluorescent indicator
UV254, 2020 cm) were purchased from Macherey–Nagel,
Germany.
NMR spectra were recorded on a JEOL ECA-500 spec-
trometer, processed with MestRENova 5.2.2 and are sup-
plied in the Supporting Information. Chemical shifts of pro-
tons were referenced to the signal of DMSO-d6 at 2.50 ppm
or CDCl3 at 7.26 ppm. Chemical shifts of carbons were ref-
erenced to the signal of DMSO-d6 at 39.5 ppm. The isolated
compounds were also analyzed by electron impact mass
spectrometry (EI-MS) or electrospray ionization mass spec-
trometry (ESI-MS) on an Auto SPEC (Micromass Co. UK
Ltd.).
Synthesis of cyclo-l-Homotrp-d-Val (1)
Compound 10 was synthesized according to the method de-
scribed by Ma et al.[26] 1H NMR (CDCl3, 500 MHz): d=7.59
(d, J=8.0 Hz, 1H), 7.46 (d, J=8.0 Hz, 1H), 7.12 (m, 2H),
6.93 (s, 1H), 4.12 (m, 1H), 4.01 (t, J=4.5 Hz, 1H), 3.74 (s,
3H), 3.71 (s, 3H), 2.72 (m, 2H), 2.27 (m, 2H), 2.11 (m, 1H),
1.07 (d, J=8.5 Hz, 3H), 0.91 (s, 9H), 0.72 (d, J=8.5 Hz,
3H), 0.57 (s, 6H); MS (EI): m/z=441, 398, 84; HR-MS:
m/z=441.280673, calcd. for C25H39N3O2Si (M
+): 441.281156.
To a stirring solution of compound 10 (106 mg,
0.24 mmol) in CHCl3 (2 mL), TMSI (6 equiv.) was added
slowly under an N2 atmosphere at 0 8C. The resulted reac-
tion mixture was stirred for 1 h at room temperature. The
reaction was quenched with several drops of MeOH, and
then evaporated under reduced pressure. The crude product
was purified by preparative TLC (acetone/CH2Cl2 1:1) to
afford compound 1; yield: 50 mg (0.17 mmol, 70%).[27]
1H NMR (DMSO-d6, 500 MHz): d=10.73 (s, 1H), 8.27 (s,
1H), 8.13 (d, J=2.0 Hz, 1H), 7.56 (d, J=8.0 Hz, 1H),
7.33(d, J=8.0 Hz, 1H), 7.11 (d, J=2.5 Hz, 1H), 7.06 (td, J=
7.5, 1.0 Hz, 1H), 6.97 (td, J=7.5, 1.0 Hz, 1H), 3.95 (t, J=
5.0 Hz, 1H), 3.68 (t, J=3.0 Hz, 1H), 2.78 (m, 1H), 2.68 (m,
1H), 2.18 (m, 1H), 2.09 (m, 2H), 0.96 (d, J=7.0 Hz, 3H),
0.87 (d, J=6.5 Hz, 3H); 13C NMR (DMSO-d6, 125 MHz):
d=168.2, 167.7, 136.3, 127.1, 122.2, 120.9, 118.4, 118.1, 113.6,
111.3, 59.7, 53.3, 33.0, 32.0, 19.6, 18.4, 17.0; MS (EI):
m/z=299 (M+, 45), 156 (100), 144 (55), 130(90), 113(50).
Overexpression and Purification of Recombinant
Proteins
Protein overproduction and purification were carried out as
described previously for BrePT,[18] FtmPT1,[19] CdpC3PT,[23]
CdpNPT,[21] AnaPT,[20] FgaPT2,[14] 5-DMATS[16] and 7-
DMATS,[17] respectively.
Enzyme Assays for Determination of Activities
Enzyme reaction mixtures (100 mL) for determination of the
activities with different proteins contained compound
1 (1 mM), CaCl2 (10 mM), DMAPP (1 mM), glycerol (1.0–
6% v/v), dimethyl sulfoxide (DMSO, 5% v/v), 50 mM Tris-
HCl (pH 7.5) and purified recombinant protein (1.5–20 mg).
The reaction mixtures were incubated at 37 8C for 16 h and
then terminated with 100 mL MeOH. Protein was removed
by centrifugation at 13000g for 20 min.
Enzyme Assays for Isolation and Structure
Elucidation
Assays for isolation of the enzyme products were carried
out in large scales (10–25 mL) containing compound
1 (1 mM), DMAPP (1 mM), CaCl2 (10 mM), glycerol (1.0–
9.9% v/v), DMSO (5% v/v), 50 mM Tris-HCl (pH 7.5) and
recombinant protein (0.02–0.2 mg per mL assay). After incu-
bation for 16 h at 37 8C, the reaction mixtures were extract-
ed 3 times with the double volume of EtOAc. The EtOAc
phase was collected, concentrated and dried on a rotary
evaporator. The residue was dissolved in MeOH (1–2 mL,
HPLC grade) and purified on HPLC.
Enzyme Assays for Determination of Kinetic
Parameters
Assays for determination of kinetic parameters contained
CaCl2 (10 mM), glycerol (1.0–9.9% v/v), DMSO (5% v/v),
50 mM Tris HCl (pH 7.5), DMAPP (1 mM) and compound
1 at final concentrations of 0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 1.0,
and 2.0 mM. Protein amount and incubation time varied be-
tween 2 and 20 mg, 25 and 120 min, respectively. The reac-
tions were then terminated with 100 mL MeOH. Protein was
removed by centrifugation at 13000g for 20 min.
HPLC Analysis and Isolation of Enzymatic Products
for Structure Elucidation
The enzyme products were routinely analyzed by HPLC on
an Agilent series 1200 by using a Multospher 120 RP-18
column (2504 mm, 5 mm C+S Chromatographie Service,
Langerwehe, Germany) at a flow rate of 1 mLmin1. Water
(solvent A) and methanol (solvent B) were used as solvents
for analysis and isolation of the enzyme products. A linear
gradient of 30–100% (v/v) solvent B in 30 min was used for
analysis of the enzymatic products. The column was then
washed with 100% solvent B for 5 min and equilibrated
with 30% solvent B for another 5 min. Detection was car-
ried out on a photodiode array detector.
The enzyme products of compound 1 (compounds 2–9)
were isolated on a Multospher 120 RP18 column (250
10 mm, 5 mm) with a linear gradients, 60–100% in 30 min, at
2.5 mLmin1. After each run, the column was then washed
with 100% solvent B for 15 min followed by 15 min of equi-
libration with 60% solvent B at the beginning of each run.
The mixtures of compound 6 and 7 were separated again on
normal phase HPLC, MultoHigh 100–5 Si column (250
4.6 mm, 5 mm) with a gradient of 0–8% MeOH (MeOH/
CHCl3) in 30 min at a flow rate of 1 mLmin
1. After each
run, the column was washed with 50% MeOH (MeOH/
CHCl3) for 5 min, followed by 5 min of equilibration with
100% CHCl3 at the beginning of each run.
Compound 2: 1H NMR (CDCl3, 500 MHz): d=7.88 (s, H-
1), 7.53 (d, J=7.5 Hz, H-4), 7.30 (d, J=7.5 Hz, H-7), 7.14
(td, J=7.5, 1.0 Hz, H-6), 7.09 (td, J=7.5, 1.0 Hz, H-5), 6.12
(dd, J=17.5, 10.5 Hz, H-2’), 6.00 (s, H-13 or H-16), 5.95 (s,
H-16 or H-13), 5.19 (dd, J=17.5, 1.0 Hz, H-1’), 5.18 (dd, J=
10.5, 1.0 Hz, H-1’), 4.15 (t, J=5.0 Hz, H-12), 3.91 (m, H-15),
2.93 (m, 2H-10), 2.45 (m, H-18), 2.25 (m, H-11), 2.14 (m, H-
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11), 1.53 (s, 3H-4’ and 3H-5’), 1.06 (d, J=7.0 Hz, 3H-19 or
3H-20), 0.97 (d, J=7.0 Hz, 3H-20 or 3H-19); MS (ESI):
m/z=368.25 (M+H)+; HR-MS: m/z=367.2289, calcd. for
C22H29N3O2: 367.2289.
Compound 3: 1H NMR (CDCl3, 500 MHz): d=7.12 (d,
J=7.5 Hz, H-4), 7.09 (td, J=7.5, 1.0 Hz, H-6), 6.76 (td, J=
7.5, 1.0 Hz, H-5), 6.60 (d, J=7.5 Hz, H-7), 6.41 (s, H-2), 6.06
(s, H-16), 5.83 (dd, J=17.5, 11.0 Hz, H-2’), 5.07 (dd, J=11.0,
1.5 Hz, H-1’), 5.06 (dd, J=17.5, 1.5 Hz, H-1’), 4.16 (dd, J=
9.0, 3.5 Hz, H-12), 3.83 (t, J=3.5 Hz, H-15), 2.40 (m, H-10),
2.31 (m, H-10), 1.79 (m, H-11), 1.69 (m, H-11), 1.58 (m, H-
18), 1.04 (d, J=7.0 Hz, 3H-19 or 3H-20), 1.03 (s, 3H-4’ or
3H-5’), 1.02 (s, 3H-5’ or 3H-4’), 0.95 (d, J=6.5 Hz, 3H-20
or 3H-19); MS (ESI): m/z=368.20 (M+H)+.
Compound 4: 1H NMR (CDCl3, 500 MHz): d=8.03 (s, H-
1), 7.21 (d, J=8.0 Hz, H-7), 7.11 (t, J=8.0 Hz, H-6), 7.02 (br
s, H-2), 6.89 (d, J=8.0 Hz, H-5), 5.97 (s, H-13 or H-16), 5.92
(s, H-16 or H-13), 5.35 (tsept, J=7.0, 1.5 Hz, H-2’), 4.14 (t,
J=6.0 Hz, H-12), 3.89 (t, J=2.5 Hz, H-15), 3.73 (d, J=
6.5 Hz, 2H-1’), 3.07 (t, J=8.0 Hz, 2H-10), 2.44 (m, H-18),
2.35 (m, H-11), 2.23 (m, H-11), 1.77 (s, 3H-4’ and 3H-5’),
1.05 (d, J=7.0 Hz, 3H-19 or 3H-20), 0.95 (d, J=7.0 Hz, 3H-
20 or 3H-19); MS (ESI): m/z=390.14 (M+Na+), 368.14
(M+H)+.
Compound 5: 1H NMR (CDCl3, 500 MHz): d=7.90 (s, H-
1), 7.36 (s, H-4), 7.27 (d, J=8.0 Hz, H-7), 7.04 (dd, J=8.0,
1.5 Hz, H-6), 6.99 (d, J=2.5 Hz, H-2), 6.13 (s, H-13 or H-
16), 6.03 (s, H-16 or H-13), 5.38 (tsept, J=7.5, 1.5 Hz, H-2’),
4.10 (t, J=5.5 Hz, H-12), 3.88 (br t, J=2.5 Hz, H-15), 3.44
(d, J=7.5 Hz, 2H-1’), 2.90 (t, J=8.0 Hz, 2H-10), 2.42 (m, H-
18), 2.35 (m, H-11), 2.25 (m, H-11), 1.77 (s, 3H-4’ or 3H-5’),
1.75 (d, J=1.0 Hz, 3H-5’ or 3H-4’), 1.04 (d, J=7.0 Hz, 3H-
19 or 3H-20), 0.94 (d, J=7.0 Hz, 3H-20 or 3H-19); MS
(ESI): m/z=390.22 (M+Na+), 368.26 (M+H)+.
Compound 6: 1H NMR (CDCl3, 500 MHz): d=7.88 (s, H-
1), 7.50 (d, J=8.5 Hz, H-4), 7.16 (s, H-7), 6.98 (br s, H-2),
6.97 (d, J=8.5 Hz, H-5), 5.87 (s,1H-13 or H-16), 5.81 (s, H-
16 or H-13), 5.38 (m, H-2’), 4.08 (t, J=5.5 Hz, H-12), 3.87 (t,
J=3.0 Hz, H-15), 3.44 (d, J=7.0 Hz, 2H-1’), 2.90 (t, J=
8.0 Hz, 2H-10), 2.42 (m, H-18), 2.33 (m, H-11), 2.24 (m, H-
11), 1.75 (s, 3H-4’ and 3H-5’), 1.03 (d, J=7.5 Hz, 3H-19 or
3H-20), 0.93 (d, J=6.5 Hz, 3H-20 or 3H-19); MS (ESI):
m/z=390.14 (M+Na)+.
Compound 7: 1H NMR (CDCl3, 500 MHz): d=7.99 (s, H-
1), 7.47 (d, J=7.5 Hz, H-4), 7.07 (t, J=7.5 Hz, H-5), 7.03 (br
s, H-2), 7.02 (d, J=7.5 Hz, H-6), 5.92 (s, H-13 or H-16), 5.84
(s, H-16 or H-13), 5.40 (tsept, J=7.0, 1.5 Hz, H-2’), 4.10 (t,
J=6.0 Hz, H-12), 3.88 (t, J=2.8 Hz, H-15), 3.56 (d, J=
7.0 Hz, 2H-1’), 2.91 (t, J=8.5 Hz, 2H-10), 2.43 (m, H-18),
2.34 (m, H-11), 2.27 (m, H-11), 1.82 (s, 3H-4’ or 3H-5’), 1.78
(d, J=1.0 Hz, 3H-5’ or 3H-4’), 1.04 (d, J=7.0 Hz, 3H-19 or
3H-20), 0.94 (d, J=7.0 Hz, 3H-20 or 3H-19); MS (ESI):
m/z=390.17 (M+Na)+.
Compound 8: 1H NMR (CDCl3, 500 MHz): d=7.58 (d,
J=7.5 Hz, H-4), 7.30 (d, J=7.5 Hz, H-7), 7.20 (t, J=7.5 Hz
H-6), 7.10 (t, J=7.5 Hz, H-5), 6.93 (s, H-2), 5.97 (s, H-13 or
H-16), 5.88 (s, H-16 or H-13), 5.35 (tsept, J=7.0, 1.5 Hz, H-
2’), 4.64 (d, J=6.5 Hz, 2H-1’), 4.09 (t, J=6.0 Hz, H-12), 3.88
(m, H-15), 2.90 (m, 2H-10), 2.43 (m, H-18), 2.32 (m, H-11),
2.24 (m, H-11), 1.81 (s, 3H-4’ or 3H-5’), 1.76 (d, J=1.5 Hz,
3H-5’ or 3H-4’), 1.04 (d, J=7.0 Hz, 3H-19 or 3H-20), 0.94
(d, J=6.5 Hz, 3H-20 or 3H-19); MS (ESI): m/z=368.24
(M+H)+.
Compound 9: 1H NMR (CDCl3, 500 MHz): d=7.82 (s, H-
1), 7.34 (s, H-4), 7.16 (s, H-7), 6.94 (br s, H-2), 5.93 (s, H-13
or H-16), 5.87 (s, H-16 or H-13), 5.30 (m, H-2 and H-2’’),
4.08 (t, J=5.5 Hz, H-12), 3.87 (t, J=2.8 Hz, H-15), 3.42 (t,
J=7.5 Hz, 2H-1’ and 2H-1’’), 2.88 (m, 2H-10), 2.42 (m, H-
11), 2.35 (m, H-11), 2.22 (m, H-18), 1.76 (d, J=1.0 Hz, 3H),
1.75 (s, 6H), 1.72 (br s, 3H, 3H-4’, 3H-4’’, 3H-5’ and 3H-
5’’), 1.03 (d, J=7.0 Hz, 3H-19 or 3H-20), 0.93 (d, J=6.5 Hz,
3H-20 or 3H-19); MS (ESI): m/z=436.28 (M+H)+.
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Figures Determination of kinetic parameters (Figure S1- S8) 
Figure S1. Determination of kinetic parameters of BrePT reaction. 
Figure S2. Determination of kinetic parameters of FtmPT1 reaction. 
Eadie Hofstee plot
0 10 20 30 40 50 60
0
10
20
v/[s]
v[
nm
ol
m
g-
1
m
in
-1
]
BrePT
0.00 0.25 0.50 0.75 1.00
0
5
10
15
[s][mM]
v[
nm
ol
m
g-
1
m
in
-1
]
KM=0.25 mM
=0.010 sKc at - 1
KM=0.26 mM
KM=0.28 mM KM=0.20 mM
Hanes-Woolf plot
0.00 0.25 0.50 0.75 1.00
0.000
0.025
0.050
0.075
0.100
[s]
[s
]/v
Lineweaver-Burk plot
0 25 50 75 100
0
1
2
1/[s]
1/
[v
]
Eadie Hofstee plot
0 5 10 15 20 25 30 35
0
1
2
3
4
5
6
v/[s]
v[
nm
ol
m
g-
1
m
in
-1
]
Hanes-Woolf plot
0.0 0.5 1.0 1.5 2.0
0.0
0.1
0.2
0.3
0.4
0.5
[s]
[s
]/v
FtmPT1
0.0 0.5 1.0 1.5 2.0
0
1
2
3
4
5
[s][mM]
v[
nm
ol
m
g-
1
m
in
-1
]
KM=0.13 m M
=0.004 sKcat
-1
KM=0.14 mM
KM=0.094 mM KM=0.19 mM
Lineweaver-Burk plot
0 25 50 75 100
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
1/[s]
1/
v
56
Figure S3. Determination of kinetic parameters of CdpC3PT reaction. 
Figure S4. Determination of kinetic parameters of CdpNPT reaction. 
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Figure S5. Determination of kinetic parameters of AnaPT reaction. 
Figure S6. Determination of kinetic parameters of FgaPT2 reaction. 
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Figure S7. Determination of kinetic parameters of 5-DMATS reaction. 
Figure S8. Determination of kinetic parameters of 7-DMATS reaction. 
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NMR spectra 
Figure S9. 1H NMR spectrum of compound 1 in DMSO-d6 (500 MHz). 
Figure S10. 13C NMR spectrum of compound 1 in DMSO-d6 (125 MHz). 
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Figure S11. 1H NMR spectrum of compound 2 in CDCl3 (500 MHz). 
Figure S12. 1H NMR spectrum of compound 3 in CDCl3 (500 MHz). 
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Figure S13. NOE spectrum of compound 3 in CDCl3 (500 MHz). 
Figure S14. 1H NMR spectrum of compound 4 in CDCl3 (500 MHz). 
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Figure S15. 1H NMR spectrum of compound 5 in CDCl3 (500 MHz). 
Figure S16. 1H NMR spectrum of compound 6 in CDCl3 (500 MHz). 
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Figure S17. 1H NMR spectrum of compound 7 in CDCl3 (500 MHz). 
Figure S18. 1H NMR spectrum of compound 8 in CDCl3 (500 MHz). 
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Figure S19. 1H NMR spectrum of compound 9 in CDCl3 (500 MHz). 
Figure S20. 1H NMR spectrum of compound 10 in CDCl3 (500 MHz). 
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Abstract A putative prenyltransferase gene of the
dimethylallyltryptophan synthase (DMATS) family,
An13g01840, was identified in the genome sequence of
Aspergillus niger. The deduced polypeptide CAK41583
consists of 465 amino acids with a calculated molecular
mass of 52.7 kDa. To evaluate gene function, the coding
sequence was cloned into pET28a and overexpressed in
Escherichia coli. The soluble His6-fusion protein was
purified to near homogeneity on Ni-NTA agarose and
used for enzyme assays with diverse aromatic substrates
in the presence of dimethylallyl diphosphate. HPLC anal-
ysis revealed product formation in the incubation mixtures
with L-tyrosine and five derivatives thereof. Structure
elucidation of the enzyme products by NMR and MS
analyses confirmed O-prenylations and proved the identi-
fication of a tyrosine O-prenyltransferase (TyrPT). As in
the case of SirD from Leptosphaeria maculans, TyrPT
also accepted 4-amino-L-phenylalanine for an N-
prenylation and L-tryptophan for a C7-prenylation. The
KM values of TyrPT for L-tyrosine, L-tryptophan, and
dimethylallyl diphosphate (DMAPP) were found to be
0.24, 0.19, and 0.71 mM, respectively. The kcat of L-
tyrosine and L-tryptophan reactions were determined at
0.58 and 0.0053 s−1, respectively. The results presented
in this study enhance the relationship of tyrosine O- and
tryptophan C7-prenyltranferases and provide meanwhile a
new enzyme for production of prenylated derivatives. In
comparison to the known tyrosine prenyltransferase SirD,
TyrPT showed significantly higher catalytic activity for
several substrates, e.g., 4-amino-L-phenylalanine as well
as 4- and 5-methyl-DL-tryptophan.
Keywords Aspergillus niger . DMATS superfamily .
DMAPP . Prenyltransferase . Enzyme catalysis
Introduction
Prenyltransferases catalyze transfer reactions of prenyl
moieties from different prenyl donors, e.g., dimethylallyl
diphosphate (DMAPP) to various aliphatic or aromatic
acceptors (Heide 2009). They are involved in nature in
both primary and secondary metabolism, and contribute
significantly to structural diversity and bioactivities of
natural products (Heide 2009). Furthermore, the biolog-
ical and pharmacological activities of the prenylated
products are usually distinct from their non-prenylated
precursors (Botta et al. 2005; Li 2010; Wollinsky et al.
2012a), which make these enzymes to be valuable
biocatalysts in the structural modification of small mol-
ecules. Based on their primary sequences, protein struc-
tures, and biochemical properties, prenyltransferases can
be classified in different subgroups (Heide 2009; Li
2009). One of the most investigated subgroup is the
dimethylallyltryptophan synthase (DMATS) superfamily. So
far, more than 30 such prenyltransferases have been identified
and characterized biochemically (Winkelblech and Li 2014; Yu
and Li 2012). The majority of the DMATS superfamily uses
indole derivatives including tryptophan and tryptophan-
containing cyclic dipeptides as substrates. One of them is 7-
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DMATS from Aspergillus fumigatus, which catalyzes the
prenylation of L-tryptophan at position C-7 of the indole ring
(Kremer et al. 2007) and is involved in the biosynthesis of
astechrome (Yin et al. 2013). A few members of the DMATS
superfamily are responsible for prenylation of non-indole deriv-
atives. For example, SirD from Leptosphaeria maculans cata-
lyzes O-prenylation of tyrosine (Kremer and Li 2010), the first
step in the biosynthesis of sirodesmin PL (Gardiner et al. 2004).
SirD also catalyzes the C7-prenylation of L-tryptophan, with a
relative activity of 8.1 % of that of L-tyrosine (Kremer and Li
2010). Detailed investigations on substrate specificity of SirD
also demonstrated the acceptance of several methylated and
halogenated tryptophan derivatives including 4-methyl-DL-tryp-
tophan (Zou et al. 2011). Recently, Rudolf and Poulter (2013)
have confirmed the C7-prenylation of four indole derivatives
including L-tryptophan and 4-methyl-DL-tryptophan by SirD.
In that study, reversely N1-prenylated derivatives were found as
additional enzyme products (mostly as minor products). It seems
that the tyrosineO-prenyltransferase SirD and the tryptophanC7-
prenyltransferase 7-DMATS share similar catalytic activity to-
ward tryptophan derivatives. An acceptance of L-tyrosine was
neither reported for the mentioned 7-DMATS from A. fumigatus
(Kremer et al. 2007) nor for the recently identified orthologue 7-
DMATSNeo from a Neosartorya sp. (Miyamoto et al. 2014). To
learn more about their relationship, it would be welcome to find
additional enzymes and to compare their biochemical features
including substrate specificity and kinetic parameters as well.We
report here on the cloning and expression ofAn13g01840, one of
the two putative prenyltransferase genes of the DMATS family
from Aspergillus niger and identification of the recombinant
protein as a tyrosine O-prenyltransferase (TyrPT).
Materials and methods
Chemicals
DMAPP was synthesized according to the method de-
scribed for geranyl diphosphate (GPP) reported previ-
ously (Woodside et al. 1988). Substrates used for the
enzyme assays were purchased from TCI (Zwijndrecht,
Belgium), Acros Organics (Geel, Belgium), Sigma-
Aldrich (Steinheim, Germany), Bachem (Bubendorf,
Switzerland), and Alfa Aesar (Karlsruhe, Germany) of
the highest available purity.
Bacterial and fungal strains, plasmids, and culture conditions
pGEM-T Easy and pET28a were obtained from Promega
(Mannheim, Germany) and Novagen (Darmstadt, Germa-
ny), respectively. pAK2 and pLW40 were used for over-
production of SirD and 7-DMATS and propagated as
described, respectively (Kremer et al. 2007; Kremer and
Li 2010). A. niger FGSC A1180 was provided by Prof.
Michael Müller (University Freiburg, Germany) and cul-
tivated in SDA medium containing dextrose (40 g/L),
peptone (10 g/L), and chloromycetin (0.2 g/L) at 30 °C.
The 2-day mycelia were used for isolation of genomic
DNA and the 3-day mycelia for isolation messenger RNA
(mRNA). mRNAs were also isolated from 3-day mycelia
from cultures in YMG medium containing yeast extracts
(4 g/L), malt extracts (10 g/L), and glucose (4 g/L), or PD
medium containing potato infusion (4 g/L) and dextrose
(20 g/L). The supernatants of the 3-day cultures in these
three media were used for LC-MS analysis of accumula-
tion of prenylated compounds.
Escherichia coliXL1 BlueMRF’ (Stratagene, Amsterdam,
the Netherlands) and SoluBL21 (Novagen, Darmstadt, Ger-
many) were used for cloning and expression experiments,
respectively. They were grown in liquid Lysogeny broth
(LB) or Terrific broth (TB) medium and on solid LB medium
with 1.5 % (w/v) agar at 37 °C. For selection of recombinant
E. coli strains, 50 μg·mL−1 of carbenicillin or 25 μg·mL−1 of
kanamycin was used.
Computer-assisted sequence analysis
Sequence identities were obtained by alignments of amino
acid sequences using the “BLAST 2 sequences” (www.ncbi.
nlm.nih.gov). DNASIS software package (version 2.1;
Hitachi Software Engineering, Tokyo, Japan) and
FGENESH-M (Softberry, Mount Kisco, NY; www.softberry.
com) were used for sequence analysis and intron prediction,
respectively.
DNA and RNA isolation, cDNA synthesis, PCR
amplification, and gene cloning
Standard procedures for DNA manipulation in E. coli were
performed as described (Sambrook and Russell 2001).
Isolation of genomic DNA from mycelia of A. niger was
performed as described previously (Yu and Li 2012). RNA
was isolated with E.Z.N.A. Fungal RNA Kit (Omega Bio-
Tek, GA, USA) and complementary DNA (cDNA) was ob-
tained with ProtoScript First Strand cDNA synthesis Kit
(Omega Bio-Tek, Norcross, GA) using oligo(dT) or specific
primers AN13G01840EXP1 (5′-CACCATGGGTAGTCTT
TCTCCCTT-3′) and AN13G01840EXP2 (5′-GCCACAAG
ATCTTGTCGTGGCAAAT-3′).
PCR amplification was carried out on an iCycler
from BioRad with annealing temperature at 55 °C.
The entire sequence of An13g01840 was obtained by
PCR amplification with Expand High Fidelity PCR Kit
(Roche Diagnostic, Mannheim, Germany) by using ge-
nomic DNA as template. The primers were aforementioned
AN13G01840EXP1 at the 5′-end and AN13G01840EXP2 at
10120 Appl Microbiol Biotechnol (2014) 98:10119–10129
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the 3′-end. The PCR fragment of 1,471 bp was cloned into
pGEM-T Easy resulting in plasmid pHC03, which was sub-
sequently sequenced (Eurofins MWG Operon, Munich, Ger-
many) to confirm the sequence. The intron sequence of 53 bp
in An13g01840 was removed by QuickChange Site-Directed
Mutagenesis PCR with pHC03 as a template, resulting in
plasmid pHC09. The primers used were INTRONF
(5′-CGTAAAGTATTCACGCACGATGCTCTCCAGCA
ACGTGGTCTAC-3′) and INTRONR (5′-CGTGCGTGAA
TACTTTACGCAGGGTTTCAGTATAGGTACGCATG-
3′). Bold letters show primer-primer overlapping sequences.
For construction of the expression plasmid pHC16,
An13g01840 was amplified from pHC09 by PCR using
primers AN13G01840EXP1 at the 5′-end and RP (5′-GATC
TTGTGTCGACAAATTTCTCGC-3′) at the 3′-end. Italic let-
ters represent mutations inserted in comparison with the orig-
inal genome sequence to give the underlined restriction site
SalI in the primer RP. The PCR fragment was digested with
NcoI and SalI, and ligated into pET28a, which was digested
with the same enzymes previously, resulting in the expression
vector pHC16.
Overproduction and purification of His-tagged recombinant
proteins TyrPT, SirD, and 7-DMATS
For overproduction of TyrPT-His6, E. coli SoluBL21
cells harboring the plasmid pHC16 were cultivated in
2.5-L cylindrical flasks containing 1 L of liquid TB
medium, supplemented with 25 μg·mL−1 of kanamycin,
and then grown at 37 °C, 220 rpm till OD600=0.6. For
induction of gene expression, isopropyl thiogalactoside
(IPTG) was added to a final concentration of 0.8 mM,
and the cells were cultivated for a further 16 h at 30 °C
before harvest. The bacterial cultures were centrifuged at
4,500×g for 8 min, and the pellets were resuspended in
lysis buffer (10 mM imidazole, 50 mM NaH2PO4,
300 mM NaCl, pH 8.0) at 2–5 mL per gram wet weight.
After addition of lysozyme to a final concentration of
1 mg·mL−1, the cell suspension was incubated on ice for
30 min before sonication six times for 10 s each at
200 W. The cellular debris was separated from the solu-
ble proteins by centrifugation at 13,000×g for 30 min at
4 °C. The recombinant His6-tagged fusion protein was
purified on affinity chromatography using nickel-
nitrilotriacetic acid-agarose (Ni-NTA) resin (Qiagen,
Hilden, Germany) according to the manufacturer’s in-
structions. The protein was eluted with 250 mM imidaz-
ole in 50 mM NaH2PO4 and 300 mM NaCl (pH 8.0). To
change the buffer, the protein fraction was passed
through a PD-10 column (GE Healthcare, Freiburg, Ger-
many), which had been equilibrated with 50 mM Tris-
HCl (pH 7.5) containing 15 % (v/v) glycerol previously.
The purified TyrPT-His6 was eluted with the same buffer
and stored at −80 °C for enzyme assays.
Overproduction and purification of SirD and 7-DMATS
were carried out as described previously (Kremer et al. 2007;
Kremer and Li 2010).
Protein analysis
Proteins were analyzed on 12 % (w/v) SDS-PAGE (Laemmli
1970) and stained with Coomassie Brilliant Blue G-250.
Protein contents were determined as described elsewhere
(Bradford 1976).
The molecular mass of the native recombinant TyrPT-
His6 was determined by size exclusion chromatography
on a HiLoad 16/60 Superdex 200 column (GE Healthcare,
Freiburg, Germany). To equilibrate the column and elute
proteins, 50 mM of Tris-HCl buffer (pH 7.5) containing
150 mM NaCl was used. The column was calibrated with
blue dextran 2000 (2,000 kDa), ferritin (440 kDa), aldol-
ase (158 kDa), conalbumin (75 kDa), carbonic anhydrase
(29 kDa), and ribonuclease A (13.7 kDa; GE Healthcare,
Freiburg, Germany).
Enzyme assays
To determine the enzyme activity of TyrPT-His6, the
enzyme assays contained 50 mM Tris-HCl (pH 7.5),
10 mM CaCl2, 1 mM aromatic substrate, 1 mM
DMAPP, 0.15–5 % (v/v) glycerol, 0–5 % (v/v) DMSO,
and 0.054–0.11 mg/mL (1–2 μM) of purified recombi-
nant protein in a total volume of 100 μL and were
incubated at 37 °C for 16 h. The reactions were termi-
nated by addition of 100 μL methanol. Protein was
removed by centrifugation at 13,000×g for 20 min and
the supernatant was analyzed on HPLC.
For determination of ion dependency of the TyrPT reaction,
the enzyme assays contained 50 mM Tri-HCl (pH7.5), 1 mM
L-tyrosine, 1 mMDMAPP, and 5 mMmetal ion or EDTA and
were incubated with 0.052 mg/mL (0.97 μM) TyrPT-His6 at
37 °C for 16 h. The enzyme activity without additive was
defined as 100 %.
In order to determine the kinetic parameters of aromatic
substrates, DMAPP at 1 mM and aromatic substrates with
concentrations of up to 2 mM were used. Variable protein
concentrations and incubation times were used for different
substrates. For determination of the kinetic parameters of
DMAPP, 0.091 mg/mL (1.68 μM) or 0.18 mg/mL
(3.36 μM) purified recombinant protein, 1 mM L-tyrosine,
or L-tryptophan with DMAPP at final concentrations of
0.005, 0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 1.0, 2.0, and 4.0 mM
were incubated at 37 °C for 5 or 90 min, respectively.
For isolation of the enzyme products, reactions were
carried out in large scales (10 mL) containing 50 mM
Appl Microbiol Biotechnol (2014) 98:10119–10129 10121
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Tris-HCl (pH 7.5), 10 mM CaCl2, 1 mM aromatic sub-
strate, 1 mM DMAPP, and 0.081–0.16 mg/mL (1.5–
3.0 μM) recombinant protein. After incubation at 37 °C
for 16 h, the reactions were terminated by addition of
10 mL of methanol. After removal of the precipitated
protein by centrifugation at 6,000 rpm for 30 min, the
reaction mixtures were concentrated on a rotating vacuum
evaporator at 35 °C to a final volume of 1 mL before
injection into HPLC.
HPLC analysis and isolation of the enzyme products
The enzyme reaction mixtures were analyzed on HPLC
(Agilent series 1200, Böblingen, Germany) by using a
Multospher 120 RP-18 column (250×4 mm, 5 μm, C +
S Chromatographie Service, Langerwehe, Germany) at a
flow rate of 1 mL·min−1. Water (solvent A) and methanol
(solvent B) were used as solvents. For analysis of the
enzyme products, a linear gradient of 30–100 % (v/v)
solvent B for 20 min was used. The column was then
washed with 100 % (v/v) solvent B for 5 min and equil-
ibrated with 30 % (v/v) solvent B for 5 min. Detection
was carried out with a photodiode array detector and
illustrated at 277 nm in this paper.
For isolation of the enzyme products, the same HPLC
equipment with a Multospher 120 RP-18 column (250×
10 mm, 5 μm, C + S Chromatographie Service,
Langerwehe, Germany) was used, with a linear gradient
of 50–100 % (v/v) of methanol (solvent B) in water
(solvent A) in 50–80 min and a flow rate at 2.5 mL·
min−1. The column was then washed with 100 % (v/v)
solvent B for 10 min and equilibrated with 50 % (v/v)
solvent B for 10 min.
NMR and mass spectrometric analyses
For structural elucidation, the isolated enzyme products
were subjected to 1H NMR and MS analyses. Electron
impact mass spectrometry (EI-MS) or electrospray ioniza-
tion mass spectrometry (ESI-MS) data were obtained on a
Micromass Auto Spec spectrometer (Waters, Milford,
MA) and are given in Table 1.
For NMR analysis, the enzyme products were dissolved
in DMSO-d6, CD3OD, or D2O. Spectra were recorded at
room temperature with an ECX-500 spectrometer (JEOL,
Tokyo, Japan) equipped with a broadband probe with z-
gradient. Chemical shifts were referenced to the solvent
signals at 2.50 ppm for DMSO-d6, 3.30 ppm for CD3OD,
or 4.79 ppm for D2O. All spectra were processed with
MestReNova 5.2.2 (Metrelab Research, Santiago de
Compostella, Spain). NMR data of the isolated products
are given in Tables 2 and 3 and spectra as Figs. S1–S9 in
Electronic supplementary materials.
Results
Sequence analysis of the putative prenyltransferase gene
An13g01840
The putative prenyltransferase gene of the DMATS superfam-
ily An13g01840, also termed as ANI_1_660114, was identi-
fied in the genome sequence of A. nigerCBS 513.88 (Pel et al.
2007) by BLAST search with sequences of SirD and 7-
DMATS. An13g01840 spans bp 451,850–453,300 of
NT_166528 and consists of two exons of 1,274 and 124 bp,
respectively, interrupted by an intron of 53 bp. Analysis of the
up- and downstream genes of An13g01840 in the genome did
not provide any evidence for the presence of a gene cluster for
secondary metabolite biosynthesis (Table S1 in Electronic
supplementary materials). The deduced product of
An13g01840, CAK41583, comprises 465 amino acids and
has a calculated molecular mass of 52.7 kDa. It shares se-
quence identities of 36 and 30 % with SirD and 7-DMATS on
the amino acid level, respectively.
DNA isolation, PCR amplification, gene cloning,
overproduction, and purification of TyrPT-His6
To investigate the function of the deduced polypeptide
CAK41583 in vitro, the entire DNA sequence of An13g01840
was PCR amplified from genomic DNA of A. niger FGSC
A1180, and the intron sequence was eliminated byQuickChange
Site-Directed Mutagenesis (see “Materials and methods”). The
coding region was then cloned into pET28a, resulting in the
expression vector pHC16.
After overproduction, the recombinant protein was pu-
rified on Ni-NTA-agarose resin to near homogeneity, as
shown on SDS-PAGE in Fig. 1. A major protein band
migrating above that of the 45 kDa protein marker
corresponded well to the calculated molecular mass of
TyrPT-His6 at 53.5 kDa. A protein yield of 4.0 mg
TyrPT-His6 was calculated for 1 L of culture. The molec-
ular mass of the native recombinant TyrPT-His6 was deter-
mined by size exclusion chromatography to be 228 kDa,
indicating that this enzyme presumably acts as a tetramer.
Acceptance of tyrosine and derivatives by TyrPT
As aforementioned, An13g01840 is not clustered with other
secondary metabolite genes (Table S1 in Supplementary
material) and shows moderate sequence similarities to
known proteins. Consequently, the natural substrate of
the encoded protein cannot be predicted by analysis of
the genetic context in genome or by sequence analysis
and comparison. Therefore, TyrPT was incubated with
diverse aromatic substrates, which had been accepted by
prenyltransferases of the DMATS superfamily. DMAPP
10122 Appl Microbiol Biotechnol (2014) 98:10119–10129
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was used as prenyl donor for these assays. HPLC anal-
ysis of the incubation mixtures revealed that tyrosine
and derivatives (1a–7a) were very well accepted by
TyrPT (Fig. 2), with product yields in the range of 30
to 100 % after incubation at 37 °C for 16 h. Therefore,
we tested the acceptance of these compounds by the
known tyrosine O-prenyltransferase SirD under the same
condition used for TyrPT and compared their conver-
sions with each other (Fig. 2). As shown in Fig. 2, both
enzymes showed comparable activities toward 1a–6a. 3-
Iodo-L-tyrosine (5a) and 3,4-dihydroxy-L-phenylalanine
(6a) were almost completely converted by both en-
zymes. Under the tested condition, TyrPT had a signif-
icantly higher conversion for 4-amino-L-phenylalanine
(7a) than SirD (98 respective 23 %). Remarkably, D-
tyrosine (2a) was a very good substrate for both en-
zymes with product yields between 30 and 33 %, dem-
onstrating their low stereoselectivity. In contrast to the
good acceptance of 3-iodo-L-tyrosine (5a), 3,5-dibromo-
L-tyrosine (8a) was a poor substrate for SirD and TyrPT.
It seems that the steric hindrance is responsible for the
low conversions.
O-prenylation of the 4-hydroxy and N-prenylation
of the 4-amino group of the selected substrates
For structural elucidation, the enzyme products 1b and 3b–7b
(Fig. 2) were isolated by preparative HPLC from the incuba-
tion mixtures of 1a and 3a–7a, respectively, and subjected to
1H NMR and MS analyses. HRMS data (Table 1) proved the
presence of molecular masses, which are 68 Da larger than
those of their respective substrates, providing evidence for
monoprenylation in all the products.
Inspection of the 1H NMR spectra of 1b and 3b–7b
(Figs. S1–S6 in Supplementary material) revealed the pres-
ence of only one product each. Furthermore, the number and
coupling pattern of the aromatic protons have not been
changed in comparison to those of the respective substrates,
Table 1 HRMS data of the en-
zyme products Isolated products Formula MS mode Calculated (Mr) Measured Deviation (ppm)
1b C14H19NO3 EI 249.1365 249.1349 [M]
+ −6.4
3b C15H21NO3 EI 263.1521 263.1543 [M]
+ 8.4
4b C14H18FNO3 EI 267.1271 267.1264 [M]
+ −2.6
5b C14H18INO3 ESI 375.0331 376.0311 [M + H]
+ −5.3
6b C14H19NO4 EI 265.1314 265.1285 [M]
+ −10.9
7b C14H20N2O2 EI 248.1525 248.1547 [M]
+ 8.9
9b C16H20N2O2 EI 272.1525 272.1541 [M]
+ 5.9
11b C17H22N2O2 EI 286.1681 286.1714 [M]
+ 11.5
12b + 12c C17H22N2O2 EI 286.1681 286.1675 [M]
+ −2.1
Table 2 NMR data of 1b and 3b–7b
multimultimulti multi multi multi
66 6
a Chemical shifts (δ) are given in parts per million and coupling constants (J) in hertz
bSignals overlapping with those of H2O
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indicating the prenylation at O- or N-atom. The 1H NMR
spectra of 1b in DMSO-d6 and 5b–7b in D2O were nearly
identical to those of the enzyme products with SirD (Kremer
and Li 2010; Zou et al. 2011), which proved their regular
prenylation at the 4-hydroxy group (1b, 5b, and 6b) or 4-
amino group (7b). The 1H NMR spectrum of 3b in DMSO-d6
was very similar to that of 1b. They differed from each other
by the signal for H-8 (3.24 ppm, t, 5.0) in 1b, which was
replaced by a singlet for a methyl group at 1.23 ppm in 3b.
This verified that 3b had the same prenylated position and
pattern as 1b. The spectrum of 4b corresponded well to that of
the O-prenylated derivatives reported previously (Zou et al.
2011). The reactions of tyrosine and derivatives catalyzed by
TyrPT are illustrated in Fig. 2b.
Acceptance of L-tryptophan and derivatives by TyrPT
Previous studies have demonstrated that the tyrosine O-
prenyltransferase SirD also accepted L-tryptophan and
several derivatives as substrates and mainly catalyzed
C7-prenylations at the indole ring (Kremer and Li 2010;
Rudolf and Poulter 2013; Zou et al. 2011). Therefore, we
carried out incubations of L-tryptophan (9a) and deriva-
tives (10a–16a) with TyrPT under conditions used for
tyrosine derivatives. The reaction mixtures of TyrPT were
then compared with those obtained with the tyrosine O-
prenyltransferase SirD and the known tryptophan C7-
prenyltransferase 7-DMATS (Fig. 3). With an exception
for D-tryptophan (10a), L-tryptophan (9a) and all other
derivatives (11a–16a) were very well accepted by 7-
DMATS, corresponding to our previously reported results
(Kremer and Li 2008). L-tryptophan (9a) was accepted by
SirD with a product yield of 25 %. Much lower conver-
sions were observed for SirD with 4-methyl-DL-trypto-
phan (11a) and L-abrine (15a). No product formation was
detected in the incubation mixtures of SirD with 5-
methyl-DL-tryptophan (12a), 6-methyl-DL-tryptophan
Table 3 NMR data of 9b, 11b, 12b, and 12c
6S
multi multi multi multi
a Chemical shifts (δ) are given in parts per million and coupling constants (J) in hertz
b Signals overlapping with those of H2O
c Signals overlapping with those of glycerol
Fig. 1 SDS-PAGE analysis of the overproduction and purification of
TyrPT-His6. The proteins were separated on a 12 % SDS-polyacrylamide
gel and stained with Coomassie Brilliant Blue G-250. Lane 1 total protein
before IPTG induction, lane 2 total protein after IPTG induction, lane 3
soluble fraction after IPTG induction, lane 4 purified TyrPT-His6, lane 5
molecular mass standard
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(14a), and L-β-homotryptophan (16a). All these results
are in good agreement with the published results (Zou
et al. 2011).
In comparison to L-tyrosine and derivatives (Fig. 2), tryp-
tophan and derivatives were poor substrates for TyrPT. TyrPT
accepted L-tryptophan (9a) with a product yield of 33 %,
slightly higher than SirD. Significant activity of 41 % was
observed for TyrPT with 4-methyl-DL-tryptophan (11a).
While at least two product peaks were detected in the incuba-
tion mixture of 11a with SirD as reported previously (Rudolf
and Poulter 2013), only one product was observed in that with
TyrPT. In the incubation mixture of 12a with TyrPT, a broad
product peak with a product yield of 15 % was detected,
which was absent in that with SirD. The other tested trypto-
phan derivatives were also poor substrates for TyrPT (Fig. 3).
C7-prenylation of the indole ring
For structural elucidation, the enzyme products of 9a, 11a, and
12a with TyrPT were isolated on HPLC and subjected to 1H
NMR and MS analyses. The HRMS data (Table 1) confirmed
the monoprenylation of the isolated products.
Fig. 2 HPLC analysis of the enzyme assays of SirD and TyrPT with
tyrosine and derivatives (a) and prenyl transfer reactions catalyzed by
TyrPT (b). The reaction mixtures contained 0.086 mg/mL (1.6 μM) of
TyrPT, 1.0 mM of aromatic substrate, 2.0 mM DMAPP, 10 mM CaCl2,
and 50 mM Tris-HCl at pH 7.5 and were incubated at 37 °C for 16 h. The
illustrated chromatograms were recorded at 277 nm. Product yields are
given in parentheses after the product numbers
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In the 1H NMR spectra of 9b and 11b, the signals of
H-2′ of the prenyl moiety in the region of 5.43–5.33 ppm
(tsept or m) verified that they are regularly prenylated
products. In the spectrum of 9b, the signals of the indole
moiety at δH 7.18 ppm (1H, d, 2.4), 7.38 ppm (1H, d,
7.3), 6.92 ppm (1H, t, 7.3), and 6.85 ppm (1H, dd, 7.3,
Fig. 3 HPLC analysis of the enzyme assays of 7-DMATS, SirD, and
TyrPT with tryptophan and derivatives (a) and prenyl transfer reactions
catalyzed by TyrPT (b). The reaction mixtures contained 0.086 mg/mL
(1.6 μM) of TyrPT, 1.0 mM of aromatic substrate, 2.0 mM DMAPP,
10 mM CaCl2, and 50 mM Tris-HCl at pH 7.5 and were incubated at
37 °C for 16 h. The illustrated chromatograms were recorded at 277 nm.
Product yields are given in parentheses after the product numbers
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0.7) were in agreement with those of C7-prenylated tryp-
tophan (Rudolf and Poulter 2013). The 1H NMR data of
11b corresponded very well to the data reported previous-
ly (Rudolf and Poulter 2013). These data proved that
TyrPT also catalyzed the regular C7-prenylation of L-
tryptophan (9a) and 4-methyl-DL-tryptophan (11a).
Inspection of the 1H NMR spectrum of the product of 5-
methyl-DL-tryptophan (12a) revealed the presence of two
regularly prenylated products in a ratio of 1:2 (12b:12c) by
detection of two set of signals for H-2′ at δH 5.25 ppm (br t,
7.0) and 5.41 ppm (br t, 7.2). Unfortunately, these two prod-
ucts could not be separated from each other in this study, even
by repeated HPLC chromatography under different condi-
tions. However, their structures can still be elucidated from
the 1H NMR spectrum of the obtained mixture. The signals of
the aromatic protons in 12c at δH 7.34 (1H, s), 7.15 (1H, s),
and 6.75 (1H, s) corresponded very well to those of the C6-
prenylated product of 6-DMATS with 12a reported previously
(Winkelblech and Li 2014). The 1H NMR spectrum of 12b
also showed three singlets at δH 7.47 (1H, s), 7.13 (1H, s), and
7.07 (1H, s), proving the attachment of the prenyl moiety to
C7 of the indole ring. In conclusion, TyrPT catalyzes both O-
prenylation of tyrosine and derivatives and C7-prenylation of
tryptophan and derivatives.
Fifteen cyclic dipeptides containing tyrosine or tryptophan
moieties were then tested as substrates. As observed for SirD and
some tryptophan prenyltransferases (Kremer et al. 2007; Kremer
and Li 2010; Steffan et al. 2007; Steffan and Li 2009; Yu et al.
2012), these dipeptides only served as poor substrates for TyrPT.
Conversion yields between 0.4 and 4.4 % were detected under
the same condition (Table S2 in Supplementary material). In
addition, 22 other potential aromatic substrates such as
hydroxybenzoic acids, hydroxynaphthalenes, flavonoids, xan-
thones, coumarins, and quinoloneswere assayedwith TyrPT.No
product formation was detected in the reaction mixture of these
compounds (Table S3 in Supplementary material).
Biochemical properties and kinetic parameters
Usually, the prenyltransferases of the DMATS superfamily are
independent of the presence of metal ions in their reactions,
although Ca2+ or Mg2+ often enhances the reaction velocities
(Steffan et al. 2009). HPLC analysis showed that addition of
K+, Na+, Mg2+, Mn2+, Co2+, or EDTA to the reaction mixture
of TyrPT-His6 did not change the enzyme activity significant-
ly. Zn2+ reduced slightly and Cu2+ strongly the enzyme activ-
ity of TyrPT (Fig. S10 in Supplementary material).
In order to get insights into the catalytic efficiency, the
kinetic parameters of TyrPT for DMAPP, 1a, 3a–7a, 9a, and
11a were determined by Lineweaver-Burk plots (Figs. S11–
S20 in Supplementary material) and compared with those
reported for SirD (Kremer and Li 2010; Zou et al. 2011). As
given in Table 4, tyrosine was better accepted by SirD than
that by TyrPT, with a threefold catalytic efficiency. The KM
values and turnover numbers of TyrPT for 3a–5a differ slight-
ly from those of SirD, so that both enzymes catalyze the O-
prenylation of these substrates with comparable catalytic effi-
ciencies. SirD and TyrPT accepted 9a with comparable KM
values (0.23 and 0.19 mM), which are also in the range of KM
values for 1a and derivatives 3a–7a. However, the turnover
numbers for 9a at 0.06 with SirD and 0.0053 s−1 with TyrPT
are significantly lower than those for 1a and derivatives. These
results justified the assignment of the function of TyrPT as a
tyrosineO-prenyltransferase. Interestingly, 11a was much bet-
ter accepted by TyrPT than SirD.
Discussion
A putative gene An13g01840 with meaningful sequence ho-
mology to enzymes of the DMATS superfamily has been
identified in the genome sequence of A. niger CBS 513.88
(Pel et al. 2007). Literature search did not result in any hits on
the isolation and identification of prenylated aromatic com-
pounds from A. niger, whose biosynthesis would involve this
putative prenyltransferase gene.
In this study, the coding sequence of the putative
prenyltransferase gene An13g01840 was cloned into the ex-
pression vector pET28a, and the soluble recombinant protein
was purified to near homogeneity after overproduction in
E. coli. Incubation with a large number of potential aromatic
substrates and subsequent analysis of the reaction mixtures on
Table 4 Comparison of kinetic parameters of TyrPT with those of SirD
published previously
SirD TyrPT
KM
(mM)
kcat
(s−1)
kcat/KM
(s−1 M−1)
KM
(mM)
kcat
(s−1)
kcat/KM
(s−1 M−1)
1a 0.13a 1.0a 7,692 0.24 0.58 2,417
3a 0.36b 0.31b 861 0.22 0.16 727
4a 0.24b 0.10b 416 0.42 0.26 619
5a 0.10b 0.07b 700 0.29 0.16 551
6a 0.21b 0.09b 429 0.19 0.27 1,421
7a – – – 0.25 0.20 800
9a 0.23a 0.06a 261 0.19 0.0053 28
11a – – – 0.69 0.030 43
DMAPPc 0.17 1.0 5,882 0.71 0.69 972
DMAPPd – – – 0.39 0.0036 9.2
– not determined
a,b The data were adopted from previous publications (Kremer and Li
2010; Zou et al. 2011)
c 1a as aromatic substrate
d 9a as aromatic substrate
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HPLC revealed acceptance of tyrosine and derivatives with
excellent activities. Structure elucidation of the isolated en-
zyme products proved an O-prenylation at the 4-phenolic
hydroxy group of tyrosine and four derivatives or N-
prenylation in the case of 4-amino-L-phenylalanine. These
data suggested that TyrPT probably functions as an O-
prenyltransferase. Analysis and comparison of the genes
down- and upstream of An13g01840 did not indicate presence
of biosynthetic gene clusters for secondary metabolites.
HPLC-MS analysis of the fungal cultures did not reveal the
presence of prenylated tyrosine, tryptophan or their deriva-
tives (data not shown). Therefore, the natural substrate of
TyrPT and its role in the fungal strain remained unknown.
To prove the tyrPT expression, the fungus was cultivated in
three different media at 30 °C (see “Materials and methods”).
mRNA was isolated from 3-day-old mycelia and used as a
template for RT-PCR to get cDNAs. No product was detected
after PCR amplification (data not shown). This indicates that
tyrPT was not expressed under the tested conditions, as ob-
served for many genes in the biosynthesis of secondary me-
tabolites (Brakhage 2013).
Acceptance of L-tryptophan and several derivatives by
TyrPT and their prenylation at C7 position just demonstrated
its broad substrate specificity, as observed for its homologue
SirD from L. maculans (Gardiner et al. 2004; Kremer and Li
2010). This conclusion is confirmed by determination of the
kinetic parameters of SirD for L-tyrosine, L-tryptophan, and
their derivatives (Table 4). As in the case of SirD, TyrPT
accepted L-tryptophan with a comparable, or even smaller
KM value (0.19 mM) than with L-tyrosine (0.24 mM). How-
ever, the turnover number for L-tyrosine at 0.58 s−1 is more
than 100-fold than that for L-tryptophan at 0.0053 s−1. As
given in Table 4, SirD accepted L-tyrosine (1a) and α-
methyl-L-tyrosine (3a) better than TyrPT. TyrPT in contrast
accepted 3,4-dihydroxy-L-phenylalanine (6a), 4-amino-L-phe-
nylalanine (7a), 4-mehyl-DL-tryptophan (11a), and 5-mehyl-
DL-tryptophan (12a) much better than SirD (Table 4, Figs. 2
and 3). It could be expected that these two enzymes can be
used as complementary biocatalysts in the chemoenzymatic
synthesis, to produce desired prenylated derivatives.
The enzymes of the DMATS superfamily usually showed
broad substrate specificity, catalyzed regiospecific
prenylations, and resulted in the formation of one dominant
product (Yu and Li 2012). However, this regioselectivity
decreased with the reduced conversion yields of unnatural
substrates and two or more products were detected in such
cases (Wollinsky et al. 2012b). This phenomenon was very
well demonstrated in this study. Tyrosine and derivatives (1a–
7a) as well as L-tryptophan were well accepted by SirD and
TyrPT, one predominant product each was found in their
reaction mixtures. 4-Methyl-DL-tryptophan (11a) was accept-
ed by SirD with a product yield of 14 %. C7- and N1-
prenylated derivatives with a ratio of about 2:1 were detected
as enzyme products. 11a was accepted by TyrPT with a
product yield of 41 %, and only C7-prenylated derivative
was detected as an enzyme product. In the case of 5-methyl-
DL-tryptophan (12a) with TyrPT, a product yield of 15 % was
detected and two products with prenylations at C6 and C7
with a ratio of 2:1 were found as enzyme products (Fig. 3).
Identification and biological investigation of TyrPT en-
hance the relationship of the substrate and catalytic promiscu-
ity of tyrosine O- and tryptophan C7-prenyltransferases.
TyrPT showed somewhat more flexible toward its aromatic
substrates than SirD. Comparable studies in the future on the
structure level with TyrPT, SirD, and 7-DMATS and identifi-
cation of the potential active sites involved in the substrate
binding could provide additional information for understand-
ing their substrate and catalytic promiscuity. Meanwhile, it
could even provide modification suggestions for creating new
biocatalysts with higher substrate flexibility and regioselectivity.
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ANI_1_656114: putative IQ calmodulin-binding motif gene 
ANI_1_250114: unknown gene 
ANI_1_658114: putative monooxygenase gene 
ANI_1_662114: putative amino acid transporter gene 
ANI_1_664114: unknown gene 
ANI_1_666114: putative triacylglycerol lipase 
ANI_1_668114: putative phospholipid methyltransferase 
 
 
 
Table S2 Enzyme activity of TyrPT towards cyclic dipeptides. 
Substance Conversion yield (%) 
Cyclo-L-Trp-L-Tyr 0.4 
Cyclo-D-Trp-L-Tyr 2.6 
Cyclo-L-Trp-L-Phe 0.7 
Cyclo-L-Trp-L-Trp 3.1 
Cyclo-L-Trp-L-Leu 3.0 
Cyclo-L-Trp-Gly 2.5 
Cyclo-L-Trp-L-His 0.5 
Cyclo-L-Trp-L-Pro 3.4 
Cyclo-L-Trp-D-Pro 1.3 
Cyclo-D-Trp-L-Pro 1.2 
Cyclo-D-Trp-D-Pro 4.2 
Cyclo-L-Tyr-L-Pro 1.4 
Cyclo-L-Ser-L-Tyr 4.0 
(R)-Benzodiazepinedione 4.2 
(S)-Benzodiazepinedione 4.4 
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Table S3 Enzyme activity of TyrPT towards other aromatic substances. 
Substance Conversion yield (%) 
2-Aminobenzoic acid <0.5 
2-Aminobenzyl alcohol 0.5 
Caffeic acid <0.5 
p-Coumaric acid 0.5 
2,5-Dihydroxybenzoic acid <0.5 
DL-4-Hydroxyphenyllactic acid <0.5 
1-Naphtol <0.5 
2-Naphtol <0.5 
1,4-dihydroxynaphthalene <0.5 
2,4-Dihydroxynaphthalene <0.5 
2,6-Dihydroxynaphthalene 0.5 
3-Hydroxyxanthone <0.5 
3-Hydroxyxathen-9-one <0.5 
Esculin <0.5 
4-Methylesculetin <0.5 
4-Hydroxy-7-methoxycoumarin <0.5 
Naringenin 0.5 
Hesperetin <0.5 
Luteolin <0.5 
8-Fluoro-4-hydroxyquinoline <0.5 
4-Hydroxyquinoline <0.5 
7-(Trifluoromethyl)quinoline-4-thiol <0.5 
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Fig. S1 1H NMR spectrum of 1b in DMSO-d6. 
 
 
Fig. S2 1H NMR spectrum of 3b in DMSO-d6. 
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Fig. S3 1H NMR spectrum of 4b in DMSO-d6. 
 
 
Fig. S4 1H NMR spectrum of 5b in D2O. 
  
83
S7 
 
 
Fig. S5 1H NMR spectrum of 6b in D2O. 
 
 
Fig. S6 1H NMR spectrum of 7b in D2O. 
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Fig. S7 1H NMR spectrum of 9b in DMSO-d6. 
 
 
Fig. S8 1H NMR spectrum of 11b in D2O. 
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Fig. S9 1H NMR spectrum of 12b and 12c in CD3OD. 
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Fig. S10 Ion dependency of the TyrPT reaction. 
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Fig. S11 Determination of kinetic parameters of TyrPT for L-tyrosine (1a). 
 
 
 
 
Fig. S12 Determination of kinetic parameters of TyrPT for α-methyl-L-tyrosine (3a). 
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Fig. S13 Determination of kinetic parameters of TyrPT for 3-fluoro-DL-tyrosine (4a). 
 
 
 
 
Fig. S14 Determination of kinetic parameters of TyrPT for 3-iodo-L-tyrosine (5a). 
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Fig. S15 Determination of kinetic parameters of TyrPT for 3, 4-dihydroxy-L-
phenylalanine (6a). 
 
 
 
 
Fig. S16 Determination of kinetic parameters of TyrPT for 4-amino-L-phenylalanine 
(7a). 
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Fig. S17 Determination of kinetic parameters of TyrPT for L-tryptophan (9a). 
 
 
 
Fig. S18 Determination of kinetic parameters of TyrPT for 4-methyl-DL-tryptophan 
(11a). 
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Fig. S19 Determination of kinetic parameters of TyrPT for DMAPP in the presence of 
L-tyrosine (1a). 
 
 
 
 
Fig. S20 Determination of kinetic parameters of TyrPT for DMAPP in the presence of 
L-tryptophan (9a). 
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7-DMATS from Aspergillus fumigatus and SirD from Leptosphaeria maculans catalyse a C7-prenylation of
L-tryptophan and an O-prenylation of L-tyrosine in nature, respectively. SirD was reported to catalyse
the C7-prenylation of L-tryptophan and some derivatives thereof in vitro. We report here the O-prenyla-
tion of tyrosine and O- or N-prenylation of its derivatives by 7-DMATS. These results provide experimen-
tal evidence for the close relationship of tyrosine O- and tryptophan C7-prenyltransferases regarding
their substrate and catalytic promiscuity.
 2014 Elsevier Ltd. All rights reserved.Prenyltransferases catalyse in nature transfer reactions of pre-
nyl moieties from different prenyl donors, for example, dimethyl-
allyl diphosphate (DMAPP) to various aliphatic or aromatic
acceptors. They are involved in both primary and secondary
metabolism in living organisms, and are responsible in part for
the structural diversity and bioactivities of natural products.1–3
Furthermore, the biological and pharmacological activities of theprenylated products are usually distinct from their non-prenylated
precursors.4 These features make prenyltransferases interesting
research topics for scientists from different disciplines. Based on
their sequences and biochemical properties, prenyltransferases
can be divided into different subgroups.1,5 One of the most investi-
gated subgroups is the dimethylallyl tryptophan synthase (DMATS)
superfamily. So far, more than 30 such prenyltransferases have
Figure 1. HPLC chromatograms of the reaction mixtures of 7-DMATS with 1a–10a as substrates as well as the prenyl transfer reactions catalysed by 7-DMATS. Detection was
carried out with a photo diode array detector and absorptions at 277 nm were illustrated.
5200 A. Fan, S.-M. Li / Tetrahedron Letters 55 (2014) 5199–5202been identified and characterised biochemically.3,6,7 The majority
of the DMATS superfamily uses indole derivatives including trypto-
phan and tryptophan-containing cyclic dipeptides as substrates.One of them is 7-DMATS from Aspergillus fumigatus (A. fumigatus),
which catalyses the prenylation of L-tryptophan at position C-7 of
the indole ring8 and is involved in the biosynthesis of astechrome95
A. Fan, S.-M. Li / Tetrahedron Letters 55 (2014) 5199–5202 5201
96(Scheme 1A).9 An orthologue 7-DMATSNeo from a Neosartorya sp.
was recently reported by Miyamoto et al.7 A few members of the
DMATS superfamily are responsible for the prenylation of non-
indole derivatives. For example, SirD from Leptosphaeria maculans
catalyses an O-prenylation of tyrosine (1a),10 the first step in the
biosynthesis of sirodesmin PL (Scheme 1B).11 SirD shares a
sequence identity of 34% on the amino acid level with 7-DMATS
and also catalyses the C7-prenylation of L-tryptophan, with a rela-
tive activity of 8.1% of that of 1a.10 Detailed investigations with
SirD also demonstrated the acceptance of several methylated and
halogenated tryptophan derivatives including 4-methyl-DL-
tryptophan.12 Recently, Rudolf and Poulter have confirmed the
C7-prenylation of three indole derivatives including L-tryptophan
and 4-methyl-DL-tryptophan by SirD.13 In addition, reversely N1-
prenylated derivatives were found as additional enzyme products
in that study (mostly as minor products). It seems that the tyrosine
O-prenyltransferase SirD shares similar catalytic activity with the
tryptophan C7-prenyltransferase 7-DMATS. Product formation for
1a was detected neither with 7-DMATS (after incubation with
2.5 lg recombinant protein for 45 min),8 nor with the recently
identified 7-DMATSNeo.7 No data on the acceptance of 1a deriva-
tives by 7-DMATS and 7-DMATSNeo are available in the literature.
Therefore, we reinvestigated the acceptance of 1a and derivatives
by 7-DMATS from A. fumigatus with higher protein concentration
and longer incubation time than used in our previous studies.8
L-Tyrosine (1a) and nine derivatives (2a–10a, Fig. 1) were tested
as substrate with 20 lg recombinant 7-DMATS in 100 lL enzyme
assays at 37 C for 16 h. HPLC analysis of the incubation mixtures
showed clear product formation in several cases (Fig. 1, B–K).
Detection was carried out with a photo diode array detector and
illustrated for absorption at 277 nm. As shown in Figure 1B, 1a
was accepted by 7-DMATS with a product yield of 36%. No product
formation was detected in the reaction mixture of its enantiomer
2a (Fig. 1C). Replacement of the phenolic hydroxyl group by an
amino group, as in the case of 4-amino-L-phenylalanine (3a),
increased the acceptance by 7-DMATS, with a product yield of
70% (Fig. 1D). Again, its enantiomer 4a was not converted by
7-DMATS (Fig. 1E), demonstrating the high stereoselectivity of
7-DMATS towards 1a and its derivatives. Therefore, L-configured
tyrosine derivatives were used for further study. Introducing an
additional hydroxyl group to C3 of tyrosine (5a) resulted in a
reduction of its acceptance by 7-DMATS, with a conversion yield
of 12% (Fig. 1F), approximate one third of that of 1a. Interestingly,
an iodine substitution to the ortho-position of the hydroxyl group
(6a) increased significantly the enzyme activity, with a remarkableScheme 2. Proposed mechanism of prenylationproduct yield of 97% (Fig. 1G). That is about 2.7 times of that of 1a,
which might be explained by the electronic effect of this substitu-
tion on the benzene ring. The electron donating iodine at C3 posi-
tion would increase the nucleophilicity of the 4-hydroxy group for
dimethylallyl cation and stabilise the formed positively charged
ion, which is proposed to be intermediates in the prenylation reac-
tions (Scheme 2).14,15 In comparison, 3-nitro-L-tyrosine (7a) with a
strong electron withdrawing group on the benzene ring was hardly
accepted by 7-DMATS (Fig. 1H). Introducing a second iodine to 6a,
as in the case of 8a, abolished the activity almost completely
(Fig. 1I). Similarly, a very low activity, with a conversion yield of
2%, was observed for 3,5-dibromo-L-tyrosine (9a) (Fig. 1J). The
low conversion of 8a and 9a by 7-DMATS seems to be results of
steric hindrance of the two large substitutions at C3 and C5 of
the benzene ring. No product peak was observed in the reaction
mixture of a-methyl-L-tyrosine (10a) under this condition
(Fig. 1K). In comparison, a-methyl-DL-tryptophan was accepted
by 7-DMATS with a relative activity of 19.1% of that of L-
tryptophan.16
To elucidate their structures, the enzyme products of 1a, 3a and
6a were isolated on HPLC from 10 ml of incubation mixtures and
then subjected to NMR and MS analyses. MS data supported the
monoprenylation of the isolated products 1b, 3b and 6b by detec-
tion of molecular masses, which are 68 Da larger than those of the
respective substrates (Table S1 in Supplementary material).
Inspection of the 1H NMR spectra (Table S2; Figs. S1–S3 in
Supplementary material) of the isolated product peaks 1b, 3b
and 6b revealed the presence of signals for a regular prenyl moi-
ety each at dH 3.76–4.55 (d, H-10), 5.36–5.43 (t or tsept, H-20),
1.73–1.79 (s or d, H-40) and 1.69–1.79 ppm (s or d, H-50). Fur-
thermore, signals of the aromatic protons at dH 7.15 (d, H-2,6),
6.83 (d, H-3,5) of 1b; 7.22 (d, H-2,6), 6.89 (d, H-3,5) of 3b and
7.65 (s, H-2), 6.92 (d, H-5), 7.22 (d, H-6) of 6b indicated the
same number and coupling pattern as those of their respective
substrates. The 1H NMR spectra of 1b in DMSO-d6 and 3b in
D2O were almost identical to those of the enzyme products with
SirD,12 which confirmed the regular prenylation at the 4-hydro-
xyl group (1b) or 4-amino group (3b). Comparison of the spec-
trum of 6b with that of 1b, the signals of H-10 (4.55, d, 6.5)
and H-20 (5.43, tsept, 6.5, 1.5) of the prenyl moiety in 6b are
very similar to those of 1b. These data proved unequivocally
the regular prenylation of 1a and derivatives at O- or N-atom,
as summarised in Figure 1A. This means that 7-DMATS catalyses
both tryptophan C7- and tyrosine O-prenylation, as observed for
the tyrosine O-prenyltransferase SirD.10,12,13of tyrosine and derivatives by 7-DMATS.
Table 1
Kinetic parameters of 7-DMATS and SirD towards L-Trp, L-Tyr (1a) and its derivatives
(3a and 6a)
Substrate SirD 7-DMATS
KM (mM) kcat (s1) KM (mM) kcat (s1)
L-Trp 0.23
b 0.06b 0.14a 0.19a
1a 0.19c 0.21c 1.7 0.0091
3a — — 0.58 0.025
6a 0.10c 0.07c 0.15 0.023
a The data were adopted from Refs. 8.
b The data were adopted from Refs. 10.
c The data were adopted from Refs. 12.
5202 A. Fan, S.-M. Li / Tetrahedron Letters 55 (2014) 5199–5202Miyamoto et al. mentioned that the tryptophan C7-prenyltrans-
ferase 7-DMATSNeo from Neosartorya sp. did not accepted 1a as the
substrate.7 Detailed inspection of the HPLC chromatograms in that
study indicated the presence of an additional minor peak at
approximate 14.7 min after incubation of 1a with 5 lg of
7-DMATSNeo for 16 h. This peak could be the prenylated product
1b identified in our present study.
To get insights into the catalytic efficiency, kinetic parameters
of 7-DMATS for 1a, 3a and 6a were determined by Eadie–Hofstee,
Hanes–Woolf and Lineweaver–Burk plots (Table 1; Figs. S4–S6 in
Supplementary material) and compared with those of the
published data for SirD10,12 and 7-DMATS.8 7-DMATS showed a
higher KM value of 1.7 mM and lower turnover number of
0.0091 s1 for 1a than those of SirD with L-tryptophan. On the
other hand, 6a was very well accepted by 7-DMATS with a compa-
rable KM value (0.15 mM) to that of SirD with 1a and of 7-DMATS
with L-tryptophan (Table 1). The turnover number of 7-DMATS
with 6a at 0.023 s1 is much higher than that with 1a.
In conclusion, the results reported in this study proved
unequivocally that the tryptophan C7-prenyltransferase 7-DMATS
from A. fumigatus can also use tyrosine and derivatives as sub-
strates and catalyses the same O- or N-prenylation as the tyrosine
O-prenyltransferase SirD, which prenylates in turn also tryptophan
and derivatives at C7 of the indole ring.10,12,13 These data demon-
strated the similar substrate and catalytic promiscuity of the two
enzymes and indicated their close relationship in the evolution.
Comparable studies in the future on the structure level with
7-DMATS and SirD and identification of the active sites involvedin the substrate binding could provide detailed insights into their
difference and similarity. Meanwhile, it could even provide modi-
fication suggestions for creation of new biocatalysts with higher
substrate flexibility and regioselectivity. Furthermore, identifica-
tion of new members from the DMATS superfamily with similar
substrate spectrum and/or catalytic ability would help us to under-
stand this group of intriguing enzymes.
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EXPERIMENTAL 
GENERAL INFORMATION 
Dimethylallyl diphosphate (DMAPP) was synthesised according to the method described for 
geranyl diphosphate (GPP) reported by Woodside et al.1 Substrates used for the enzyme assays 
are commercially available of highest quality. 
EXPERIMENTAL PROCEDURE 
Overproduction and purification of 7-DMATS were carried out as described previously by 
Kremer et al.2 
 
ASSAYS FOR DETERMINATION OF ENZYME ACTIVITY. The enzyme assays (100 µl) contained L-
tyrosine or derivatives (1 mM), CaCl2 (10 mM), DMAPP (2 mM), glycerol [1.0 - 1.5% (v/v)], 
dimethyl sulfoxide [DMSO, 0 - 2.5% (v/v)], Tris-HCl (50 mM, pH 7.5) and 7-DMATS (20 µg). 
The reaction mixtures were incubated at 37 ℃ for 16 h and then terminated with 100 µl MeOH. 
Protein was removed by centrifugation at 13.000 × g for 20 min. Product yields were calculated 
by peak areas in HPLC chromatograms at 277 nm as well as by comparison of signal intensities 
of substrate and product in the 1H NMR spectra of the respective reaction mixture. The extinction 
coefficients of substrate to product were found to be 120%, 135% and 76% for 1a, 3a and 6a, 
respectively. 
 
ENZYME ASSAYS FOR DETERMINATION OF THE KINETIC PARAMETERS. The enzyme assays (100 
µl) contained 1a, 3a or 6a (0.01 - 5 mM), CaCl2 (10 mM), DMAPP (1 mM), glycerol [1.0 - 1.5% 
(v/v)], dimethyl sulfoxide [DMSO, 0 - 2.5% (v/v)], Tris-HCl (50 mM, pH 7.5) and 3 (6a), 7.5 
(3a), or 10 µg (1a) 7-DMATS. The reaction mixtures were incubated at 37 ℃ for 20 (3a), 90 (6a) 
or 120 min (1a) and then terminated with 100 µl MeOH. Protein was removed by centrifugation 
at 13.000 × g for 20 min.  
 
ENZYME ASSAYS FOR ISOLATION OF THE ENZYME PRODUCTS. The enzyme assays (10 ml) 
contained 1a, 3a or 6a (1 mM), CaCl2 (10 mM), DMAPP (1.5 mM), dimethyl sulfoxide [DMSO, 
0 - 2.5% (v/v)], Tris-HCl (50 mM, pH 7.5) and 7-DMATS (2 mg). The reaction mixtures were 
incubated at 37 ℃ for 16 h and then terminated with 10 ml MeOH. Protein was removed by 
centrifugation at 6.000 × g for 30 min. The supernatant was concentrated on a rotary evaporator 
to 1 - 2 ml and used as samples for separation on HPLC. 
 
HPLC ANALYSIS AND ISOLATION OF ENZYME PRODUCTS FOR STRUCTURE ELUCIDATION. The 
reaction mixtures were routinely analysed by HPLC on an Agilent series 1200 by using a 
Multospher 120 RP-18 column (250 × 4 mm, 5 µm C+S Chromatographie Service, Langerwehe, 
Germany) at a flow rate of 1 ml min-1. Water (solvent A) and methanol (solvent B) were used as 
solvents for analysis and isolation of the enzyme products. A linear gradient of 30 - 100% (v/v) 
solvent B in 20 min was used for analysis of the enzyme reactions. The column was then washed 
with 100 % solvent B for 5 min and equilibrated with 30% solvent B for another 5 min. Detection 
was carried out by photo diode array detector. 
98
The products of 7-DMATS with 1a, 3a and 6a were isolated on a Multospher 120 RP18 column 
(250 × 10 mm, 5 µm) with different gradients, e.g. 60 – 100 % in 30 min, at 2.5 ml min-1. After 
each run, the columns were then washed with 100 % solvent B for 10 min followed by 8 min of 
equilibration with the corresponding condition at the beginning of each run. 
 
NMR AND MS ANALYSES. 1H spectra were recorded on a JEOL ECA-500 MHz spectrometer. 
Chemical shifts were referenced to the signal of DMSO-d6 at 2.50 ppm or D2O at 4.79 ppm. 
Spectra were processed with MestRENova 5.2.2. The isolated compounds were also analysed by 
electrospray ionization mass spectrometry (ESI-MS) on an Auto SPEC (Micromass Co. UK 
Ltd.). 
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Table S1. ESI-MS data of the enzyme products 
Isolated products Formula 
Molecular mass 
Calculated Measured [M+H]+ 
1b C14H19NO3 249.14 250.14  
3b C14H20N2O2 248.15 249.12  
6b C14H18INO3 375.03 375.96  
 
Table S2. 1H NMR data of the enzyme products 1b, 3b and 6b. 
Compound 
   
Position δ, multi, J/Hz δ, multi, J/Hz δ, multi, J/Hz 
2 7.15, d, 8.4 7.22, d, 8.0 7.65, s 
3 6.83, d, 8.4 6.89, d, 8.0 - 
5 6.83, d, 8.4 6.89, d, 8.0 6.92, d, 8.5 
6 7.15, d, 8.4 7.22, d, 8.0 7.22, d, 8.5 
7a 3.06, dd, 14.4, 4.0 3.24, dd, 14.7, 5.0 3.02, br d, 13.0 
7b 2.78, dd, 14.4, 8.0 3.08, dd, 14.7,7.9 2.80, dd, 13.0, 6.0 
8 approx. 3.3a 3.98, dd, 7.9, 5.0 approx. 3.3a 
1’ 4.48, d, 6.5 3.76, d, 6.8 4.55, d, 6.5 
2’ 5.41, t, 6,5 5.36, t sept, 6.8, 1.3 5.43, t sept, 6.5, 1.5 
4’ 1.73, d, 3.8 1.79, d, 1.3 1.75, s 
5’ 1.69, d, 3.8 1.79, d, 1.3 1.72, s 
Solvent DMSO-d6 D2O DMSO-d6 
a Signals overlapping with those of H2O 
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 Figure S1. 1H NMR spectrum of 1b in DMSO-d6. 
 
 
Figure S2. 1H NMR spectrum of 3b in D2O. 
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 Figure S3. 1H NMR spectrum of 6b in DMSO-d6. 
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 Figure S4. Determination of kinetic parameters of 7-DMATS for L-tyrosine (1a). 
 
 
Figure S5. Determination of kinetic parameters of 7-DMATS for 4-amino-L-phenylalanine (3a). 
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Figure S6. Determination of kinetic parameters of 7-DMATS for 3-iodo-L-tyrosine (6a). 
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Site-directed Mutagenesis Switching a Dimethylallyl
Tryptophan Synthase to a Specific Tyrosine C3-Prenylating
Enzyme*
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Background: Dimethylallyl tryptophan synthase FgaPT2 catalyzes in nature the C4-prenylation of indole ring.
Results: FgaPT2 also catalyzes in vitro a regular C3-prenylation of L-tyrosine; its mutant FgaPT2_K174F showed a much higher
catalytic activity toward L-tyrosine than L-tryptophan.
Conclusion: Single mutation on the key amino acid switches the tryptophan C4-prenyltransferase to a tyrosine C3-prenylating
enzyme.
Significance: The first L-tyrosine C3-prenylating enzyme was created by molecular modeling-guided mutagenesis.
The tryptophan prenyltransferases FgaPT2 and 7-DMATS
(7-dimethylallyl tryptophan synthase) fromAspergillus fumiga-
tus catalyze C4- and C7-prenylation of the indole ring, respec-
tively. 7-DMATS was found to accept L-tyrosine as substrate as
well and converted it to an O-prenylated derivative. An accept-
ance of L-tyrosine by FgaPT2 was also observed in this study.
Interestingly, isolation and structure elucidation revealed the
identification of a C3-prenylated L-tyrosine as enzyme product.
Molecular modeling and site-directed mutagenesis led to cre-
ation of a mutant FgaPT2_K174F, which showed much higher
specificity toward L-tyrosine than L-tryptophan. Its catalytic
efficiency toward L-tyrosine was found to be 4.9-fold in compar-
ison with that of non-mutated FgaPT2, whereas the activity
toward L-tryptophan was less than 0.4% of that of the wild-type.
To the best of our knowledge, this is the first report on an enzy-
maticC-prenylationof L-tyrosine as free amino acid and altering
the substrate preference of a prenyltransferase by mutagenesis.
Prenyltransferases catalyze the transfer reactions of prenyl
moieties from different prenyl donors, e.g. dimethylallyl
diphosphate (DMAPP),3 to various aliphatic or aromatic accep-
tors and play an important role as modification enzymes for
creating structural diversity of numerous natural products (1).
Prenylated derivatives often show biological and pharmacolog-
ical activities clearly distinct from their non-prenylated precur-
sors (1–5), which make these enzymes valuable biocatalysts in
the structural modification of small molecules. These features
have drawn noteworthy attention of scientists from different
disciplines (6–8).
According to their sequences, biochemical properties, and
structures, prenyltransferases can be divided into several sub-
groups (1, 9, 10). One of the most investigated subgroups is the
dimethylallyl tryptophan synthase (DMATS) superfamily from
microorganisms. Until now, more than 40 such enzymes have
been identified and characterized biochemically (8, 11–14).
The majority of the DMATS superfamily is involved in the bio-
synthesis of prenylated indole alkaloids and takes indole deriv-
atives including tryptophan and tryptophan-containing cyclic
dipeptides as substrates (3, 8). Usually, they showed significant
substrate tolerance toward different aromatic substrates, but
catalyzed regiospecific Friedel-Crafts alkylations of the indole
ring. These features make the DMATS prenyltransferases use-
ful tools as biocatalysts for production of prenylated products
(8). For example, FgaPT2 catalyzes the first pathway-specific
step in the biosynthesis of the ergot alkaloid fumigaclavine C in
Aspergillus fumigatus, i.e. a regular prenylation of L-tryptophan
at position C-4 of the indole moiety in the presence of DMAPP
(Fig. 1) (15, 16). It was later demonstrated that FgaPT2 also
accepted DMAPP analogues as alkyl donors (17, 18) and
accepted simple tryptophan derivatives (19), tryptophan-con-
taining cyclic dipeptides (19), or even hydroxynaphthalenes
(20) as acceptors. The crystal structure of FgaPT2 was deter-
mined in 2009 and used as basis for understanding the preny-
lation mechanism (21, 22). Another example of this superfam-
ily, 7-DMATS, catalyzes a C7-prenylation of L-tryptophan on
the indole ring (23) and is involved in the biosynthesis of
astechrome in A. fumigatus (24). FgaPT2 and 7-DMATS share
a sequence identity of 31% on the amino acid level.
A few members of the DMATS superfamily catalyze preny-
lations of non-indole derivatives, and in some cases, O-preny-
lations (25, 26). One example of such enzymes, SirD from Lep-
tosphaeria maculans, is involved in the biosynthesis of
sirodesmin PL and responsible for the O-prenylation of the
phenolic hydroxyl group in L-tyrosine (26, 27). SirD shares a
sequence identity of 34% on the amino acid level with
7-DMATS and also accepts L-tryptophan and some of its deriv-
atives as aromatic substrates. It catalyzes mainly a C7-prenyla-
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tion of the indole ring (26, 28, 29). C7-Prenylation of L-trypto-
phan by tyrosine prenyltransferases was also demonstrated
recently with TyrPT fromAspergillus niger (14). Encouraged by
the results obtained for SirD and TyrPT with L-tryptophan as
substrate, we investigated the behavior of 7-DMATS from
A. fumigatus toward L-tyrosine in the presence of DMAPP.
7-DMATS was also able to take L-tyrosine and two derivatives
thereof as substrates and catalyzed the same O- or N-prenyla-
tion as the two tyrosine O-prenyltransferases SirD and TyrPT
(14, 28–30). These results demonstrated the complementary
substrate and catalytic promiscuity of tryptophan and tyrosine
prenyltransferases and meanwhile raised the question about
the acceptance of L-tyrosine and derivatives by other trypto-
phan prenyltransferases, such as FgaPT2, 5-DMATS, and
6-DMATSSa, which catalyze the L-tryptophan prenylation at
C-4, C-5, and C-6, respectively (11, 15, 31). To gain more
insights into the behavior of these enzymes toward tyrosine and
derivatives, FgaPT2, 5-DMATS, and 6-DMATSSa were over-
produced and purified as described previously (11, 19, 31) and
incubated with L-tyrosine at 37 °C for 16 h. Incubations with
L-tryptophan were used as positive controls. The incubation
mixtures were then analyzed on HPLC.
EXPERIMENTAL PROCEDURES
Chemicals—DMAPP was synthesized according to the
method described for geranyl diphosphate reported previously
(32). Substrates used for the enzyme assays were purchased at
the highest available purity.
Bacterial Strains, Plasmids, and Culture Conditions—Esche-
richia coli XL1 Blue MRF (Stratagene, Heidelberg, Germany)
and E. coli BL21 (DE3)pLysS (Invitrogen, Karlsruhe, Germany)
were used for cloning and expression experiments, respectively.
pIU18 was used as construct for FgaPT2 overproduction as
described previously (19) and as DNA template for site-di-
rected mutagenesis experiments. E. coli cells harboring plas-
mids were grown in liquid Lysogeny Broth (LB) or Terrific
Broth (TB) medium and on solid LB medium with 1.5% (w/v)
agar at 37 °C. 25 g ml1 of kanamycin were used for selection
of recombinant E. coli strains.
Site-directedMutagenesis—One-step site-directedmutagen-
esis protocols were used to generate the mutated derivatives of
FgaPT2 listed in Table 1. The QuikChange site-directed
mutagenesis kit (Stratagene, Heidelberg, Germany) was used
for construction of plasmids pES23 to pES26 and pES34, the
Expand Long Template PCR dNTP pack (Roche Diagnostics,
Mannheim, Germany) was used for plasmids pALF13, pALF15,
pALF16, pALF18, and pALF22, and the Expand LongTemplate
PCR system (Roche Diagnostic, Mannheim, Germany) was
used for plasmids pALF23 to pALF28. pES26 was used as tem-
plate for construction of the double mutant K174F_R244E in
pES34 with the primers R244E 2fw and R244E 2rev (Table 1).
The obtained plasmids were subjected to sequencing to con-
firm the desired mutations in the respective constructs.
Overproduction and Purification of the Recombinant Pro-
teins—FgaPT2 and its mutated derivatives were overproduced
and purified as described previously (19) and analyzed on SDS-
PAGE (Fig. 2). Protein yields between 0.6 and 4.9 mg/liter of
culture were obtained in this study.
Enzyme Assays with Recombinant Purified Proteins—To
determine the enzyme activity, the incubation mixtures con-
tained 50 mM Tris-HCl (pH 7.5), 5 mM CaCl2, 1 mM aromatic
substrate, 1 or 2 mM DMAPP, 0.15–5% (v/v) glycerol, 0–5%
(v/v) dimethyl sulfoxide (DMSO), and 0.2–0.4mgml1 of puri-
fied recombinant protein in a total volume of 100 l. After
incubation at 37 °C for 6 or 16 h, the reactions were terminated
by the addition of 100 l of methanol. Protein was removed by
centrifugation at 13,000 rpm for 20 min, and the supernatant
was analyzed onHPLC.Data given in this studywere calculated
from two or three independent measurements.
To determine the kinetic parameters of aromatic substrates,
DMAPP at 1 mM and aromatic substrates with concentrations
of up to 2 mM were used. Variable protein concentrations and
incubation times were used for different enzymes.
FIGURE 1. Prenyl transfer reaction catalyzed by FgaPT2 in the biosynthesis of fumigaclavine C.
TABLE 1
Mutated derivatives of FgaPT2 and respective primers used for site-
directed mutagenesis
Annealing temperatures for PCR varied from 55 to 65 °C, and elongation time was
7.5 min; bold letters in primers indicated mutation in comparison with the original
sequence of FgaPT2.
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For isolation of the enzyme products, reactions were carried
out in large scales (10 ml) containing 50 mM Tris-HCl (pH 7.5),
5 mM CaCl2, 1 mM aromatic substrate, 1.5 mM DMAPP, and
0.2–0.4 mg ml1 recombinant protein. After incubation at
37 °C for 16 h, the reactions were terminated by the addition of
10ml of methanol. After removal of the precipitated protein by
centrifugation at 6000 rpm for 30 min, the reaction mixtures
were concentrated on a rotating vacuum evaporator at 35 °C to
a final volume of 1 ml before injection into HPLC.
HPLC Analysis and Isolation of the Enzyme Products—The
enzyme reaction mixtures were analyzed on HPLC (Agilent
series 1200, Bo¨blingen, Germany) by using a Multospher 120
RP-18 column (250 4 mm, 5 m, CS-Chromatographie Ser-
vice, Langerwehe, Germany) at a flow rate of 1mlmin1.Water
(solvent A) andmethanol (solvent B) were used as solvents. For
analysis of the enzyme products, a linear gradient of 30–100%
(v/v) solvent B in 20 min was used. The column was then washed
with100%(v/v) solventB for5minandequilibratedwith30%(v/v)
solvent B for 5 min. Detection was carried out with a photodiode
array detector and illustrated at 277 nm in this study. For isolation
of the enzyme products, the same HPLC equipment with a Mul-
tospher 120RP-18 column (250 10mm, 5m,CS-Chromatog-
raphie Service) was used. A linear gradient of 50–100% (v/v) of
methanol (solvent B) in water (solvent A) in 50–80 min was car-
ried out with a flow rate at 2.5 ml min1. The column was then
washedwith 100% (v/v) solvent B for 10min and equilibratedwith
50% (v/v) solvent B for 10min.
NMR and Mass Spectrometric Analyses—For structural elu-
cidation, the isolated enzyme products were subjected to 1H
NMR, HSQC, HMBC, andMS analyses. High resolution electron
impact mass spectrometry data were obtained on a Micromass
Auto Spec spectrometer (Waters, Milford, MA). The enzyme
products were: 1b, m/z 249.1361 (C14H19NO3, calculated,
249.1365); 3b,m/z 248.1524 (C14H20N2O2, calculated, 248.1525).
For NMR analysis, the enzyme products were dissolved in
CD3OD or D2O. Spectra were recorded at room temperature
with an ECX-500 spectrometer (JEOL, Tokyo, Japan) equipped
with a broadband probe with z-gradient. Chemical shifts were
referenced to the solvent signal at 3.30 ppm for CD3OD or 4.79
ppm for D2O. All spectra were processed with MestReNova
5.2.2 (Mestrelab Research, Santiago de Compostela, Spain).
NMR data of the isolated products are given in Table 2.
Molecular Docking Calculation—The structure of FgaPT2
(3I4X) in complex with tryptophan was used as a template for
the docking calculation using AUTODOCK4 (33). The trypto-
phan and surrounding watermolecules were removed, and the pre-
nylation substrate, dimethylallyl S-thiolodiphosphate (DMSPP), was
kept in the active site and assumed to be rigid. For docking
calculations with L-tyrosine, Lys-174 was mutated to phenyla-
lanine in silico. Docking calculations (genetic algorithm) were
prepared with ADT (33) using a grid that covers the complete
binding site. The results were visualized with PyMOL (48) and
verified for chemical sense.
RESULTS
Acceptance of L-Tyrosine and 4-Amino-L-phenylalanine by
FgaPT2—HPLC analysis of the incubation mixture of L-trypto-
phan with 0.36 M FgaPT2 showed a conversion yield of 58 
FIGURE 2. Analysis of the overproduced and purified FgaPT2 and its 17
mutants on SDS-PAGE. The purified proteins were separated, together with
the low molecular weight calibration kit (GE Healthcare), on 12% SDS-poly-
acrylamide gels and stained with Coomassie Brilliant Blue G-250.
TABLE 2
NMR data of the enzyme products in D2O (500 MHz)
Chemical shifts () are given in ppm, and coupling constants (J) are in Hz.
a Signals overlapping with those of methanol.
Creating a Specific Tyrosine C3-Prenylating Enzyme
1366 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 3• JANUARY 16, 2015
108
1.0% (Fig. 3A). Using the same amount of protein, aminor addi-
tional peak with an approximate conversion of 1.8 0.15%was
detected in the incubation mixture of L-tyrosine (1a) (Fig. 3B).
By increasing the FgaPT2 concentration to 3.6 M, a clear and
unique product peak with a yield of 18 1.0% was observed in
the HPLC chromatogram of 1a (Fig. 3D). Under this condition,
L-tryptophan was completely converted to 4-dimethylallyl
tryptophan (4-DMAT) (Fig. 3C). No product formation was
detected in the incubation mixtures of 1a with 3.6 M
5-DMATS or 6-DMATSSa (data not shown). Interestingly, the
retention time of the enzyme product of FgaPT2 with 1a was
found to be 10 min, which is 2 min shorter than that of the
O-prenylated derivative obtained from the 7-DMATS assay
under the same HPLC condition (data not shown) (30). This
indicated the presence of different products in the reaction
mixtures of 1awith both tryptophan prenyltransferases. To test
the substrate specificity of FgaPT2 toward tyrosine derivatives,
D-tyrosine (2a), 4-amino-L-phenylalanine (3a), -methyl-L-ty-
rosine (4a), 3-fluoro-DL-tyrosine (5a), 3-iodo-L-tyrosine (6a),
3-nitro-L-tyrosine (7a), 3,5-dibromo-L-tyrosine (8a), and 3,5-
diiodo-L-tyrosine (9a) were incubatedwith 3.6Mrecombinant
FgaPT2 at 37 °C for 16 h. As shown in Fig. 4, FgaPT2 showed a
relatively high substrate specificity toward L-tyrosine and its
analogue 3a. Clear product formation was only observed in the
reactionmixture of 3a (data for 2a and 4a–9anot shown).With
a total product yield of 70 4.9%, 3a was even better accepted
by FgaPT2 than 1a. Inspection of the HPLC chromatogram of
the reactionmixture of 3a revealed the presence of two product
peaks 3b and 3c at 9.7 and 12 min, with product yields of 67
4.5 and 3 0.46%, respectively (Fig. 4B).
Enzyme Product Characterization—For structure elucida-
tion, the enzyme products 1b, 3b, and 3c were isolated from
10-ml enzyme reactionmixtures of 1a and 3a, respectively, and
subjected to MS and NMR analyses. The obtained NMR data
are given in Table 2. MS data indicated a monoprenylation in
the isolated products 1b, 3b, and 3c by detection of molecular
masses, which are 68 Da larger than those of the respective
substrates (see “Experimental Procedures”). The 1HNMRspec-
FIGURE3.HPLCanalysisof incubationmixturesof L-tryptophanandL-tyrosine (1a)withFgaPT2 (A–D) and itsmutantFgaPT2_K174F (E–H).Theenzyme
assays contained 0.36 or 3.6M of the recombinant enzymes andwere incubated at 37 °C for 16 h. Detectionwas carried outwith a photodiode array detector
and illustrated for absorption at 277 nm.mAU, milliabsorbance units.
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trum of 3c corresponded perfectly to that of the regularly
N-prenylated derivative of 3a, which had been identified as an
enzyme product of SirD previously (28).
Inspection of the 1H NMR spectra of 1b and 3b revealed the
presence of only one product each. The signal of H-2 at 5.41
ppm (triple septettes, 7.3, 1.4 Hz for 1b) or 5.34 ppm (triple
septettes, 7.2, 1.4 Hz for 3b) proved them to be regularly pre-
nylated products. Signals of three coupling aromatic protons
were observed in spectra of both 1b and 3b, indicating the pre-
nylation at an aromatic carbon atomof 1a and 3a. The coupling
patterns of one doublet with a small coupling constant of 2.0
(1a) or 1.6 Hz (3b), one doublet with a large coupling constant
of 8.1Hz, andone double doubletwith coupling constants of 8.1
and 2.0 Hz (1b) or 8.1 and 1.6 Hz (3b) also proved a C2- or
C3-prenylation in 1b and 3b (Table 2). Given the electron
donating effects of the 4-hydroxyl in 1a or 4-amino group in 3a,
the Friedel-Crafts alkylation should take place at C-3 of the
benzene ring. To prove this hypothesis, HSQC and HMBC
spectra of 1b and 3b were then taken for structure determina-
tion. In the HSQC spectrum of 1b, the chemical shifts of the
three aromatic proton-bearing carbons are found at 130.7,
115.7, and 128.0 ppm,whichwere assigned toC-2, C-5, andC-6
of the C3-prenylated product, respectively (Table 2). Clear
HMBC correlations betweenH-1 of the prenylmoiety andC-4
of the benzene ring as well as H-2 and C-1 proved unequivo-
cally that 1b was the C3-prenylated product. Furthermore, the
1H NMR spectrum of 1b taken in CD3OD corresponded per-
fectly to that of the natural product isolated from Streptomyces
sp. IFM 10937 (34). Similar correlations were observed in the
HMBC spectrum of 3b, and the same conclusion can be there-
fore drawn for this compound. These results confirmed the
C3-prenylation of 1a and 3a by FgaPT2 (Fig. 4, E and F) as the
unique or main reaction (95.7%). In the case of 3a, the N-pre-
nylation was only 4.3% of the total product formation.
Molecular Modeling and Site-directed Mutagenesis of
FgaPT2—To get more insights into the catalytic mechanism of
FgaPT2 toward 1a and 3a, we carried out amolecularmodeling
study with FgaPT2 and 1a based on the crystal ternary complex
of FgaPT2 with DMSPP and L-tryptophan (21). We performed
in silico docking of L-tyrosine (blue) into the binding pocket of
L-tryptophan (Fig. 5). The final docking result is in good agree-
ment with the observed catalytic activity and shows that the
hydroxyl group occurs near a cavity occupied with water mol-
ecules (Fig. 5, red spheres). TheC3-atom of 1a or 3a (Fig. 5, blue
sphere) can easily attack the C1-atom of DMSPP. This model
explainedwell our experimental results that1a and3awere also
substrates for FgaPT2 and that the resulting products were
C3-prenylated derivatives.
According to this model, Thr-102 was proposed to interact
with the hydroxyl group of 1a or amino group of 3a through
hydrogen bond. Arg-244, Tyr-191, Leu-81, and Ile-80 tend to
stabilize the side chain. Tyr-413, Lys-187, Arg-100, Tyr-409,
Arg-404, Arg-257, Gln-343, and Lys-259 are involved in the
diphosphate binding sites. In a previous study for the FgaPT2
reactionwith L-tryptophan (21), Lys-174was proposed to act as
a base for abstracting the proton at C-4 from an intermediate,
which was formed after attacking of C-4 to the prenyl cation,
and rebuilding the aromatic ring. Later, Luk et al. (35) reported
that the FgaPT2 reaction with tryptophan might undergo a
reverse prenylation at C-3 followed by a Cope rearrangement
and rearomatization. In both proposed mechanisms, Lys-174
always acted as a base for regaining the aromatic ring. The func-
tion as a base is lost for K174F at this position, which is accom-
panied by the prenylation of L-tyrosine at its C-3 atom. In our
structural model, the carboxyl entity of Glu-89, which has an
interaction with N-1 of L-tryptophan (21, 35), is oriented
toward the C-3 of 1a or 3a and therefore suitable to function as
a base to abstract the proton from the -complex.
To prove the proposedmechanism, we determined the activ-
ity of I80F, E89A, K174E, and K174Q obtained in a previous
study (21) toward L-tryptophan and L-tyrosine by incubation at
37 °C for 6 h. As shown in Fig. 6, relative activities of 43.2 2.0,
2.3 0.21, 2.0 0.24, and 119.0 9.3% of that of FgaPT2 were
detected for I80F, E89A, K174E, and K174Qwith L-tryptophan,
respectively. The results for I80F, E89A, and K174E are similar
to those obtained in the previous study (21). Differing from that
observed byMetzger et al. (21), K174Q showed a slightly higher
activity than FgaPT2. This result indicated that Gln could elim-
FIGURE 4. HPLC analysis of the reaction mixtures of 1a (A and C) and 3a (B and D) with FgaPT2 or FgaPT2_K174F as well as prenyl transfer reactions
catalyzed by both enzymes (E and F). The enzyme assays contained 3.6Mof the recombinant enzymes andwere incubated at 37 °C for 16 h. Detectionwas
carried out with a photodiode array detector and illustrated for absorption at 277 nm.mAU, milliabsorbance units.
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inate a proton, or that another amino acid acts as a base instead.
Using L-tyrosine as prenyl acceptor, relative activities of 0.62
0.05, 5.7  1.0, 3.2  0.26, and 9.8  0.89% of that of FgaPT2
were detected for I80F, E89A, K174E, and K174Q, respectively.
This indicated different behaviors of I80F and K174Q toward
L-tryptophan and L-tyrosine and suggested that Lys-174 was
important but not the base to abstract a proton.Meanwhile, the
significant activity decrease of E89A implied that it could be the
base and supported our molecular model for the FgaPT2 reac-
tion with L-tyrosine.
For further investigation, we chose three amino acids resi-
dues, Thr-102, Lys-174, andArg-244 in the structure of FgaPT2
as “hot spots” for site-directedmutagenesis using primers listed
in Table 1. We speculated that replacement of Lys-174 by an
aromatic amino acid residue would have more interaction with
the benzene ring of the substrate L-tyrosine and stabilize the
intermediates of the prenylation. Therefore, we prepared addi-
tional Lys-174 mutants FgaPT2_K174F, FgaPT2_K174Y, and
FgaPT2_K174W.
In another previous study, we showed that the cyclic dipep-
tide brevianamide F prenyltransferase FtmPT1 fromA. fumiga-
tus shared a similar structure and reaction chamber with
FgaPT2 (36). However, the amino acid residues involved in the
substrate binding differ slightly from each other. For example,
Gly-115 in FtmPT1 was proposed to be involved in the binding
of brevianamide F (36). The corresponding Thr-102 in FgaPT2
FIGURE 5. The stereo view of active sites and proposed reactionmodel of FgaPT2 with 1a and 3a. The active site of FgaPT2 is shown in a stick represen-
tation (gray). Three -strands and Tyr-189 were removed to give a detailed view into the active site. The substrates 1a and 3a (blue; aminomoiety or hydroxyl
group ismarked as a green sphere) are docked into the active site of FgaPT2_K174F using AUTODOCK4 and superimposed very well with the natural substrate
tryptophan (black). This is possible because the binding site is designed to be occupied by a larger tryptophan residue. The hydroxyl or amino group of 1a and
3a, respectively, occurs near a cavity occupied with water molecules (red spheres). The C3-atom of L-tyrosine (blue sphere) can easily attack the C1-atom of
DMSPP (pink dotted lines). Amino acids that were mutated in our experiments are colored inmagenta.
FIGURE 6. Relative activities of FgaPT2 and its mutants with L-tryptophan or L-tyrosine as aromatic substrate. The assays with L-tryptophan and
L-tyrosine contained 0.36 and 3.6 M recombinant proteins, respectively, and were incubated at 37 °C for 6 h. The absolute product yield of FgaPT2 with
L-tryptophan (42  2.0%) was defined as 100% relative activity. For L-tyrosine with FgaPT2, this value was 19  1.6%. Error bars represent S.D. from three
independent measurements.
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is likely not directly involved in the binding of L-tryptophan, but
located in the active site of the enzyme (21). Mutation of Gly-
115 in FtmPT1 to threonine resulted in a derivative, which cat-
alyzed a reverse C3- instead of a regular C2-prenylation of bre-
vianamide F (36). As shown in Fig. 5, Thr-102 in FgaPT2 is
suggested to be involved in the binding of L-tyrosine. Therefore,
we changed this residue to five different amino acids to get
FgaPT2_T102X (X  Val, Arg, Cys, Gly, or Ser). In addition,
molecular modeling indicated the binding of the amino group
of the L-tyrosine side chain to Arg-244. Thus, differentmutants
at this position, FgaPT2_R244X (X  Glu, Asn, Asp, or Gln),
were constructed as described under “Experimental Proce-
dures.” In total, we designed 13 additional mutants (Table 1) on
the basis of the proposed mechanism as well as physical and
chemical properties of the amino acids for investigation on
enzyme activities.
Identification of the FgaPT2 Mutant Carrying Tyrosine C3-
Prenyltransferase but Almost No Tryptophan Prenyltransferase
Activity—To evaluate the activity of the resulting mutants, the
constructs obtained from site-directed mutagenesis experi-
ments were introduced into E. coli BL21 (DE3)pLysS cells.
After induction of the gene expression as described previously
(19), the overproduced proteins were purified on nickel-nitri-
lotriacetic acid-agarose and used for enzyme assayswith L-tryp-
tophan or L-tyrosine under the same condition for FgaPT2
mentioned above (37 °C for 6 h). The obtained results for all of
the 17mutants with L-tryptophan and L-tyrosine are illustrated
in Fig. 6 and compared with those of FgaPT2.
As shown in Figs. 3 and 6, clearly different activity profiles
were observed for thesemutants toward L-tryptophan and L-ty-
rosine. Similar or slightly higher, but inmost cases, lower activ-
ity than that of non-mutated FgaPT2 was detected in the incu-
bation mixtures of L-tryptophan with 0.36 M recombinant
mutants. Using L-tyrosine as substrate, most mutants showed
much lower activities than FgaPT2. No significant changes on
the activities were detected for T102C with L-tryptophan and
L-tyrosine. Substantial increase of the enzyme activity toward
L-tyrosine was detected for K174F. Approximate 3-fold activity
of that of FgaPT2was calculated for this mutant (Fig. 3). On the
other hand, no conversion was detected in the incubation mix-
ture of L-tryptophan with 0.36MK174F, even after an incuba-
tion for 16 h (Fig. 3E). Increasing the protein concentration to
3.6 M and incubation time to 16 h, a minor product peak with
a yield of 0.24 0.073%was detected for K174F (Fig. 3G).With
this protein concentration, a product yield of 50  3.5% was
calculated for K174F with 1a as substrate (Fig. 3H). Isolation
and structure elucidation confirmed the same enzyme product
as that identified from the incubation mixture of FgaPT2 with
1a. From these results, it can be concluded that K174F func-
tions as a tyrosine C3-prenyltransferase and not as tryptophan
prenyltransferase anymore. K174F in a concentration of 3.6M
was then incubated with eight tyrosine derivatives 2a–9a at
37 °C for 16 h. The product yield of 3a with K174F was slightly
increased to 76  4.4% (Fig. 4). No product formation was
detected in the incubation mixtures of other substrates (data
not shown).
Determination of Kinetic Parameters for FgaPT2 and Its
Mutant by Using L-Tyrosine as Substrate—To compare the cat-
alytic efficiencies of FgaPT2 and FgaPT2_K174F toward 1a,
kinetic parameters were determined by Eadie-Hofstee, Hanes-
Woolf, and Lineweaver-Burk plots as described under
“Experimental Procedures.” Km value of 0.58  0.0082 mM
was found for K174F, significantly lower than that of FgaPT2
at 0.82  0.070 mM. The turnover number of K174F toward
1a at 0.010  0.000049 s1 was 3.4-fold of that of FgaPT2 at
0.0029  0.000034 s1. As consequence, the catalytic effi-
ciency (kcat/Km) of K174F with 1a as substrate was improved
to 4.9-fold, in comparison with the non-mutated FgaPT2.
DISCUSSION
Prenylated aromatic compounds represent a large group of
secondary metabolites and are widely distributed in bacteria,
fungi, and plants (1, 3, 5, 37). In comparison with their non-
prenylated precursors, these compounds show distinct and in
general more potent biological and pharmacological activities
(2, 3, 38, 39). Prenylated tyrosine and derivatives build a small
groupwithin the prenylated aromatic natural products (40, 41).
3-Dimethylallyl-L-tyrosine was isolated from Streptomyces sp.
IFM10937 in 2008 during a screening program forTNF-related
apoptosis-inducing ligand (TRAIL) resistance-overcoming
activity, together withN-acetyl-3-prenyl-L-tyrosine (34). How-
ever, neither the biosynthetic pathway of this type of natural
products nor an enzyme for L-tyrosineC3-prenylation has been
reported until now.
Prenyltransferases represent key enzymes in the biosynthesis
of prenylated natural products (1, 3, 4, 8, 42). Because of
genome sequencing and mining of biosynthetic pathways, sig-
nificant progress has been achieved on the genetics, enzymol-
ogy, and structure of prenyltransferases using various aromatic
substrates such as indoles including tryptophan, flavonoids,
coumarins, xanthones, and naphthalenes (1, 3, 4, 8, 43). A num-
ber of studies have demonstrated the high flexibility of prenyl-
transferases, especially the members of the DMATS superfam-
ily, toward their aromatic substrates (8). However, a switching
of substrate preference by structure-based rational engineering
has not been reported prior to this study.
Based on the fact that the L-tyrosine O-prenyltransferases
SirD and TyrPT catalyzed C7-prenylation of L-tryptophan and
the tryptophan C7-prenyltransferase 7-DMATS catalyzed the
O-prenylation of L-tyrosine (14, 28, 30), we detected in this
study the prenylation of L-tyrosine by the tryptophan C4-pre-
nyltransferase FgaPT2. Identification of enzyme product
revealed aC3-prenylation of L-tyrosine by FgaPT2, demonstrat-
ing the first enzymatic Friedel-Crafts alkylation of L-tyrosine as
free amino acid. Subsequent molecular modeling-guided site-
directedmutagenesis led to create an enzyme derivative K174F,
which showed practically no activity toward L-tryptophan,
whereas the acceptance of L-tyrosine by this enzyme was
improved significantly. With 3.6 M enzyme, a product yield of
50 3.5% was detected for K174F after incubation at 37 °C for
16 h. Therefore, FgaPT2 and especially its mutant K174F rep-
resent the first series of L-tyrosine C-prenylating enzymes.
Meanwhile, this study demonstrated the possibility to change
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the substrate preference of a prenyltransferase by site-directed
mutagenesis.
C-Prenylated tyrosyl residuewas found in cyclic peptides, e.g.
cyanobactins, from cyanobacteria (40, 44). A prenyltransferase
LynF in Lyngbya aestuarii from the TruF enzyme family was
proven to catalyze reverseO-prenylations of tyrosyl residues in
such ribosomal cyclic peptides.C-Prenylated tyrosine-contain-
ing derivatives are then formed from the O-prenylated tyrosyl
residue by Claisen rearrangement afterward (44, 45). To
exclude the possibility that the C3-prenylated products 1b and
3b are rearrangement rather than enzyme products during the
incubation procedure, we carried out incubations with 1a and
3a for 10, 15, 30, 60, 120, and 960 min. Similar profiles of the
HPLC chromatograms were observed for different incubation
times (data not shown). In the incubation mixtures of 1a, only
the product peak1bwas detected. In the incubationmixtures of
3a, the ratio of the peak area of 3b to that of 3c remained almost
constant after different incubation times (approximately 22 
0.65:1). It seems that 3b and 3c are independently formed dur-
ing the incubation. To provide more details on stability of 3b
and 3c, 3a was incubated with FgaPT2 at 37 °C for 2 h. The
reaction mixture was then heated to 80 °C and maintained for
3 h. No change was observed for the ratio of 3b and 3c in the
HPLC chromatogram of the treated sample, excluding the
heat-catalyzed rearrangement between 3b and 3c.
Taking the results obtained from molecular modeling and
mutagenesis experiments into consideration (Figs. 5 and 6), a
mechanism was proposed for FgaPT2 reaction with 1a.
According to this hypothesis, the residue Thr-102 in FgaPT2
interacts with the 4-hydroxyl group of 1a in the reaction cavity
and contributes to the stabilization of the intermediate. A num-
ber of basic amino acids and tyrosine residues mentioned
before are involved in the binding of DMAPP and responsible
for the formation of the dimethylallyl carbon cation (21, 46). A
detailed course of the reaction remained to be elucidated and
might start by a nucleophilic attack of electron-rich C-3 of the
benzene ring onto C-1of the dimethylallyl carbon cation,
resulting in the formation of an intermediate with a non-aro-
matic system. A plausible deprotonation to regain aromaticity
might involve Glu-89 of FgaPT2, resulting in the formation of
C3-prenylated product 1b (Fig. 7). In comparison with that of
FgaPT2, FgaPT2_E89A showed only a relative activity of 5.7
1.0% toward L-tyrosine, providing strong support for this
hypothesis. It is also considerable that a reverse prenylation at
C-1 is followed by a Cope rearrangement as proposed for
FgaPT2 with L-tryptophan (35).
Using themolecularmodelmentioned above, the activities of
other mutants obtained in this study can also be interpreted.
For the mutation at Thr-102, substitution of Thr with similar
amino acids, such as Cys and Ser, (partly) retained the catalytic
ability toward L-tryptophan, whereas T102C demonstrated
similar catalytic ability toward 1a as FgaPT2, 1.9-fold of that of
T102V, and 7.1-fold of that of T102S. This indicates that both
the hydrogen donor and themethyl group are important for the
activity of FgaPT2 toward 1a. Although the hydrogen bond is
not crucial for the reaction (T102V), steric collisions (T102R)
abolish the reaction, whereas smaller side chains avoid the cor-
rect positioning of the aromatic ring systems (T102G). Interest-
ingly, mutant T102C slightly increases the catalytic turnover as
the nucleophilic sulfur atom is more suitable to stabilize the
partial positive charge of the cationic intermediate.
By substitution of Lys-174withGlu, Tyr, orTrp, the activities
toward both L-tryptophan and 1a were reduced or abolished,
whereas K174F demonstrated a specific and 4.9-fold catalytic
efficiency toward 1a, but almost complete loss of activity
toward L-tryptophan. The rigidity and increased size of the phe-
nyl side chain of K174F seem to support the stabilization of a
smaller substrate (tyrosine) in a cavity that was designed to
incorporate a larger educt (tryptophan). Besides, the introduc-
tion of themutation K174F is likely to induceminor conforma-
tional rearrangements to its neighboring residues of the indole
binding site by steric restrains. The higher activity of K174F for
1a could be interpreted bymuch better interaction of the mod-
ified cavity to the phenyl moiety with the benzene ring of L-ty-
rosine compared with the interaction with the indole ring of
L-tryptophan.
All fourmutated derivatives at Arg-244 showed poor conver-
sion of L-tryptophan. Although FgaPT2 does accept the
removal of the positive charge by the Arg-244 head group
(R224Q and R244N), the introduction of a negative charge by
R244E would abolish the prenylation of tryptophan due to
charge-charge repulsion. The enzyme activities of these four
FIGURE 7. Proposed mechanism for the conversion of 1a by FgaPT2 to the C3-prenylated product 1b. Interactions between the substrates and FgaPT2
were shown with dotted lines. The curved arrows show the direction of electron flow.
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Arg-244 mutants toward L-tyrosine were abolished completely
(Fig. 6), demonstrating its essential role in the interaction of
FgaPT2 with the side chain of L-tyrosine. The absolute impor-
tance of this amino acid residue was also demonstrated by the
double mutant K174F_R244E.
In this study, we reported the C3-prenylation of L-tyrosine
and 4-amino-L-phenylalanine by the tryptophan C4-prenyl-
transferase FgaPT2 from the fungus A. fumigatus and demon-
strated, to the best of our knowledge, the first enzymatic Frie-
del-Crafts alkylation of tyrosine and derivative as free amino
acids. Our results provided additional evidence for the relation-
ships of substrate and catalytic promiscuity between trypto-
phan and tyrosine prenyltransferases. Furthermore, a binding
site different from that of L-tryptophan was proposed for L-ty-
rosine and used as the basis for rational design of FgaPT2
mutants. K174F exhibited much higher catalytic efficiency
toward L-tyrosine than FgaPT2, whereas its activity toward
L-tryptophan was almost abolished. C3-Prenylated L-tyrosine
and 4-amino-L-phenylalanine remained unique or predomi-
nant product of the mutant. The ratio of the product yields of
L-tyrosine to L-tryptophan was increased from 1:31 with
FgaPT2 to 208:1 with K174F. This means that K174F does not
function as tryptophan prenyltransferase anymore. Moreover,
it acts as L-tyrosineC3-prenyltransferase and could serve as new
biocatalyst for C3-prenylation of L-tyrosine. Therefore, the
result provides an exciting example for creating biocatalysts by
mutation of known enzymes. It is also considerable that
enzymes for specific prenylation of flavonoids or hydroxynaph-
thalenes could be created by mutation of some members of the
DMATS superfamily because such compounds have already
been accepted by some of these enzymes as prenylation sub-
strates (20, 47). Meanwhile, this study presents an excellent
example of successful interdisciplinary cooperation and of the
importance of structure biology in the discovery and develop-
ment of novel biocatalysts.
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Tryptophan prenyltransferases FgaPT2, 5-DMATS, 6-DMATSSv and 7-DMATS catalyse 
regiospecific C-prenylations on the indole ring, while tyrosine prenyltransferases SirD and 
TyrPT catalyse the O-prenylation of the phenolic hydroxyl group. In this study, we report the 
Friedel-Crafts alkylation of L-o-tyrosine by these enzymes. Surprisingly, no conversion was 
detected with SirD and three tryptophan prenyltransferases showed significantly higher activity 
than another tyrosine prenyltransferase TyrPT. C5-prenylated L-o-tyrosine was identified as 
unique product of these enzymes. Using L-m-tyrosine as prenylation substrate, product 
formation was only observed with the tryptophan prenyltransferases FgaPT2 and 7-DMATS. 
C4- and C6-prenylated derivatives were identified in the reaction mixture of FgaPT2. These 
results provided additional evidence for the similarities and differences of these two subgroups 
within the DMATS superfamily in their catalytic behaviours. 
 
Introduction 
Prenylated secondary metabolites are widely distributed in 
nature. The biological and pharmacological activities of 
prenylated products are usually distinct from their non-
prenylated precursors and therefore contribute largely to drug 
discovery and development programmes.1-3 Prenyltransferases 
are involved in the biosynthesis of these natural products and 
catalyse the regiospecific, in most cases Friedel-Crafts 
alkylations by transferring prenyl moieties from different 
prenyl donors to various acceptors. The prenyl moieties with 
different carbon chain lengths (C5, C10, C15 or C20 units) can 
be attached in reverse or regular pattern and further modified by 
cyclization, oxidation and more. Therefore, prenyltransferases 
play an important role in the formation of the structural 
diversity of such products.4-6 These features have drawn 
considerable attention from scientists in different disciplines to 
prenyltransferases and prenylated derivatives. Based on their 
primary sequences, biochemical properties and structures, 
prenyltransferases can be divided into different subgroups 
including protein prenyltransferases, prenyl diphosphate 
synthases and aromatic prenyltransferases.4,7 In the last years, 
significant progress has been achieved for aromatic 
prenyltransferases, especially for those from the dimethylallyl 
tryptophan synthase (DMATS) superfamily.6,8,9 So far, more 
than 40 such prenyltransferases have been identified and 
characterised biochemically from microorganisms, especially 
from fungi and bateria.6,8,9 The majority of the DMATS 
superfamily takes indole derivatives including tryptophan and 
tryptophan-containing cyclic dipeptides as substrates. In the 
presence of dimethylallyl diphosphate (DMAPP), for example, 
FgaPT2,10 5-DMATS,11 6-DMATSSv
8 and 7-DMATS12 from 
this family catalyse regiospecific prenylations of L-tryptophan 
(1a) at C-4, C-5, C-6 and C-7 of the indole ring, respectively 
(Fig. 1). FgaPT2 and 7-DMATS from Aspergillus fumigatus are 
involved in the biosynthesis of fumigaclavine C13 and 
astechrome14, respectively. 6-DMATSSv is likely involved in 
the biosynthesis of 6-dimethylallylindole-carbardehyde in 
Streptomyces violaceusniger.8 A few members of the DMATS 
superfamily are responsible for the prenylation of non-indole 
substances. For example, SirD from Leptosphaeria maculans 
catalyses an O-prenylation of tyrosine (2a) (Fig. 1),15 the first 
specific step in the biosynthesis of sirodesmin PL.16 Last year, a 
new tyrosine O-prenyltransferase TyrPT (Fig. 1) was identified 
in Aspergillus. niger, which was demonstrated to have similar 
functions as SirD.17 Further study showed that SirD and TyrPT 
also accepted L-tryptophan (1a) as substrate in vitro and 
catalyse the same C7-prenylation as 7-DMATS (Fig. 1).15,17 
Correspondingly, 7-DMATS catalyse the same O-prenylation 
of tyrosine as SirD and TyrPT (Fig. 1). Very recently, we 
demonstrated the C3-prenylation of L-tyrosine (2a) by the 
tryptophan C4-prenyltransferase FgaPT2 (Fig. 1).18 These 
results demonstrated the close relationship between tryptophan 
C-prenyltransferases and tyrosine O-prenyltransferases. The 
different regioselectivities of the mentioned enzymes with 2a 
encouraged us to test the acceptance of the 2a isomers, L-o-
tyrosine (3a) and L-m-tyrosine (4a), by tryptophan and tyrosine 
prenyltransferases. 3a and 4a are import amino acid analogues 
found in metabolic pathways of human being and have shown 
potentials for treatments of different diseases.19-21 Prenylation 
of these two compounds have not been reported yet and their 
prenylated derivatives could be interesting candidates for 
further biological and pharmacological investigations. 
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Fig. 1. Selected examples of prenyl transfer reactions catalysed by tryptophan and tyrosine prenyltransferases. 
 
 
Results and discussion 
Comparison of the enzyme activities of tryptophan and tyrosine 
prenyltransferases towards tryptophan (1a) and tyrosine (2a) 
For better comparison of their catalytic activities, we carried out 
incubations of 1a and 2a with FgaPT2, 5-DMATS, 6-DMATSSv, 7-
DMATS, SirD and TyrPT under the same conditions, i.e. 2 µg 
enzyme for 1a and 20 µg for 2a, 1 mM 1a or 2a, 5 mM CaCl2 and 1 
mM DMAPP in 100 µL reaction mixtures. With the exception for 2a 
with 5-DMATS and 6-DMATSSv, HPLC analysis of the reaction 
mixtures (Figs. 2A - 2L) revealed the formation of one product each, 
confirming the results published previously.17,18,22 Product yields of 
these reactions were summarized in Table 1. It is obvious that 
tryptophan prenyltransferases FgaPT2, 5-DMATS, 6-DMATSSv and 
7-DMATS accepted 1a much better than 2a. Over 50 % conversion 
yields were observed with 1a as substrate by tryptophan 
prenyltransferases after incubation at 37 °C for 1.5 h (Table 1; Figs. 
2A - 2D). With 2a as substrate, product formation was detected only 
in the reaction mixtures of FgaPT2 and 7-DMATS for tryptophan 
prenyltransferases, with product yields of 6.2 ± 1.0 and 13.8 ± 1.3 %, 
respectively (Table 1). As expected, 2a was much better accepted by 
tyrosine than by tryptophan prenyltransferases. Almost total 
conversion of 2a was observed for TyrPT and SirD (Table 1; Figs. 
2K and 2L). Product yields of 1a with TyrPT and SirD were found 
to be 5.2 ± 0.40 and 5.9 ± 1.0 % (Table 1, Fig. 2), respectively. 
 
Acceptance of L-o-tyrosine (3a) by all the tested tryptophan 
prenyltransferases, but not by the tyrosine 
prenyltransferase SirD  
 
In the presence of 1 mM DMAPP, L-o-tyrosine (3a) was 
incubated with the six prenyltransferases (20 µg in 100 µL 
assay) mentioned in Fig. 2 at 37 ℃ for 1.5 h. Subsequent HPLC 
analysis revealed product formation in five reaction mixtures 
(Figs. 2M – 2Q). Surprisingly, 3a was accepted by all the tested 
tryptophan prenyltransferases, but not by the tyrosine 
prenyltransferase SirD (Fig. 2R), although TyrPT and SirD 
shared nearly the same behaviour towards diverse substrates 
tested before.17 Furthermore, the tryptophan prenyltransferases 
FgaPT2, 6-DMATSSv and 7-DMATS with product yields of 
73.6 ± 3.6, 29.9 ± 2.5 and 40.2 ± 3.8 %, respectively, showed 
significantly higher activities than TyrPT with a product yield 
of 10.8 ± 0.7 %, which is comparable to that of 5-DMATS. The 
product peaks detected in these assays display the same 
retention time, indicating the formation of an identical enzyme 
product by different prenyltransferases. 
 
C5-prenylated o-tyrosine (3b) as the unique product of 
tyrosine and tryptophan prenyltransferases 
 
To elucidate their structures, the enzyme products of 3a with 
FgaPT2, 5-DMATS, 6-DMATSSv, 7-DMATS and TyrPT were 
isolated on HPLC from 5 - 10 ml of incubation mixtures and 
subjected to NMR (Table 2, Fig. S1 in ESI) and HR-MS 
analyses (Experimental Section). HR-MS data confirmed the 
monoprenylation of the isolated products by detection of 
molecular masses, which are 68 Da larger than that of 3a. 1H-
NMR data proved that FgaPT2, 5-DMATS, 6-DMATSSv,  
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Fig. 2. HPLC analysis of the reaction mixtures of 1a - 4a with tryptophan and tyrosine prenyltransferases and the enzyme reactions of 3a and 
4a. The assays contained 1 mM aromatic substrate, 5 mM CaCl2, 1 mM DMAPP, and 2 (for 1a) or 20 (for 2a – 4a) µg purified recombinant 
protein and were incubated at 37 ℃ for 1.5 h. Results were illustrated for absorption at 277 nm.  
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Table 1. Prenylation positions and product yields [%] of enzyme reactions. 
 1a  2a  3a  4a 
 
Prenylated 
positiona 
Product 
yield [%] 
 Prenylated 
positiona 
Product 
yield [%] 
 Prenylated 
positiona 
Product 
yield [%] 
 Prenylated 
positiona 
Product 
yield [%] 
FgaPT2 C-4 51.2 ± 4.6  C-3 6.2 ± 1.0  C-5 73.6 ± 3.6  C-4;C-6 33.4 ± 1.4 
5-DMATS C-5 62.1 ± 2.8  - ≤0.5  C-5 10.9 ± 2.5  - ≤0.5 
6-DMATSSv C-6 63.6 ± 2.9  - ≤0.5  C-5 29.9 ± 2.5  - ≤0.5 
7-DMATS C-7 52.1 ± 1.9  O-4 13.8 ± 1.3  C-5 40.2 ± 3.8  - 4.8 ± 1.6 
TyrPT C-7 5.2 ± 0.40  O-4 100  C-5 10.8 ± 0.7  - ≤0.5 
SirD C-7 5.9 ± 1.0  O-4 100  C-5 ≤0.5  - ≤0.5 
a;for structures see Fig. 1; “-” not determined. 
 
7-DMATS and TyrPT converted indeed 3a to the same product 
3b. Inspection of the 1H-NMR spectra (Fig. S1 in ESI) of 3b 
revealed the presence of signals for a regular prenyl moiety at 
δH 3.21 (d, H-1’), 5.25 (tsept, H-2’), 1.70 (d, H-4´) and 1.69 
ppm (br s, H-5´). Furthermore, signals for three aromatic 
protons indicated that the prenylation took place on the 
aromatic ring, rather than at the hydroxyl group. The signals of 
the aromatic protons at δH 6.76 (d, 8.0 Hz), 6.91 (dd, 8.0, 2.0 
Hz) and 6.99 (d, 2.0 Hz) of 3b proved the prenylation at C-4 or 
C-5 of 3a (Table 2). For the C5-prenylated 3a, it is expected 
that the signal of H-3 should be found in the high-field with a 
coupling constant of approximate 8.0 Hz and the signal of H-6 
in low-field with a coupling constant of 2.0 Hz. The obtained 
data corresponded very well to this prediction and therefore 
confirmed 3b to be the C5-prenylated product (Fig. 2Y). These 
results sound somewhat surprising, because O-prenylated 
derivative was identified in the reaction mixtures of L-tyrosine 
(2a) with 7-DMATS and TyrPT.17,22 However, C3-prenylated 
derivative was the enzyme product of FgaPT2 with 2a (Fig. 
1).18 
 
Table 2. 1H-NMR and 13C-NMR data of the enzyme products 
(500 MHz). 
 
   
Pos δH, multi, J δH, multi, J δC δH, multi, J 
1 - - 134.9 - 
2 - 6.69, d, 2.5 116.4 6.69, s 
3 6.76, d, 8.0 - 155.4 - 
4 6.91, dd, 8.0, 2.0 6.64, dd, 8.0, 2.5 114.1 - 
5 - 7.00, d, 8.0 130.6 7.00, d, 7.5 
6 6.99, d, 2.0 - 131.2 6.67, d, 7.5 
7 
approx. 3.30a 
2.95, dd, 14.3, 8.5 
3.42, dd, 15.0, 4.5 
2.80, dd, 15.0, 10.5 
34.4 
3.19, dd, 14.0, 3.0 
2.86, dd, 14.0, 9.3 
8 3.85, dd, 8.5, 4.0 3.72, dd, 10.5, 4.5 55.5 3.69, m 
9 - - 172.6 - 
1´ 3.21, d, 7.0 3.33, d, 7.0 30.0 3.24, d, 7.5 
2´ 5.25, tsept, 7.5, 1.5 5.19, br t, 7.0 123.4 5.28, br t, 7.5 
3´ - - 131.3 - 
4´ 1.70, d, 1.0 1.73, s 16.6 1.70, d, 1.0 
5´ 1.69, br s 1.72, s 24.4 1.69, s 
 MeOH-d4 MeOH-d4 MeOH-d4 MeOH-d4 
 
Acceptance of L-m-tyrosine (4a) by two tryptophan 
prenyltransferases and identification of C4- and C6-
prenylated derivatives as products of the FgaPT2 reaction 
 
After identification of C5-prenylated 3a from reaction mixtures 
of tyrosine and tryptophan prenyltransferases, we tested the 
behaviour of these enzymes towards L-m-tyrosine (4a) under 
the same conditions as for 3a. As shown in Figs. 2S - 2X, 
product formation was only observed in the reaction mixtures 
of FgaPT2 and 7-DMATS, with product yields of 33.4 ± 1.4 
and 4.8 ± 1.6% (Table 1), respectively. Unexpectedly, 4a was 
not accepted by the two tyrosine prenyltransferases SirD and 
TyrPT (Figs. 2W and 2X). Another surprise is the much better 
acceptance of 4a by FgaPT2 than by 7-DMATS (Figs. 2S and 
2V), which differs clearly from the preference of 2a towards 
these two enzymes (Figs. 2G and 2J). It seems that the positions 
of the hydroxyl groups at the benzene ring of phenylalanine 
have critical influence on their acceptance by tryptophan and 
tyrosine prenyltransferases. 
Inspection of the HPLC chromatograms in Figs. 2S and 2V 
revealed the presence of two product peaks 4b and 4c with a 
ratio of 1:2 in the reaction mixture of FgaPT2 at 10.3 and 11.4 
min and only one in that of 7-DMATS at 11.4 min. The UV 
maxima of 4b at 220 and 283 nm differed slightly from those of 
4c at 220 and 278 nm. For structure elucidation, 4b and 4c were 
isolated on HPLC from incubation mixture of 4a with FgaPT2 
and subjected to NMR (Table 2; Figs. S2 - S5 in ESI) and HR-
MS analyses (Experimental Section). HR-MS data confirmed 
the monoprenylation of the isolated products. Inspection of the 
1H-NMR spectra (Table 2) of 4b and 4c revealed the presence 
of signals for a regular prenyl moiety each at δH 3.33 or 3.24 (d, 
H-1’), 5.19 or 5.28 (br t H-2’), 1.73 or 1.70 (s H-4´) and 1.72 or 
1.69 ppm (s, H-5´). The signals of the aromatic protons at 6.69 
(d, 2.5 Hz, H-2), 6.64 (dd, 8.0, 2.5 Hz, H-4), 7.00 (d, 8.0 Hz, H-
5) of 4b and 6.69 (s, H-2), 7.00 (d,7.5 Hz, H-5), 6.67 (d, 7.5 Hz, 
H-6) of 4c indicated the prenylation at C-4 in one case and C-6 
in another case. To determine the structure of 4b and 4c, we 
took HSQC and HMBC spectra for 4b (Fig. 3, Figs. S3 and S4 
in ESI). The important correlation between H-1’ and C-1 prove 
unequivocally that 4b is the C6-prenylated derivative, i.e. 
prenylation at the para-position to the phenolic hydroxyl group 
(Fig. 2Z). Consequently, 4c is the C4-prenylated product (Fig. 
2Z). Due to the low quality, the structure of the enzyme product 
of 4a with 7-DMATS could not be elucidated in this study. 
However, from its same retention time and UV absorption 
maxima with those of 4c, it could be speculated that this 
substance has the same structure as 4c.  
 
 
Fig. 3. Important HMBC correlations of 4b. 
 
Our results mentioned above suggest that the acceptance of a 
substrate by tryptophan or tyrosine prenyltransferases would 
not strictly depend on the chemical category of the aromatic 
nucleus, but strongly rely on the position of the functional 
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groups on the aromatic nucleus, which perform the direct 
interaction with the enzyme active sites. Furthermore, these 
results reveal that tryptophan and tyrosine prenyltransferases 
possess very likely similar active sites and strengthen their 
close relationship in the evolution. 
 
Kinetic study of the enzymatic Friedel-Crafts reactions 
 
To get insights into the catalytic efficiency, kinetic parameters 
were determined for FgaPT2, 5-DMATS, 6-DMATSSv, 7-
DMATS and TyrPT towards 3a and FgaPT2 towards 4a (Table 
3; Figs. S6 – S11 in ESI). As expected for unnatural substrates, 
KM values between 0.17 ± 0.0076 and 0.58 ± 0.081mM were 
determined for 3a, much higher than for their natural 
substrates.8,10-12,17 The KM value of FgaPT2 towards 4a was 
found to be 0.90 ± 0.013 mM, higher than that with 3a (Table 
3). In agreement with the product yields given in Table 1, 
FgaPT2 showed the highest turnover number and catalytic 
efficiency toward 3a, followed by 7-DMATS and 6-DMATSSv. 
TyrPT and 5-DMATS demonstrated comparable kinetic 
parameters for their reactions with 3a (Table 3). 
 
Table 3. Kinetic parameters of tested enzymes for 3a and 4a. 
 KM (mM) kcat (s
-1) kcat / KM (s
-1M-1) 
L-o-tyrosine (3a) 
FgaPT2 0.47 ± 0.0024 0.29 ± 0.029 600 ± 58 
5-DMATS 0.49 ± 0.0031 0.013 ± 0.00011 27  ± 0.40 
6-DMATSSv 0.58 ± 0.081 0.034 ± 0.00038 59  ± 3.6 
7-DMATS 0.17 ± 0.0076 0.045 ± 0.036 270  ± 8.9 
TyrPT 0.58 ± 0.014 0.014 ± 0.00066 24  ± 1.7 
L-m-tyrosine (4a) 
FgaPT2  0.90 ± 0.013 
0.0065 ± 
0.00044 
6.8  ± 0.093 
 
Proposed reaction mechanisms of Friedel-Crafts alkylation 
of o- and m-tyrosine 
 
Previous studies on structures of several prenyltransferases and 
mutagenesis experiments have shown that the prenyl transfer 
reactions catalysed by the prenyltransferases of the DMATS 
superfamily are initiated by the formation of a dimethylallyl 
carbocation.23-26 Nucleophilic attack of this ion by electron-rich 
aromatic ring leads to the formation of non-aromatic 
intermediates, which will be rearomatized by elimination of a 
proton and result in the formation of the prenylated derivatives. 
Similar mechanism could also be proposed for reactions 
observed in this study. As shown in Fig. 4, attack of the 
dimethylallyl carbocation by C-5 of 3a would result in the 
formation of the intermediate I, which would undergo proton 
elimination to form the final product 3b. For the FgaPT2 
reaction with 4a, attack from two positions, C-6 and C-4, would 
be possible. It can be expected that two different intermediate II 
and III will be formed via route A and B, respectively, and then 
converted to 4b and 4c after proton elimination (Fig. 4). 
 
Experimental Section 
 
Chemicals 
 
DMAPP was synthesized according to the method described for 
geranyl diphosphate (GPP) reported previously.27 L-o-tyrosine 
and L-m-tyrosine used for the enzyme assays were purchased 
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA) and 
Alfa Aesar (Karlsruhe, Germany), respectively. 
 
 
Fig. 4. Proposed reaction mechanisms for the formation of 3b 
from 3a as well as 4b and 4c from 4a. 
 
Overexpression and purification of recombinant proteins 
Protein overproduction and purification were carried out for 
FgaPT2,10 5-DMATS,11 6-DMATSSv,
8 7-DMATS,12 SirD15 and 
TyrPT17 as described previously. 
 
Assays for determination of enzyme activities 
Reaction mixtures (100 µl) for determination of the enzyme 
activities contained aromatic substrate (1 mM), CaCl2 (5 mM), 
DMAPP (1 mM), glycerol (1.0 – 6.0 % v/v), dimethyl sulfoxide 
(DMSO, 0 – 5.0 % v/v), 50 mM Tris-HCl (pH 7.5) and purified 
recombinant protein (2 or 20 µg). The reaction mixtures were 
incubated at 37 ℃ for 1.5 h and then terminated by addition of 
100 µl MeOH. Protein was removed by centrifugation at 17,000 
rpm for 20 min. 
 
Enzyme assays for product isolation and structure elucidation 
Assays for isolation of the enzyme products were carried out in 
large scales (5 - 10 ml) containing aromatic substrate (1 mM), 
DMAPP (1.5 mM), CaCl2 (5 mM), glycerol (1.0 - 9.9 % v/v), 
DMSO (0 – 5.0 % v/v), 50 mM Tris-HCl (pH 7.5) and 
recombinant protein (0.2 - 0.6 mg per ml assay). After 
incubation for 16 h at 37 °C, the reaction mixtures were 
terminated by addition of 5 - 10 ml methanol. After removal of 
the precipitated protein by centrifugation at 6,000 rpm for 30 
min, the reaction mixtures were concentrated on a rotating 
vacuum evaporator at 35 ℃ to a final volume of 1 ml before 
injection into HPLC. 
 
Enzyme assays for determination of the kinetic parameters 
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Assays for determination of the kinetic parameters contained 
CaCl2 (5 mM), glycerol (1.0 - 9.9 % v/v), DMSO (0 – 5.0 % 
v/v), 50 mM Tris HCl (pH 7.5), DMAPP (1 mM) and aromatic 
substrate at final concentrations of up to 2.0 mM. The reactions 
were then terminated with 100 µl MeOH. Protein was removed 
by centrifugation at 17,000 rpm for 20 min. 
 
HPLC analysis and isolation of enzyme products for structure 
elucidation 
The enzyme products were routinely analysed by HPLC on an 
Agilent series 1200 by using a Multospher 120 RP-18 column 
(250 × 4 mm, 5 µm C+S Chromatographie Service, 
Langerwehe, Germany) at a flow rate of 1 ml min-1. Water 
(solvent A) and methanol (solvent B) were used as solvents for 
analysis and isolation of the enzyme products. A linear gradient 
of 30 – 100 % (v/v) solvent B in 20 min was used for analysis 
of the enzymatic products. The column was then washed with 
100 % solvent B for 5 min and equilibrated with 30 % solvent 
B for another 5 min. Detection was carried out on a photo diode 
array detector. 
For isolation of the enzyme products, the same HPLC 
equipment with a Multospher 120 RP-18 column (250×10 mm, 
5 µm, C+S Chromatographie Service, Langerwehe, Germany) 
was used. A linear gradient was run with 50 - 100 % (v/v) of 
methanol (solvent B) in water (solvent A) in 50 - 80 min and a 
flow rate at 2.5 ml min-1. The column was then washed with 
100 % (v/v) solvent B for 10 min and equilibrated with 50 % 
(v/v) solvent B for 10 min. 
 
HR-ESI-MS and NMR analysis of the enzyme products 
 
The obtained products were analysed by NMR (in CD3OD) and 
MS analyses. NMR spectra were recorded at room temperature 
on a Bruker Avance 600 MHz or a JEOL ECA-500 
spectrometer. The heteronuclear single quantum correlation 
(HSQC) and heteronuclear multiple bond correlation (HMBC) 
spectra were recorded with standard methods28 and processed 
with MestReNova.5.2.2. The positive HR-ESI-MS was carried 
out on an AutoSpec instrument (Micromass Co. UK Ltd) with 
the following results: 
3b: m/z 249.1374 [M]+ (C14H19NO3, cal.: 249.1365); 4b: m/z 
249.1373 [M]+ (C14H19NO3, cal.: 249.1365); 4c: m/z 249.1348 
[M]+ (C14H19NO3, cal.: 249.1365). 
 
Conclusions 
 
Prenyltransferases of the DMATS superfamily are known for 
their broad aromatic substrates.6 As shown in Fig. 2, tyrosine 
prenyltransferases TyrPT and SirD also accepted tryptophan as 
substrate, but with lower activity than with tyrosine. 
Correspondingly, tryptophan prenyltransferases FgaPT2 and 7-
DMATS also prenylated tyrosine, but with lower activity than 
for tryptophan. In this study, we demonstrated surprisingly that 
L-o-tyrosine (3a) was accepted by all of the tested tryptophan 
prenyltransferases for prenylations at C-4, C-5, C-6 and C-7 of 
the indole ring, but not by the tyrosine prenyltransferase SirD. 
The unique product, C5-prenylated o-tyrosine was identified in 
all the reaction mixtures of FgaPT2, 5-DMATS, 6-DMATSSv, 
7-DMATS and TyrPT, although these enzymes utilized 
different natural substrates and catalysed diverse regioselective 
reactions.  
L-m-tyrosine (4a) was only converted by two tryptophan 
prenyltransferases, but by none of the tyrosine 
prenyltransferases. Structure elucidation of the enzyme 
products of 4a with FgaPT2 revealed a low regioselectivity. 
C4- and C6-prenylated m-tyrosine with a ratio of approximate 
2:1 were identified as reaction products. 
Compared studies in the future on the structure level of these 
two groups of prenyltransferases could provide detailed insights 
into their difference and similarity of their substrate and 
catalytic promiscuities. Meanwhile, it could even provide 
suggestions for protein engineering to create new biocatalysts 
in order to meet a given target, such as broader substrate spectra 
and/or different regioselectivity.29,30 
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 Fig. S1. 1H-NMR spectrum of 3b in MeOH-d4. 
 
 
 
Fig. S2. 1H-NMR spectrum of 4b in MeOH-d4. 
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Fig. S3. HSQC spectrum of 4b in MeOH-d4. 
 
 
Fig. S4. HMBC spectrum of 4b in MeOH-d4. 
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 Fig. S5. 1H-NMR spectrum of 4c in MeOH-d4. 
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 Fig. S6. Determination of kinetic parameters of FgaPT2 for 3a. 
 
 
 
 
Fig. S7. Determination of kinetic parameters of 5-DMATS for 3a. 
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 Fig. S8. Determination of kinetic parameters of 6-DMATSSv for 3a. 
 
 
 
 
Fig. S9. Determination of kinetic parameters of 7-DMATS for 3a. 
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 Fig. S10. Determination of kinetic parameters of TyrPT for 3a. 
 
 
 
 
Fig. S11. Determination of kinetic parameters of FgaPT2 for 4a. 
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Creation of FgaPT2 mutants with enhanced catalytic ability and 
different preferences toward cyclic dipeptides by saturation 
mutagenesis 
Aili Fan[a] and Shu-Ming Li*[a] 
Abstract: FgaPT2 from Aspergillus fumigatus catalyzes a Friedel-
Crafts alkylation at C-4 of L-tryptophan and is involved in the 
biosynthesis of the ergot alkaloids fumigaclavines. Several 
tryptophan-containing cyclic dipeptides had also been prenylated by 
FgaPT2 at high protein concentrations. Here, we report the generation 
of FgaPT2 mutants by saturation mutagenesis at amino acid residue 
Arg244 to improve its catalytic efficiency toward cyclic dipeptides. 
Thirteen mutated enzymes demonstrated of up to 155-fold higher 
catalytic efficiency toward eight cyclic dipeptides than FgaPT2. More 
importantly, the mutated enzymes exhibited different preferences 
toward these substrates. This study provides not only new 
biocatalysts for production of C4-prenylated cyclic dipeptides, but also 
abundant data for further investigations on the catalytic mechanism of 
FgaPT2 reactions toward cyclic dipeptides. 
Introduction 
Prenylated natural products are widespread in nature and 
demonstrate a wide range of promising biological activities, which 
contribute largely to the drug discovery and development 
process.[1-8] Among them, prenylated tryptophan-containing cyclic 
dipeptides and derivatives thereof comprise a huge group of 
secondary metabolites with high structural diversity and various 
biological activities such as the well-known cytotoxic tryprostatins 
and derivatives fumitremorgins.[9] Additional examples are the 
reversely C2-prenylated cyclo-tryptophanyl-alaninyl derivatives 
echinulins and isoechinulins as well as the syn-cis C3-prenylated 
cyclo-tryptophanyl-histidinyl derivatives roquefortines.[10-14] So far, 
cyclic dipeptides with prenyl moieties at N-1, C-2, C-3, C-4, C-5, 
C-6 and C-7 of the indole ring were frequently observed in nature 
with anti-inflammatory, cytotoxic, anti-feeding, antifungal, 
antimicrobial and selective PTK inhibitory activities.[5;6;8;11;12;15-18] 
Consequently, synthesis of prenylated cyclic dipeptides has 
drawn lots of attention and different strategies have been 
developed, such as addition of prenyl moiety from prenyl bromide 
in the presence of strong base or coupling reactions catalyzed by 
metal salts.[19-21] These reactions are usually carried out under 
anhydrous or anaerobic conditions using environment hazardous 
chemicals and under special temperature control.[19-21] 
Nevertheless, only electron-rich positions, e.g. N-1, C-2 and C-3 
of the indole ring are preferred by classic chemical synthesis. 
Meanwhile, additional steps are usually necessary for protection 
and deprotection of the functional groups.[21;22] 
In nature, prenyl transfer reactions on the indole ring are 
catalyzed by prenyltransferases, especially by those from the 
dimethylallyltryptophan synthase (DMATS) superfamily. DMATS 
enzymes are soluble prenyltransferases, mainly catalyze Friedel-
Crafts alkylations by attachment of prenyl moieties to various 
aromatic acceptors and are involved in the biosynthesis of 
secondary metabolites. Until now, more than forty members of 
this group were characterized biochemically.[23-27] About 50 % of 
the DMATS enzymes use tryptophan and tryptophan-containing 
cyclic dipeptides as substrates. Twelve tryptophan 
prenyltransferases catalyze prenylations at N-1, C-4, C-5, C-6 
and C-7 of the indole ring.[23;28-31] For example, FgaPT2 from 
Aspergillus fumigatus is involved in the biosynthesis of 
fumigaclavines and catalyzes a regular C4-prenylation of L-
tryptophan.[32;33] To date, eleven tryptophan-containing cyclic 
dipeptide prenyltransferases including four C2-, three C3- and 
four C7-prenyltransferases have been identified and 
characterized.[31;34-39] The C7-prenyltransferase CTrpPT also 
catalyzes an N1-penylation of cyclic dipeptides. Cyclic dipeptide 
C4-, C5- and C6-prenyltransferases have not been characterized 
biochemically. In contrast to other prenylated cyclic dipeptides, 
C4-prenylated cyclic dipeptides and derivatives thereof are not 
commonly found in nature. However, such compounds might 
exhibit interesting and potent biological activities.  
Prenyltransferases of the DMATS superfamily usually 
demonstrated remarkable substrate promiscuity, especially 
toward their aromatic substrates. For example, with high protein 
amount, FgaPT2 was able to catalyze the C4-prenylation of five 
tryptophan-containing cyclic dipeptides[40] and C3-prenylation of 
tyrosine.[41] The catalytic ability of FgaPT2 toward tyrosine was 
enhanced by molecular modeling-guided site directed-
mutagenesis.[41] This result inspires us to improve the catalytic 
efficiency of FgaPT2 toward cyclic dipeptides by mutagenesis, so 
that biocatalysts for production of C4-prenylated diketopiperazine 
derivatives could be made available in this way. Fortunately, the 
crystal structures of FgaPT2 with and without its substrates were 
solved in 2009 and provided a basis for understanding the 
mechanism of the prenyl transfer reaction.[42] A three-step 
mechanism was proposed for the prenyl transfer reaction with 
FgaPT2 (Figure 1). Formation of a dimethylallyl cation by removal 
of the pyrophosphate group is considered as initiation.[43] 
Subsequent nucleophilic attack of this cation by the C-4 position 
of the indole nucleus will form the σ-complex. The resulting 
intermediate was then deprotonated to generate the final 
product.[42] 
  
[a] A. Fan, Prof. Dr. S.-M. Li 
Institut für Pharmazeutische Biologie und Biotechnologie 
Philipps-Universität Marburg 
Deutschhausstrasse 17A, 35037 Marburg, Germany 
Fax: ++496421 282-5365 
E-mail: shuming.li@staff.uni-marburg.de 
 Supporting information for this article is given via a link at the end of 
the document.  
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Figure 1. Proposed mechanism of FgaPT2 reaction toward L-tryptophan and important amino acids involved in the reaction.
It was later proposed that the substitution might occur directly at 
C-3 instead of C-4, followed by a rearrangement to generate the 
final product.[44] Based on the crystal structures of FgaPT2 and 
three cyclic dipeptide prenyltransferases FtmPT1, CdpNPT and 
AnaPT,[37;45;46] it was found that the amino acids of the DMAPP 
binding sites seem to be conserved, while the binding sites of the 
aromatic substrates differ from each other.  
As aforementioned, FgaPT2 also catalyzed C4-prenylation at the 
indole ring of tryptophan-containing cyclic dipeptides as for its 
natural substrate tryptophan, but with much lower efficiency. This 
indicated that the indolyl moiety of the cyclic dipeptides might be 
positioned similarly in the active site of FgaPT2 as the free amino 
acid tryptophan. The poor acceptance of cyclic dipeptides by 
FgaPT2 might result from the non-perfect fitting of the 
diketopiperazine ring and the second amino acid moiety in the 
active site. This could be overcome by changing amino acid 
residues involved in the binding of tryptophan side chain in the 
reaction cavity, so that the cyclic dipeptides can be better placed 
in the pocket of FgaPT2. In a previous study, fifteen FgaPT2 
mutants at E89, T102, K174 and R244 were demonstrated to 
have different activity profiles toward L-tryptophan and L-
tyrosine.[41] T102C and K174F showed significantly higher activity 
for tyrosine than the non-mutated FgaPT2. Their activities toward 
tryptophan was almost unchanged (T102C) or reduced to only 
0.4 % of that of FgaPT2.[41] Therefore, the available fifteen 
FgaPT2 mutants were assayed with cyclo-L-Trp-L-Tyr (1a), the 
best identified cyclic dipeptide substrate of FgaPT2 previously.[40] 
Results and Discussion 
Identification of R244 as a “hot spot” for increasing 
prenylation activity toward cyclo-L-Trp-L-Tyr (1a) 
 
In the presence of DMAPP (1 mM), cyclo-L-Trp-L-Tyr (1a) was 
incubated individually with 10 µg recombinant FgaPT2 and the 
fifteen mutants including E89A, T102V, T102C, T102S, T102R, 
K174E, K174Q, K174F, K174W, K174Y, R244E, R244N, R244Q, 
R244D and K174F_R244E in 100 µL enzyme assays at 37 ℃ for 
16 h. HPLC analysis of the incubation mixtures demonstrated that 
1a was accepted by the tested enzymes with clearly different 
activities (Figure 2). Under this condition, 1a was converted by 
FgaPT2 with a product yield of 10.0 %. Compared to the strongly 
reduced activity toward tyrosine and tryptophan, I80F 
demonstrated similar catalytic ability as FgaPT2 toward 1a, while 
E89A hardly accepted all these three substrates.[41] Mutation of 
T102 and K174 resulted in derivatives with strongly reduced 
activity with 1a, which differed significantly from those with 
tryptophan and tyrosine as substrates observed in a previous 
study.[41] In that study, T102C and K174F were found to accept 
tyrosine much better than FgaPT2, while T102C, T102S and 
K174Q showed comparable activities as FgaPT2 for 
tryptophan.[41] Both T102 and K174 seem to be of essential 
importance for an acceptance of 1a, so that alteration of these 
amino acids is not allowed. Interestingly, three of the four R244 
mutants, R244Q, R244N and R244D, accepted 1a much better 
than FgaPT2. Product yield of 44.1 %, 47.4 % and 22.4 %, were 
calculated for the reactions of 1a with R244Q, R244N and R244D, 
respectively. That is 2.2 to 4.7-fold of that of FgaPT2. In 
comparison, these three mutants showed almost no activity 
toward tyrosine and comparable or lower activity with tryptophan 
than FgaPT2.[41] The results of the acceptance of tryptophan, 
tyrosine and the cyclic dipeptide 1a by the fifteen mutants 
indicated that different amino acids are involved in the binding 
sites of these substrates and the roles of these amino acids can 
be changed in the presence of different substrates. R244 was  
Figure 2. Product yields of FgaPT2 and mutated proteins with 1a as substrate. 
The assays (100 µL) contained 1 mM 1a, 5 mM CaCl2, 1 mM DMAPP, and 10 
µg purified protein and were incubated at 37 ℃ for 16 h. 
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proposed to be involved in the binding of the tryptophan side 
chain.[42] From the results obtained in this study, R244 can be 
considered as a “hot spot” for enhancing the catalytic efficiency of 
FgaPT2 toward cyclic dipeptides. 
 
Enhanced activity and slightly different preferences of 
R244N and R244Q toward cyclic dipeptides 
 
To learn more about their behavior toward tryptophan-containing 
cyclic dipeptides, R244N and R244Q were incubated with cyclo-
L-Trp-L-Tyr (1a), cyclo-D-Trp-L-Tyr (2a), cyclo-L-Trp-L-Pro (3a), 
cyclo-L-Trp-D-Pro (4a), cyclo-D-Trp-L-Pro (5a), cyclo-D-Trp-D-Pro 
(6a), cyclo-L-Trp-L-Leu (7a), cyclo-L-Trp-Gly (8a), cyclo-L-Trp-L-
Trp (9a) and cyclo-L-Trp-L-Phe (10a). As shown in Figures 3A and 
3B, both mutants showed slightly different substrate preferences. 
R244N accepted 7a as the best substrate with a product yield of 
63.4 %, followed by 4a of 50.1%. Product yields in the range of 
34.0 – 48.3 % were observed for 1a, 3a, 8a and 9a (Figure 3A). 
In comparison, R244Q used 4a as the best substrate with a 
product yield of 69.7 %, followed by 1a of 45.5 %. The product 
yields of 40.0, 44.0, 36.6 and 27.3 % were calculated for 3a, 7a, 
8a and 9a, respectively. Both R244Q and R244N accepted 2a, 5a, 
6a and 10a with much lower activities. To elucidate the structures, 
enzyme products 1b, 3b, 4b, 5b, 7b – 9b were isolated from 
reaction mixtures of R244N and R244Q with 1a, 3a, 4a, 5a, 7a - 
9a, respectively and subjected to NMR and MS analyses. 
Interpretation and comparison of the obtained spectroscopic data 
with those published previously[40] confirmed the unique regularly 
C4-prenylated derivatives as enzyme products of 1a, 3a, 4a, 5a, 
7a - 9a (Figure 3C). This proved that R244N and R244Q catalyze 
the same regiospecific prenylation of cyclic dipeptides as the non-
mutated FgaPT2. 
Taken the results mentioned above together, R244N and R244Q 
showed not only higher activity toward cyclic dipeptides than non-
mutated FgaPT2, but also different preferences toward these 
compounds from FgaPT2 and from each other. On the other hand, 
all the three enzymes catalyze the same C4-prenylation at the 
indole ring. This means the mutants with higher catalytic efficiency 
can be used as effective catalysts for production of C4-prenylated 
cyclic dipeptides. 
Saturation mutagenesis resulting in mutants with enhanced 
catalytic ability toward eight tryptophan-containing cyclic 
dipeptides 
 
The much higher catalytic ability of R244Q and R244N toward 
cyclic dipeptides encouraged us to get additional R244 mutants 
for enhancing activity toward cyclic dipeptides by different 
mutants. For generation of additional mutants, the saturation 
mutagenesis experiments were then carried out on the key amino 
acid R244 by site-directed mutagenesis (Tables S1 and S2). With 
the exception of R244C, all the other 14 remained mutants were 
obtained (Table S1). The plasmids obtained from this and a 
previous study[41] were then transformed into E. coli SoluBL21. 
Single colonies containing the respective mutated plasmids were 
inoculated into 1 mL of LB media with 25 μg mL-1 kanamycin and 
0.5 mM IPTG and cultivated for 24 h. The crude protein fractions 
were used directly for screening of the mutants with high catalytic 
efficiency. For an initial selection, 7a or a mixture containing 1a, 
3a, 5a, 7a and 8a or 2a, 4a, 6a, 9a and 10a was incubated with 
crude enzyme extract of a given mutant (Experimental section). 
Due to their different retention times on HPLC, the reaction 
mixtures containing products of different cyclic dipeptides could 
be separated from each other. With the exception for those of 
R244P, R244F and R244W, product formation was observed in 
enzyme assays of the fifteen mutants (data not shown).  
FgaPT2 and the fifteen mutants were then overproduced and 
purified for further investigations. Each of the ten cyclic dipeptides 
1a - 10a was incubated individually with 4 µg FgaPT2 and the 
fifteen mutants in 50 µL assays for 1.5 h. Under this condition 1a 
- 10a were converted by FgaPT2 with yields between 0.28 and 
7.7 %. R244E and R244D displayed poor catalytic activity toward 
all the tested substrates, with product yields of lower than 5 and 
15 %, respectively (Data not shown). Their results are therefore 
not presented in Figure 4. 2a and 6a were poorly accepted by 
FgaPT2 and its mutants, with product yields of lower than 1.2 % 
and 5.3 %, respectively (Data not shown). Other thirteen mutants 
including R244G, R244A, R244S, R244T, R244V, R244L, R244I, 
R244M, R244Y, R244N, R244Q, R244H and R244K utilized the 
eight dipeptides 1a, 3a, 4a, 5a and 7a - 10a as good substrates 
and significant enhancement on the catalytic ability was observed 
(Figure 4).
 
Figure 3. Product yields of R244N and R244Q reactions toward 1a – 10a (A and B) and enzyme reactions catalyzed by FgaPT2 and mutants (C). The assays (100 
µL) contained 1 mM aromatic substrate, 5 mM CaCl2, 1 mM DMAPP, and 10 µg purified protein and were incubated at 37 ℃ for 16 h.  
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Figure 4. Product yields of FgaPT2 and mutated proteins reactions with 1a, 3a - 5a, 7a – 10a as substrates. The assays (50 µL) contained 1 mM aromatic substrate, 
5 mM CaCl2, 1 mM DMAPP and 4 µg purified recombinant protein and were incubated at 37 ℃ for 1.5 h. 
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From Figure 4, it is obvious that R244L accepted most of the 
tested cyclic dipeptides better than other mutants. Toward 1a, 
R244L demonstrated the highest product yield of 28.2 %, which 
is 28–fold of that of FgaPT2. The highest product yields of 32.8, 
49.9, 10.3 and 10.1 % were obtained with R244L for 3a, 4a, 5a 
and 8a, respectively. For 4a, R244T, R244V, R244I and R244M 
showed slightly lower activities than R244L. With 5a as substrate, 
R244T, R244V, R244I and R244M exhibited similar catalytic 
activity as R244L. Furthermore, R244L displayed comparable 
catalytic activity toward 7a with R244S, R244T, R244Y and 
R244H with product yields between 35.4 – 37.8 %. 9a was better 
converted by R244M, R244G, R244L and R244Y with product 
yields of 26.0, 22.9, 22.1 and 20.8 %, respectively. R244Y 
showed a 16.5-fold activity of that of FgaPT2 toward 10a. This 
improvement might be the result of better stabilization of the 
phenylalanine ring in substrate by the aromatic tyrosyl residue of 
R244Y. Overall product yields of more than 10.5 % were achieved 
for the eight cyclic dipeptides by using the respective best mutants. 
3a, 4a and 7a were the most well accepted substrates by these 
mutated proteins, with highest product yields of 32.8, 49.9 and 
37.8 %, respectively. 
To elucidate its structure, the enzyme product 10b was isolated 
from the reaction mixture of R244Y with 10a and proved to be the 
C4-prenylated cyclo-L-Trp-L-Phe by NMR and MS analyses. To 
confirm the structures of the enzyme products with different 
mutants, 1a, 3a, 4a, 5a and 7a - 10a were incubated with the 
thirteen mutated proteins listed in Figure 4 for 16 h. The ethyl 
acetate extracts of the reaction mixtures were subjected to 1H 
NMR analysis. All the signals of the enzyme products 
corresponded well to those obtained with R244Q and R244N, 
confirming the C4-prenylation by these mutants.  
 
Different substrate preferences of FgaPT2 mutants toward 
cyclic dipeptides 
 
From Figure 4, it is also obvious that these mutants showed 
different preferences toward these dipeptides. For better 
understanding the preferences of different FgaPT2 mutants 
toward cyclic dipeptides, dotted lines are added to indicate the 
product yields of different substrates with the same protein. Under 
the conditions used in this study, 4a and 7a with product yields of 
7.7, and 7.4 %, respectively, were found to be the best substrates 
for FgaPT2. R244G accepted 7a and 9a better than other 
substrates, with comparable product yields of 22.5 and 22.9 %, 
respectively, while 4a and 7a are the best substrates for R244A 
with product yields of 30.8 and 27.1 %, respectively. For R244S, 
R244N and R244H, 7a was clearly better accepted than other 
substrates. R244T converted 4a and 7a with comparable product 
yields about 33 %. R244V, R244L, R244I and R244K 
demonstrated similar substrate preferences toward the tested 
substrates and accepted 4a as best substrate, followed by 7a, 2a 
and 9a.  
 
The R244 mutants showing lower activity toward L-
tryptophan than FgaPT2  
Figure 5. Product yields of tryptophan with FgaPT2 and R244 mutants. The 
assays (50 µL) contained 1 mM aromatic substrate, 5 mM CaCl2, 1 mM DMAPP 
and 4 µg purified protein and were incubated at 37 ℃ for 1.5 h. 
To prove the behavior of the R244 mutants toward tryptophan, we 
carried out incubations with the same amount protein, incubation 
time and temperature as for cyclic dipeptides by using FgaPT2 as 
positive control. Under this condition, tryptophan was converted 
by FgaPT2 with a product yield of 72.7 %. As shown in Figure 5, 
R244H and R244K displayed slightly lower activities than FgaPT2. 
R244E lost almost completely its activity toward tryptophan, while 
other mutants showed lower, but still clear detectable activities. 
This proved that the amino acids at position 244 are in most cases 
not critical for the acceptance of tryptophan. 
 
Kinetic parameters of the prenyl transfer reactions of 1a, 3a 
- 5a, 7a – 10a with the best identified R244 mutants  
 
To compare the catalytic efficiency of FgaPT2 and mutated 
proteins toward cyclic dipeptides, kinetic parameters were 
determined for the eight cyclic dipeptides with the best identified 
mutants as described under “Experimental section” and 
summarized in Table 1 (see also Supporting information Figure 
S1 - S8). The KM values of the mutated proteins toward cyclic 
dipeptides are found in the range of 0.17 – 0.74 mM, comparable 
to those with FgaPT2[47]. However, the turnover numbers of the 
reactions with the mutated proteins in the range of 0.83 to 6.4 
min-1 are 8.3 to 76.5-fold of those with FgaPT2. The largest kcat 
was calculated for R244L toward 4a, which also exhibited highest 
product yield of 49.9 %. In the case of 3a, the mutant R244L 
demonstrated a substantial 155-fold catalytic efficiency of that of 
FgaPT2. With 8a as substrate, mutant R244L displayed the 
relatively low catalytic efficiency of 1.6 min-1 mM-1 among all the 
tested mutants. Even though, it is still 10.7- fold of that of FgaPT2 
toward 8a. The higher catalytic efficiencies of mutated enzymes 
toward cyclic dipeptides than FgaPT2 are corresponded to their 
higher product yields.  Therefore, FgaPT2 mutants with enhanced 
catalytic ability toward cyclic dipeptides are generated by 
saturation mutagenesis.
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Table 1. Comparison of kinetic parameters of mutated proteins with those of FgaPT2 published previously. 
Substrate Enzyme KM (mM) kcat (min-1) 
kcat / KM / 
min-1 mM-1 
Enzyme KM (mM) kcat (min-1) 
kcat / KM / 
min-1 mM-1 
Ratio of kcat / KM 
mutant/FgaPT2 
1a R244L 0.40 0.83 2.1 FgaPT2[a] 0.35 0.10 0.29 7.2 
3a R244L 0.28 5.2 18.6 FgaPT2[a] 0.54 0.068 0.12 155 
4a R244L 0.46 6.4 13.9      
5a R244L 0.65 0.95 1.5      
7a R244Y 0.42 5.6 13.3 FgaPT2[a] 0.14 0.10 0.71 18.7 
8a R244L 0.74 1.2 1.6 FgaPT2[a] 0.44 0.064 0.15 10.7 
9a R244M 0.22 1.9 8.6 FgaPT2[a] 0.33 0.13 0.39 22.1 
10a R244Y 0.17 1.9 11.2      
[a] the data are adopted from [47]  
 
Conclusions 
Prenyltransferases of the DMATS superfamily are capable of 
prenylating a wide range of substrates with different skeletons 
including indole, tyrosine, xanthone, flavonoid and naphthalene 
derivatives.[24] However, for some of the unnatural substrates, 
these enzymes could not be directly used as biocatalysts, due to 
low catalytic efficiency or regioselectivity. Therefore, protein 
engineering of known enzymes are needed to improve such 
features. In the present study, we enhanced significantly the 
catalytic efficiency of FgaPT2 toward different cyclic dipeptides by 
saturation mutagenesis on the key amino acid R244. Thirteen 
R244 mutants displayed differently increased enzyme activities 
for tryptophan-containing cyclic dipeptides, with up to 155-fold 
catalytic efficiency of that of FgaPT2. More importantly, different 
preferences for cyclic dipeptides were observed for these mutants. 
These results provide not only new biocatalysts for production of 
C4-prenylated cyclic dipeptides, but also abundant data for further 
investigations on the catalytic mechanism of FgaPT2 and its 
mutants toward cyclic dipeptides. 
Experimental Section 
Chemicals 
DMAPP was synthesized according to the method described for geranyl 
diphosphate reported previously.[48] Substrates used for the enzyme 
assays were purchased from Bachem (Bubendorf, Switzerland) or 
synthesized as described previously.[49] 
Bacterial strains, plasmids and culture conditions 
Escherichia coli XL1 Blue MRF’ (Stratagene, Heidelberg, Germany) was 
used as host strain for site-directed mutagenesis experiments. E. coli BL21 
(DE3)pLysS (Invitrogen, Karlsruhe, Germany) and SoluBL21 (Novagen, 
Darmstadt, Germany) were used for expression experiments. pIU18 was 
used as construct for FgaPT2 overproduction as described previously [40] 
and as DNA template for site-directed mutagenesis experiments.  
Expression constructs for overproduction of T102 and K174 mutants as 
well as I80F, R244E, R244N, R244Q and R244D are described 
previously.[41;42] 
E. coli cells harboring plasmids were grown in liquid Lysogeny-Broth (LB) 
or Terrific-Broth (TB) medium and on solid LB medium with 1.5 % (w/v) 
agar at 37 °C. 25 μg mL-1 of kanamycin were used for selection of 
recombinant E. coli strains. 
Site-directed mutagenesis 
Expand Long Template PCR system (Roche Diagnostic, Mannheim, 
Germany) was used for construction of plasmids pALF39 – pALF53 (Table 
S1). The obtained plasmids were sequenced to confirm the desired 
mutations in the respective constructs. 
Overproduction and purification of the recombinant proteins 
FgaPT2 and its mutated derivatives were overproduced and purified as 
described previously[40] and protein yields between 0.6 and 6.6 mg per liter 
culture were obtained in this study. 
Enzyme assays with recombinant purified proteins 
To determine the enzyme activity toward 1a, the incubation mixtures 
contained 50 mM Tris-HCl (pH 7.5), 5 mM CaCl2, 1 mM 1a, 1 mM DMAPP, 
0.15 - 5 % (v/v) glycerol, 0 - 5 % (v/v) DMSO and 0.1 µg µL-1 of purified 
recombinant protein in a total volume of 100 µL. After incubation at 37 °C 
for 16 h, the reactions were terminated by addition of 100 µL methanol. 
Protein was removed by centrifugation at 13.000 rpm for 20 min and the 
supernatant was analyzed on HPLC.  
To determine the enzyme activities of R244N and R244Q toward 1a - 10a, 
the incubation mixtures contained 50 mM Tris-HCl (pH 7.5), 5 mM CaCl2, 
1 mM aromatic substrate, 1 mM DMAPP, 0.15 - 5 % (v/v) glycerol, 0 - 5 % 
(v/v) DMSO and 0.1 µg µL-1 of purified recombinant protein in a total 
volume of 100 µL. After incubation at 37 °C for 16 h, the reactions were 
terminated by addition of 100 µL methanol. Protein was removed by 
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centrifugation at 13.000 rpm for 20 min and the supernatant was analyzed 
on HPLC. 
To determine the enzyme activities of FgaPT2 and its mutants with crude 
protein extracts, single colonies of E. coli harboring the respective 
plasmids were inoculated into 1 mL of TB media with 25 μg mL-1 of 
kanamycin and 0.5 mM IPTG and cultivated at 37 oC with shaking at 220 
rpm for 24 h. The cultures were harvested by centrifugation at 4500 rpm 
for 10 min. 100 µL Tris-HCl (50 mM, pH 7.5) were added to the pellets. 
The suspensions were frozen at -30 oC for 45 min and then thaw on ice 
with vortex. Repeat the freeze-thaw procedure for twice and the lysates 
were centrifuged at 13.000 rpm for 10 min and the supernatants were used 
directly for enzyme assays. Each assay contains 60 µL supernatant, 5 mM 
CaCl2, 1 mM aromatic substrate, 1 mM DMAPP, 0 - 5 % (v/v) DMSO in a 
total volume of 100 µL. After incubation at 37 °C for 16 h, the reactions 
were terminated by addition of 100 µL methanol. Due to the numbers of 
cyclic dipeptides and different substrate preferences of known mutants, 
two cyclic dipeptide mixtures for the first trial of desired variants were used 
as aromatic substrates. The mixture contained 1a, 3a, 5a, 7a and 8a or 2a, 
4a, 6a, 9a and 10a, with different retention times on HPLC. Due to the high 
product yields observed for 7a with known mutants, 7a was also used as 
positive control. After incubation, proteins were removed by centrifugation 
at 13.000 rpm for 20 min and the supernatants were analyzed on HPLC. 
To determine the enzyme activities of FgaPT2 and mutants toward 1a, 3a 
-5a, 7a – 10a, the incubation mixtures contained 50 mM Tris-HCl (pH 7.5), 
5 mM CaCl2, 1 mM aromatic substrate, 1 mM DMAPP, 0.15 - 5 % (v/v) 
glycerol, 0 - 5 % (v/v) DMSO and 0.08 µg µL-1 of purified recombinant 
protein in a total volume of 50 µL. After incubation at 37 °C for 1.5 h, the 
reactions were terminated by addition of 50 µL methanol. Protein was 
removed by centrifugation at 13.000 rpm for 20 min and the supernatant 
was analyzed on HPLC. Data given in Figure 3 and 4 were calculated from 
two to four independent measurements. 
In order to determine the kinetic parameters of prenyl transfer reaction, 
DMAPP at 1 mM and aromatic substrates with concentrations of up to 5 
mM were used. Variable protein concentrations and incubation times were 
used for different enzymes. 
For isolation of the enzyme products, reactions were carried out in large 
scales (5 or 10 mL) containing 50 mM Tris-HCl (pH 7.5), 5 mM CaCl2, 1 
mM aromatic substrate, 1.5 mM DMAPP and 0.2 – 0.4 mg mL-1 
recombinant protein. After incubation at 37 °C for 16 h, the reaction 
mixtures were extracted with 10 mL EtOAc for three times and 
concentrated on a rotating vacuum evaporator at 35 °C to a final volume 
of 1 mL before injection into HPLC. 
HPLC analysis and isolation of the enzyme products 
The enzyme reaction mixtures were analyzed on HPLC (Agilent series 
1200, Böblingen, Germany) by using a Multospher 120 RP-18 column 
(250×4 mm, 5 μm, C+S Chromatographie Service, Langerwehe, 
Germany) at a flow rate of 1 mL min-1. Water and methanol were used as 
solvents. For analysis of the enzyme products, a linear gradient of 30 - 
100 % (v/v) methanol in 20 min was used. The column was then washed 
with 100 % (v/v) methanol for 5 min and equilibrated with 30 % (v/v) 
methanol for 5 min. Detection was carried out with a photodiode array 
detector and illustrated at 277 nm in this paper. For isolation of the enzyme 
products, the same HPLC equipment with a Multospher 120 RP-18 column 
(250×10 mm, 5 μm, C+S Chromatographie Service, Langerwehe, 
Germany) was used. A linear gradient of 60 - 100 % (v/v) of methanol in 
water in 50 - 80 min was carried out with a flow rate at 2.5 mL min-1. The 
column was then washed with 100 % (v/v) methanol for 10 min and 
equilibrated with 60 % (v/v) methanol for 10 min. 
NMR and mass spectrometric analyses 
For structural elucidation, the isolated enzyme products were subjected to 
1H NMR and MS analyses. Mass spectrometry was carried out on a Q-
Trap Quantum (Applied Biosystems, Darmstadt, Germany). 1H NMR 
spectra were recorded at room temperature with an ECX-500 
spectrometer (JEOL, Tokyo, Japan) equipped with a broadband probe with 
z-gradient. Chemical shifts were referenced to the solvent signal at 7.26 
ppm for CDCl3 or 2.49 ppm for DMSO-d6. All spectra were processed with 
MestReNova 5.2.2 (Metrelab Research, Santiago de Compostella, Spain). 
Compound 1b: 1H NMR (500 MHz, DMSO-d6): δ=10.86 (d, 2.0 Hz, 1H; 
NH), 7.92 (d, 2.5 Hz, 1H; NH), 7.49 (d, 2.7 Hz, 1H; NH), 7.15 (dd, 7.6, 1.0 
Hz, 1H; CH), 6.93 (t, 7.6 Hz, 1H; CH), 6.84 (d, 8.5 Hz, 2H; CH), 6.82 (d, 
2.5 Hz, 1H; CH), 6.69 (dd, 7.6, 1.0 Hz, 1H; CH), 6.68 (d, 8.5 Hz, 2H; CH), 
5.25 (tsept, 7.0, 1.5 Hz, 1H; CH), 3.98 (dd, 7.0, 4.5 Hz, 1H; CH), 3.79 (dt, 
8.5, 3.0 Hz, 1H; CH), 3.62 (d, 7.0 Hz, 2H; CH2), 3.08 (dd, 14.6, 3.5 Hz, 1H; 
CH2), 2.67 (dd, 13.5, 4.5 Hz, 1H; CH2), 2.57 (dd, 13.5, 5.5 Hz, 1H; CH2), 
1.96 (dd, 14.6, 9.0 Hz, 1H; CH2), 1.70 (br s, 3H; CH3), 1.69 (s, 3H; CH3). 
MS (ESI): m/z=440.17 [M+Na]+. 
Compound 3b: 1H NMR (500 MHz, CDCl3): δ=8.18 (br s, 1H; NH), 7.25 
(dd, 8.5, 1.0 Hz, 1H; CH), 7.15 (t, 8.0 Hz, 1H; CH), 7.07 (d, 2.5 Hz, 1H; 
CH), 6.93 (dd, 7.5, 1.0 Hz, 1H; CH), 5.82 (br s, 1H; NH), 5.32 (tsept, 6.8, 
1.5 Hz, 1H; CH), 4.29 (dd, 11.5, 1.8 Hz, 1H; CH), 4.09 (t, 8.0 Hz, 1H; CH), 
3.97 (ddd, 15.4, 3.5, 1.0 Hz, 1H; CH2), 3.75 (dd, 16.5, 6.8 Hz, 1H; CH2), 
3.72 (dd, 16.5, 6.8 Hz, 1H; CH2), 3.66 (m, 1H; CH2), 3.60 (m, 1H; CH2), 
2.98 (dd, 15.4, 11.5 Hz, 1H; CH2), 2.35 (m, 1H; CH2), 2.11 (m, 1H; CH2), 
2.05 (m, 1H; CH2), 1.93 (m, 1H; CH2), 1.75 (s, 3H; CH3), 1.74 (d, 1.0 Hz, 
3H; CH3). MS (ESI): m/z=374.17 [M+Na]+. 
Compound 4b: 1H NMR (500 MHz, CDCl3): δ=8.22 (br s, 1H; NH), 7.23 (dd, 
7.5, 1.0 Hz, 1H; CH), 7.13 (t, 7.5 Hz, 1H; CH), 7.03 (d, 2.5 Hz, 1H; CH), 
6.92 (dd, 7.5, 1.0 Hz, 1H; CH), 5.93 (d, 2.5 Hz, 1H; NH), 5.31 (tsept, 6.8, 
1.5 Hz, 1H; CH), 4.15 (dt, 9.0, 4.0 Hz, 1H; CH), 3.77 (br t, 5.5 Hz, 2H; CH2), 
3.67 (t, 8.8 Hz, 1H; CH), 3.65 (ddd, 14.8, 3.8, 1.0 Hz, 1H; CH2), 3.63 (m, 
1H; CH2), 3.44 (ddd, 12.0, 9.3, 2.8 Hz, 1H; CH2), 3.19 (dd, 14.8, 9.3 Hz, 
1H; CH2), 2.31 (dtd, 12.0, 7.0, 1.5 Hz, 1H; CH2), 1.98 (m, 1H; CH2), 1.89 
(m, 1H; CH2), 1.78 (d, 1.0 Hz, 3H; CH3), 1.74 (d, 1.0 Hz, 3H; CH3), 1.73 
(m, 1H; CH2). MS (ESI): m/z=374.17 [M+Na]+. 
Compound 5b: 1H NMR (500 MHz, CDCl3): δ=8.29 (br s, 1H; NH), 7.23 (d, 
7.0 Hz, 1H; CH), 7.12 (t, 7.0 Hz, 1H; CH), 7.03 (d, 2.0 Hz, 1H; CH), 6.92 
(d, 7.0 Hz, 1H; CH), 5.91 (br s, 1H; NH), 5.33 (tsept, 7.0, 1.5 Hz, 1H; CH), 
4.15 (m, 1H; CH), 3.77 (approx. m, 2H; CH2), 3.67 (approx. m,1H; CH), 
3.64 (m, 1H; CH2), 3.63 (m, 1H; CH2), 3.44 (m, 1H; CH2), 3.18 (approx. m, 
1H; CH2), 2.31 (m, 1H; CH2), 1.97 (m, 1H; CH2), 1.87 (m, 1H; CH2), 1.78 
(br s, 3H; CH3), 1.74 (br s, 3H; CH3), 1.73 (approx. m, 1H; CH2). MS (ESI): 
m/z=374.17 [M+Na]+. 
Compound 7b: 1H NMR (500 MHz, CDCl3): δ=8.20 (br s, 1H; NH), 7.24 (d, 
7.5 Hz, 1H; CH), 7.15 (t, 7.5 Hz, 1H; CH), 7.08 (d, 2.0 Hz, 1H; CH), 6.94 
(d, 7.5 Hz, 1H; CH), 6.00 (br s, 1H; NH), 5.87 (br s, 1H; NH), 5.33 (tsept, 
6.6, 1.3 Hz, 1H; CH), 4.22 (br d, 10.5 Hz, 1H; CH), 3.98 (br d, 9.5 Hz, 1H; 
CH), 3.87 (dd, 15.0, 3.0 Hz, 1H; CH2), 3.79 (dd, 15.5, 6.5 Hz, 1H; CH2), 
3.72 (dd, 15.5, 6.5 Hz, 1H; CH2), 3.04 (dd, 15.0, 11.0 Hz, 1H; CH2), 1.84 
(ddd, 13.8, 9.5, 3.5 Hz, 1H; CH2), 1.76 (s, 3H; CH3), 1.75 (d, 1.0 Hz, 3H; 
CH3), 1.74 (m, 1H; CH),1.51 (ddd, 13.8, 10.0, 4.5 Hz, 1H; CH2), 0.98 (d, 
6.5 Hz, 3H; CH3), 0.94 (d, 6.5 Hz, 3H; CH3). MS (ESI): m/z=390.24 
[M+Na]+. 
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Compound 8b: 1H NMR (500 MHz, CDCl3): δ=8.20 (br s, 1H; NH), 7.25 (d, 
7.5 Hz, 1H; CH), 7.15 (t, 7.5 Hz, 1H; CH), 7.09 (d, 2.5 Hz, 1H; CH), 6.94 
(d, 7.5 Hz, 1H; CH), 5.91 (br s, 1H; NH), 5.76 (br s, 1H; NH), 5.32 (tsept, 
6.8, 1.5 Hz, 1H; CH), 4.21 (br d, 10.5 Hz, 1H; CH), 3.95 (br dd, 17.3, 2.3 
Hz, 1H; CH2), 3.82 (dd, 14.7, 1.0 Hz, 1H; CH2), 3.81 (dd, 17.3, 2.0 Hz, 1H; 
CH2), 3.76 (br t, 7.5 Hz, 2H; CH2), 3.11 (dd, 14.7, 5.0 Hz, 1H; CH2), 1,76 
(br s, 3H; CH3), 1.75 (d, 1.0 Hz, 3H; CH3). MS (ESI): m/z=334.14 [M+Na]+. 
Compound 9b: 1H NMR (500 MHz, CDCl3): δ=8.21 (br s, 1H; NH), 8.01 (br 
s, 1H; NH), 7.7 (d, 8.0 Hz, 1H; CH), 7.39 (d, 8.0 Hz, 1H; CH), 7.24 (td, 7.5, 
1.3 Hz, 1H; CH), 7.22 (td, 7.5, 1.3 Hz, 1H; CH), 7.17 (d, 8.0 Hz, 1H; CH), 
7.09 (t, 7,5 Hz, 1H; CH), 7.06 (d, 2.5 Hz, 1H; CH), 6.88 (d, 7.0 Hz, 1H; CH), 
6.00 (d, 2.0 Hz, 1H; CH), 5.95 (br s, 1H; NH), 5.65 (br s, 1H; NH), 5.27 
(tsept, 6.5, 1.5 Hz, 1H; CH), 4.33 (m, 1H; CH), 4.01 (br d, 11.0 Hz, 1H; 
CH), 3.69 (dd, 11.5, 5.5 Hz, 2H; CH2), 3.52 (dd, 14.5, 3.0 Hz, 1H; CH2), 
3.28 (d, 6.0 Hz, 1H; CH2), 3.28 (d, 3.5 Hz, 1H; CH2), 1.80 (dd, 14.5, 11.0 
Hz, 1H; CH2), 1.72 (s, 6H; CH3). MS (ESI): m/z=463.16 [M+Na]+. 
Compound 10b: 1H NMR (500 MHz, CDCl3): δ=8.15 (br s, 1H; NH), 7.38 
(m, 2H; CH), 7.31 (m, 1H; CH), 7.22 (m, 2H; CH7.20 (br d, 7.0 Hz, 1H; CH), 
7.14 (t, 7.7 Hz, 1H; CH), 6.93 (dd, 7.0, 1.0 Hz, 1H; CH), ), 6.90 (d, 2.5 Hz, 
1H; CH), 5.78 (br s, 1H; NH), 5.73 (br s, 1H; NH), 5.30 (tsept, 6.8, 1.5 Hz, 
1H; CH), 4.25 (m, 1H; CH), 4.10 (m, 1H; CH), 3.74 (dd, 17.0, 6.0 Hz, 1H; 
CH2), 3.68 (dd, 13.5, 7.0 Hz, 1H; CH2), 3.64 (dd, 15.0, 2.5 Hz, 1H; CH2), 
3.25 (dd, 13.8, 3.8 Hz, CH2), 2.87 (dd, 13.8, 8.3 Hz, 1H; CH2), 2.28 (dd, 
15.0, 11.0 Hz, 1H; CH2), 1.74 (s, 6H; CH3). MS (ESI): m/z=803.43 [2M+ 
H]+. 
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Table S1. Mutated derivatives of FgaPT2 and respective primers used for site-directed mutagenesis. 
 
Mutant Designed mutation Primer Sequence (5’-3’) Plasmid 
FgaPT2_R244I C730A, G731T, C732A 
R244X_Fw 
R244X_Rev 
GCCAGTCCCNNNCTAGTGTCCTGTGAT 
GGACACTAGNNNGGGACTGGCAGTGCT 
pALF39 
FgaPT2_R244F C730T, G731T, C732T pALF40 
FgaPT2_R244A C730G, G731C, C732A pALF41 
FgaPT2_R244G C730G pALF42 
FgaPT2_R244Y C730T, G731A, C732T pALF43 
FgaPT2_R244P G731C pALF44 
FgaPT2_R244H G731A, C732T pALF45 
FgaPT2_R244T C730A, G731C, C732G pALF47 
FgaPT2_R244L C730T, G731T, C732A pALF49 
     
FgaPT2_R244M C730A, G731T, C732G 
R244KVM_fw 
R244KVM_rev 
GCCAGTCCCRWRCTAGTGTCCTGTGAT 
GGACACTAGYSYGGGACTGGCAGTGCT 
pALF48 
FgaPT2_R244K C730A, G731A, C732G pALF50 
FgaPT2_R244V C730G, G731T, C732G pALF52 
     
FgaPT2_R244S C730T, G731C, C732G 
R244SCW_fw GCCAGTCCCTSSCTAGTGTCCTGTGAT 
pALF46 
R244SCW_rev GGACACTAGWWAGGGACTGGCAGTGCT 
FgaPT2_R244W C730T, C732G 
R244CW_fw GCCAGTCCCTGSCTAGTGTCCTGTGAT 
pALF51 
R244CW_rev GGACACTAGWCAGGGACTGGCAGTGCT 
 
 
 
Table S2. PCR protocol for construction of FgaPT2 mutants a. 
 
Step Duration Temperature cycle 
initial denaturation 30 s 95 °C 1 
denaturation 60 s 95 °C 
20 - 30 annealing 60 s 55 - 65 °C 
elongation 7 min 30 sec 68 °C 
final elongation 7 min 68 °C 1 
End ∞ 4 °C 1 
a Expanded long template PCR system (Roche Diagnostics, Mannheim, Germany) was used. 
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Figure S1. Determination of kinetic parameters of R244L for 1a. 
 
 
 
 
 
Figure S2. Determination of kinetic parameters of R244L for 3a. 
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Figure S3. Determination of kinetic parameters of R244L for 4a. 
 
 
 
Figure S4. Determination of kinetic parameters of R244L for 5a. 
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Figure S5. Determination of kinetic parameters of R244Y for 7a. 
 
 
 
Figure S6. Determination of kinetic parameters of R244L for 8a. 
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Figure S7. Determination of kinetic parameters of R244M for 9a. 
 
 
 
Figure S8. Determination of kinetic parameters of R244Y for 10a. 
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Abstract 
Prenylated natural products are ubiquitously found in nature and demonstrate 
interesting biological and pharmacological activities. Prenyltransferases catalyze the 
attachment of prenyl moieties from different prenyl donors to various acceptors and 
contribute significantly to the structural and biological diversity of natural products. In 
the last decade, significant progress has been achieved for the prenyltransferases of the 
dimethylallyltryptophan synthase (DMATS) superfamily. More than forty members of 
these soluble enzymes are identified in microorganisms and characterized 
biochemically. These enzymes were also successfully used for production of a large 
number of prenylated derivatives. C4-, C5-, C6- and C7-prenylated tryptophan and N1-, 
C2-, C3-, C4- and C7-prenylated tryptophan-containing peptides were obtained by 
using DMATS enzymes as biocatalysts. Tyrosine and xanthone prenyltransferases were 
used for prenylation of O-prenylated derivatives of their analogs. More interestingly, 
the members of the DMATS superfamily demonstrated intriguing substrate and 
catalytic promiscuity and also used structurally quite different compounds as prenyl 
acceptors. Prenylated hydroxynaphthalenes, flavonoids, indolocarbazoles and 
acylphloroglucinols, which are typical bacterial or plant metabolites, were produced by 
using several fungal DMATS enzymes. Furthermore, the potential usage of these 
enzymes was further expanded by using natural or unnatural DMAPP analogs as well 
as by coexpression with other genes like NRPS and by development of whole cell 
biocatalyst. 
Keywords 
Prenyltransferase; Dimethylallyltryptophan synthase; Biocatalyst; Chemoenzymatic 
synthesis; Prenylated compound.  
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Introduction 
Prenylated natural products including prenylated indole derivatives are widely 
distributed in terrestrial and marine organisms and exhibit a wide range of biological 
activities (Li 2010; Liu et al. 2013; Oya et al. 2015; Raju et al. 2011; Sunassee and 
Davies-Coleman 2012). Therefore, different strategies have been developed for 
synthesis of such compounds. The most commonly used synthetic strategies are either 
by addition of a prenyl moiety from prenyl bromide to a substrate, which was activated 
by strong base before, or by coupling reactions catalyzed by metal salts (Schkeryantz 
et al. 1999; Yamakawa et al. 2010; Zhao et al. 2002). Both types of reactions are usually 
carried out under extreme conditions, e.g. anhydrous or anaerobic condition with 
special temperature control (Schkeryantz et al. 1999; Yamakawa et al. 2010; Zhao et al. 
2002). Even so, some positions, e.g. C-4 to C-7 of the indole ring, are not preferred by 
chemical prenylation. Meanwhile, additional steps are usually needed for protection 
and deprotection of the functional group in the reactants (Yamakawa et al. 2010; Zhao 
et al. 2012).  
Chemoenzymatic synthesis by using enzymes as biocatalysts has drawn attention from 
scientists of different disciplines and now widely considered as a practical alternative 
in the chemical synthesis, because it is more efficient, environment-friendly and easier 
to handle than the traditional organic synthesis (Alcantara et al. 2014; Gröger and 
Hummel 2014; Okamoto et al. 2014). The reactions catalyzed by enzymes are mostly 
regio- and stereoselective and occur under mild conditions, e.g. in aqueous solution at 
low temperature, e.g. 37 °C, without involvement of any protection groups (Alcantara 
et al. 2014; Gröger and Hummel 2014; Okamoto et al. 2014). This strategy was also 
successfully used for synthesis of prenylated aromatic compounds (Li 2009a; Yu and 
Li 2012). 
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In nature, the prenyl (nxC5) moieties are transferred from activated prenyl donors, 
usually prenyl diphosphates, by prenyltransferases (PTs) to aliphatic or aromatic 
acceptors (Winkelblech et al. 2015a). During the past decade, PTs have received a 
substantial amount of attention, among which the dimethylallyltryptophan synthase 
(DMATS) superfamily involved in the biosynthesis of diverse secondary metabolites 
is one of the most investigated subgroup. Since the first reviews on the DMATS 
enzymes in 2009 (Li 2009a; Li 2009b; Steffan et al. 2009), significant progress has 
been achieved for the enzymes of this group. Until now, more than forty members of 
this superfamily were identified in bacteria and fungi and characterized biochemically.   
The members of the DMATS superfamily usually demonstrate significant substrate 
flexibility toward aromatic substrates. They accept not only natural substrate analogs 
with similar structures, but also compounds with quite different skeletons. For example, 
tryptophan, tryptophan-containing cyclic dipeptides, tyrosine and xanthones are natural 
substrates of a number of DMATS enzymes. Therefore, a large number of simple indole 
derivatives, cyclic dipeptides, tyrosine and xanthone derivatives can be converted by 
these enzymes to their prenylated derivatives (Fan et al. 2014; Pockrandt et al. 2012; 
Zou et al. 2011). So far, regularly C4-, C5-, C6- and C7-monoprenylated tryptophan as 
well as C4- and C7-diprenylated tryptophan were synthesized by the DMATSs (Kremer 
et al. 2007; Ruan et al. 2009; Unsöld and Li 2005; Winkelblech and Li 2014; Yu et al. 
2012b). Regiospecific production of N1-, C2-, C3-, C4- and C7-prenylated tryptophan 
containing cyclic dipeptides with different stereoselectivity were also reported 
(Grundmann and Li 2005; Mundt and Li 2013; Wunsch et al. 2015b; Yu et al. 2013; 
Zou et al. 2010). Interestingly, the bacterial metabolites such as prenylated 
hydroxynaphthalenes and indolocarbazoles as well as plant metabolites like prenylated 
flavonoids and acylphloroglucinols can also be produced from their non-prenylated 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
154
5 
 
precursors by using DMATS enzymes (Yu et al. 2012a; Yu et al. 2011; Yu and Li 2011; 
Zhou et al. 2015). 
Compared to their aromatic substrates, one bottleneck for the use of DMATS enzymes 
in the biotechnology is their high specificity toward prenyl donors. Dimethylallyl 
diphosphate (DMAPP) serves as the most common prenyl donor of the DMATS 
enzymes and other prenyl diphosphates like geranyl or farnesyl diphosphate (GPP or 
FPP) are only accepted by few enyzmes. Efforts and progresses have been made 
recently to expand their acceptance for other prenyl donors like GPP or FPP as well as 
some unnatural alkyl, even benzyl donors, which can be used to produce novel 
unnatural prenylated products (Liebhold et al. 2012; Liebhold et al. 2013; Liebhold and 
Li 2013; Winkelblech et al. 2015b).  
To understand these prenyl transfer reactions, crystal structures of DMATS enzymes 
provide not only detailed insights into the reaction mechanism, but also basic 
information for protein engineering to create new biocatalysts with desirable features 
(Fan et al. 2015; Jost et al. 2010). Coexpression of PT genes with non-ribosomal peptide 
synthases (NRPS) for production of prenylated cyclic dipeptides in vivo and 
development of whole cell biocatalyst with PTs are new potential application of these 
intriguing enzymes. 
 
Chemoenzymatic synthesis of prenylated simple indole derivatives 
 
Until now, twelve tryptophan PTs have been identified in bacteria and fungi and 
characterized biochemically (Winkelblech et al. 2015a). These enzymes showed 
remarkable flexibility toward tryptophan analogs with modifications at both the indole 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
155
6 
 
ring and the side chain and several of them were used for production of prenylated 
tryptophan analogs (Table 1). In this way, C4-, C5-, C6- and C7-prenylated simple 
indoles were obtained by regiospecific transfer reactions catalyzed by FgaPT2 (Steffan 
et al. 2007), 5-DMATS (Yu et al. 2012b), 6-DMATSSa (Winkelblech and Li 2014) and 
7-DMATS (Kremer et al. 2007), respectively. C4- and C7-diprenylated derivatives 
were obtained by tandem incubation with FgaPT2 and 7-DMATS (Ruan et al. 2009). 
In addition, the two tyrosine PTs SirD and TyrPT were also found to catalyze the same 
C7-prenylation of L-tryptophan and derivatives as 7-DMATS (Fan et al. 2014; Rudolf 
and Poulter 2013). More than one product with prenylations at different positions of the 
indole ring were obtained by these two enzymes in most cases (Fan et al. 2014; Rudolf 
and Poulter 2013). These results demonstrated that more prenylated products could be 
obtained by using DMATS enzymes, which provided targets for protein engineering in 
the future for creation of enzymes with regiospecific prenylation of other substrates or 
at other positions than for their natural substrates. 
 
Chemoenzymatic synthesis of prenylated cyclic dipeptides  
 
Cyclic dipeptide PTs from fungi take dipeptides with a diketopiperazine or 
benzodiazepinedinone system as substrates, while indolactams are prenylated by cyclic 
dipeptide PTs from bacteria (Edwards and Gerwick 2004; Winkelblech et al. 2015a). 
The first group of cyclic dipeptide PTs were also utilized for production of prenylated 
cyclic dipeptides (Table 2). For example, FtmPT1 from Aspergillus fumigatus (A. 
fumigatus) catalyzes in nature a regular C2-prenylation of brevianamide F (cyclo-L-
Trp-L-Pro) in the biosynthesis of fumitremorgins (Grundmann and Li 2005). Further 
study showed that it also accepted other cyclic dipeptides as substrates and produced 
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mainly C2-prenylated derivatives and regularly C3-prenylated pyrrolo[2,3]indole 
diketopiperazines as byproducts (Table 2) (Grundmann and Li 2005; Wollinsky et al. 
2012). The two reverse C2-PTs BrePT from Aspergillus versicolor and CdpC2PT from 
Neosartorya fischeri also prenylate a series of cyclic dipeptides at C-2, but with reverse 
pattern and different substrate preference (Mundt and Li 2013; Yin et al. 2013). In total, 
thirty regularly or reversely C2-prenylated compounds were synthesized by these three 
enzymes (Table 2).  
CTrpPT from Aspergillus oryzae catalyzed the simultaneous regular C7- (major) and 
reverse N1-prenylation (minor) of cyclo-L-Trp-L-Trp with high substrate specificity 
(Zou et al. 2010), which could not be used for production of other prenylated dipeptides. 
Recently, regularly C7-prenylated cyclic dipeptides were successfully obtained by 
using a new member of the DMATS family, CdpC7PT from Aspergillus terreus 
(Wunsch et al. 2015b). CdpC7PT demonstrated much higher substrate flexibility and 
converted six cyclic dipeptides to 10 prenylated products (Table 2). It also accepted 
cyclo-L-Tyr-L-Tyr as substrate and catalyzed an O-prenylation at the tyrosyl residue, 
which was the first example of DMATS enzymes with an O-prenyltransferase activity 
toward such dipeptides (Wunsch et al. 2015b). Five regularly C4-prenylated cyclic 
dipeptides were obtained by using the tryptophan PT FgaPT2 (Steffan and Li 2009). In 
comparison to those with cyclic dipeptide PTs, product yields with FgaPT2 between 22 
- 35 % are relatively low (Table 2). 
The cyclic dipeptide C3-PTs, AnaPT, CdpC3PT and CdpNPT all accepted a number of 
cyclic dipeptides as substrates and catalyzed stereoselective prenylation, resulting in 
the formation of different stereoisomers (Table 3). The stereoselectivities of AnaPT and 
CdpC3PT toward cyclo-Trp-Ala and cyclo-Trp-Pro mainly depended on the 
configuration of the tryptophanyl moiety in the substrates. They produced anti-cis and 
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syn-cis configured prenylated pyrroloindolines, respectively. CdpNPT catalyzed both 
syn-cis and anti-cis configured prenylations (Table 3) (Yu et al. 2013). 
As mentioned before, tryptophan PTs accept cyclic dipeptides as well, but with very 
low activity (Steffan et al. 2007; Steffan and Li 2009). In return, tryptophan is a poor 
substrate for cyclic dipeptide PTs (Zou et al. 2009). However, one unnatural cyclic 
dipeptide, cyclo-L-homotryptophan-D-valine with one additional C-atom between the 
indole and the diketopiperazine rings was demonstrated to be well accepted by five 
cyclic dipeptide PTs (BrePT, FtmPT1, AnaPT, CdpNPT and CdpC3PT) and three 
tryptophan PTs (FgaPT2, 5-DMATS and 7-DMATS). Seven enzymatic products with 
one prenyl moiety at each position of the indole nucleus (N-1, C-2 to C-7) were 
produced (Fan and Li 2013). This was the first report on production of seven 
monoprenylated products from one substrate by one-step reactions. 
The prenylation reaction mentioned above all took place on the aromatic nucleus. The 
first exception reported in 2012 by Chen et al showed that cyclic dipeptide C2-PT 
FtmPT1 also accepted (E)-4-(1H-indol-3-yl)but-3-en-2-one as substrate and catalyzed 
the formation of the unnatural α-prenylindolylbutenone, demonstrating the prenylation 
of a nonaromatic carbon by a indole PT (Chen et al. 2012). These examples indicated 
that further investigations on the substrate promiscuity and catalytic ability of PTs could 
lead to production of novel unnatural products. 
 
Chemoenzymatic synthesis of prenylated phenylalanine/tyrosine derivatives 
 
The tyrosine PTs SirD and TyrPT catalyze the O-, N- or S- prenylations of tyrosine and 
derivatives thereof (Table 4) (Fan et al. 2014; Rudolf and Poulter 2013; Zou et al. 
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2011).Two tryptophan PTs FgaPT2 and 7-DMATS take L-tyrosine and 4-amino-L-
phenylalanine as substrates as well and produce the unique C3- and O-prenylated 
tyrosine or 4-amino-L-phenylalanine, respectively (Table 4) (Fan et al. 2015; Fan and 
Li 2014). Together with the results of C7-prenylation of L-tryptophan by SirD and 
TyrPT, these four PTs demonstrated complementary substrate and catalytic promiscuity 
and share very likely similar reaction cavities in their structures. 
 
Chemoenzymatic synthesis of prenylated xanthones 
 
In the presence of DMAPP, the xanthone PT XptB from Aspergillus nidulans (A. 
nidulans) involved in the biosynthesis of shamixanthone converted four of the ten tested 
xanthones to O7-prenylated derivatives (Table 5) (Pockrandt et al. 2012). One special 
feature of XptB was that Mn2+ and Co2+ strongly enhanced its activity (up to eightfold), 
which has not been reported for the DMATS before. Recently, an N1- and C2-PT AstPT 
from Aspergillus terreus was proven to be highly specific for its substrate bisindolyl 
benzoquinone. Tryptophan and derivatives as well as tryptophan-containing cyclic 
dipeptides were not accepted by this enzyme (Tarcz et al. 2014a). However, AstPT used 
DMAPP, GPP and FPP for O-prenylation of hydroxyxanthones (Table 5) (Tarcz et al. 
2014b). AstPT and XptB showed different substrate preference and regioselectivity 
toward xanthones. 
 
Chemoenzymatic synthesis of prenylated naphthalenes 
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The structure of FgaPT2 unexpectedly revealed the common architecture with another 
PT NphB from the CloQ/NphB subgroup, which utilizes hydroxynaphthalenes as 
aromatic substrates (Kuzuyama et al. 2005). This result indicated a possibility for 
production of prenylated hydroxynaphthalenes by DMATS enzymes. Four indole PTs, 
7-DMATS, AnaPT, CdpNPT and CdpC3PT (Kremer et al. 2007; Schuller et al. 2012; 
Yin et al. 2009b; Yin et al. 2010b), were found indeed to accept diverse 
hydroxynaphthalenes as substrates and catalyzed mainly a regular C-prenylation at 
para- or ortho-position to the hydroxyl group of 1-naphthol or 2-naphthol derivatives. 
11 prenylated hydroxynaphthalenes were isolated and identified as main products 
(Table 6) (Yu et al. 2011). Additionally, the recently characterized 6-DMATSSa and 6-
DMATSSv from Streptomyces species were also found to catalyze prenylation of three 
hydroxynaphthalenes. Interestingly, different from the products with 7-DMATS, 
AnaPT, CdpNPT and CdpC3PT mentioned above, the prenyl moieties were transferred 
onto the unsubstituted ring of naphthalenes (Table 6) (Winkelblech and Li 2014). 
Therefore, these four enzymes could be considered as complementary biocatalysts for 
production of prenylated hydroxynaphthalenes. 
 
Chemoenzymatic synthesis of prenylated flavonoids 
 
Prenylated flavonoids and isoflavonoids are widely distributed in nature, predominantly 
in plants (Botta et al. 2005; Botta et al. 2009). Prenylations of flavonoids in plants are 
catalyzed by membrane-bound proteins, which are generally more difficult to be 
overproduced and purified than soluble DMATS enzymes. In addition, they usually 
exhibit very high substrate specificity and relative low catalytic ability (Chen et al. 2013; 
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Sasaki et al. 2011). These features prohibit their potential use in biotechnology. 
Tryptophan C7-PT 7-DMATS (Table 1) was reported to convert a number of flavonoids 
to their prenylated derivatives, especially C6-prenylated flavanones and isoflavonoids 
(Figure 1) (Yu and Li 2011). Thus, 7-DMATS could be a valuable alternative 
biocatalyst for chemoenzymatic synthesis or in vivo-production of prenylated 
flavonoids.  
 
Chemoenzymatic synthesis of prenylated indolocarbazoles 
 
Indolocarbazoles are a class of natural products with remarkable biological activities. 
Several of these compounds have already entered clinical trials for treatment of cancer 
and other diseases (Salas and Mendez 2009; Sánchez et al. 2006). FgaPT2 and 5-
DMATS were reported to catalyze regiospecific prenylations of indolocarbazoles at the 
para-position of the indole N-atom and four prenylated products were obtained. These 
results expanded not only the potential usage of these enzymes in the structural 
modification, but also provided leading compounds for further biological research 
(Figure 2) (Yu et al. 2012a). 
 
Chemoenzymatic synthesis of prenylated acylphloroglucinol 
 
Naturally occurring prenylated acylphloroglucinol derivatives are plant metabolites 
with diverse biological activities and membrane-bound PTs are responsible for the 
prenylation steps (Li et al. 2015; Tsurumaru et al. 2012). Recently, Zhou et al 
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demonstrated the prenylation of such compounds by the soluble cyclic dipeptide C3-
PT AnaPT and nine prenylated acylphloroglucinols were then acquired (Table 7). 
Compared to a microsomal fraction containing an overproduced PT from the plant hop, 
AnaPT is more efficient for the chemoenzymatic synthesis (Zhou et al. 2015). 
 
Expanding the usage of the DMATS enzymes by altering the prenyl donors 
 
In the last years, the potential usage of DMATS enzymes as biocatalysts was expanded 
significantly by their acceptance of different prenyl donors. In addition to their 
remarkable high flexibility toward aromatic substrates, recent studies manifested that 
several members of this family accepted not only DMAPP, but also other alkyl donors 
such as GPP and FPP. Before 2012, the acceptance of these donors was only reported 
for several bacterial PTs of the CloQ/NphB subgroup such as NphB (Kumano et al. 
2008; Kuzuyama et al. 2005), Fnq26 (Haagen et al. 2007) and Fur7 (Kumano et al. 
2010). Meanwhile, we demonstrated that the unnatural DMAPP analogs like 
monomethylallyl (MAPP), 2-pentenyl (2-pentenyl-PP) and benzyl diphosphate 
(benzyl-PP) can also be used for alkylation or benzylation of tryptophan and 
tryptophan-containing cyclic dipeptides by a number of DMATS enzymes (Liebhold et 
al. 2012; Liebhold et al. 2013; Liebhold and Li 2013; Winkelblech et al. 2015b). 
 
Acceptance of GPP and FPP by the DMATS enzymes 
 
Identification of the DMATS enzyme VrtC from Penicillium aethiopicum as a 
geranyltransferase in the biosynthesis of viridicatumtoxin (Chooi et al. 2010) 
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demonstrated that the prenyl donors of these enzymes are not limited to DMAPP in 
nature. This led to intensive investigations on known DMATS enzymes regarding their 
acceptance of GPP as prenyl donor. Indeed, GPP can be used by AnaPT from N. fischeri 
for geranylation of (R)-benzodiazepinedione (cyclo-L-Trp-Ant) and five other cyclic 
dipeptides. C6- and C7-geranylated derivatives were identified as enzyme products 
(Table 8) (Pockrandt and Li 2013). Obviously, the regioselectivity of the prenyl transfer 
reaction was reduced in the presence of the long chain donor. 
Moreover, GPP also serves as a prenyl donor for the recently identified 6-DMATSSa 
and 6-DMATSSv, but with retained prenylation position at C-6 of the indole ring. Thus, 
these bacterial enzymes represent the first examples of tryptophan PTs that accept both 
DMAPP and GPP as prenyl donors and produce 6-dimethylallyl or 6-geranyl 
tryptophan and derivatives thereof (Winkelblech and Li 2014). 
AstPT demonstrated extraordinarily high substrate specificity toward both prenyl donor 
DMAPP and acceptor bisindolyl benzoquinone (AQ D) (Tarcz et al. 2014a). In the 
presence of GPP or FPP, none of the tested indole derivatives including tryptophan and 
cyclic dipeptides, hydroxynaphthalenes and flavonoids was accepted by this enzyme. 
Remarkably, AstPT accepted a number of hydroxyxanthones in the presence of not only 
DMAPP, but also GPP and FPP and catalyzed O-prenylations at the same position of 
the benzene ring (Table 9) (Tarcz et al. 2014b). 
Furthermore, the acceptance of DMAPP, GPP and FPP was reported for C-prenylations 
of hydroxynaphthalenes by BAE61387, a member of the DMATS superfamily from 
Aspergillus oryzae (Pockrandt et al. 2014). BAE61387 catalyzed the prenyl transfer 
reactions to the same position with all the used donors and produced nine dimethylallyl-
, geranyl- and farnesylhydroxynaphthalenes with product yields of up to 72 % (Figure 
3). 
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Acceptance of unnatural DMAPP analogs by the DMATS enzymes 
 
In 2012, several unnatural DMAPP analogs were synthesized and tested as alkyl donors 
for L-tryptophan PTs (Liebhold et al. 2012). It has shown that the double bond at the ß-
position to pyrophosphate is essential for an acceptance by these enzymes. One methyl 
group can be deleted as in the case of MAPP or shifted to the δ-position as in the case 
of 2-pentenyl-PP (Liebhold et al. 2012). Furthermore, the alkylation position of the 
products can differ from those with DMAPP, depending on the used prenyl donors. In 
the presence of 2-pentenyl-PP, C5- and C6-alkylated tryptophan was obtained with the 
C4-PT FgaPT2 and C5-PT 5-DMATS, respectively (Table 10). In the presence of 
MAPP, a mixture of C4- and C5-alkylated tryptophan was observed for FgaPT2 
reaction, and C5- and C6-alkylated derivatives for 5-DMATS reaction (Table 10). 
Latter, it has been shown that FgaPT2 even used the more space-demanding substrate 
benzyl-PP as donor and produced regiospecifically C5-benzylated tryptophan (Table 
10) and eight derivatives thereof (Liebhold and Li 2013).  
The chemoenzymatic synthesis of unnatural alkylated or benzylated products was 
expanded by further investigations with tryptophan C5-, C6- and C7-prenylating 
enzymes. The behaviors of two C5-PTs 5-DMATS from Aspergillus clavatus (Yu et al. 
2012b) and 5-DMATSSc from Streptomyces coelicolor (Subramanian et al. 2012), two 
C6-PTs 6-DMATSSa and 6-DMATSSv from Streptomyces species (Winkelblech and Li 
2014) as well as TyrPT with a tryptophan C7-prenylation activity (Fan et al. 2014), 
were investigated in the presence of MAPP, 2-pentenyl-PP and benzyl-PP (Table 10). 
All the tested enzymes accepted the three DMAPP analogs with different relative 
activities. Enzyme products with the allyl or benzyl moiety attached to different 
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positions were identified, whereby C6-alkylated or benzylated L-tryptophan was found 
as sole or one of the main products in all of these assays (Table 10) (Winkelblech et al. 
2015b). This demonstrated a clear preference of the five PTs toward C-6 of the indole 
ring in the presence of unnatural DMAPP analogs. Molecular dynamics simulation 
experiments with a homologous model of 5-DMATS from A. clavatus leading to a 
distance-based explanation of their reactions with MAPP and 2-pentenyl-PP 
(Winkelblech et al. 2015b). Site-directed mutagenesis based on the molecular modeling 
experiments could lead to enzymes with increased regioselectivity for DMAPP analogs. 
The acceptance of the unnatural DMAPP analogs was also demonstrated with three 
cyclic dipeptide reverse C3-PTs, AnaPT, CdpNPT and CdpC3P (Schuller et al. 2012; 
Yin et al. 2009b; Yu et al. 2013), as well as with two C2-PTs FtmPT1 and BrePT 
(Grundmann and Li 2005; Yin et al. 2013). All of these enzymes catalyzed the Friedel-
Crafts alkylation of cyclic dipeptides. Remarkably, C2- and C3-reverse monoalkylated 
derivatives were identified as enzyme products in all the reaction mixtures, although 
different ratios were observed depending on the used donor and enzyme (Table 11) 
(Liebhold et al. 2013).  
Moreover, we reported very recently the alkylation or benzylation of tyrosine and its 
derivatives with these DMAPP analogs by the two tyrosine O-PTs TyrPT and SirD 
(Table 12). In the presence of MAPP, 2-pentenyl-PP and benzyl-PP, TyrPT and SirD 
produced the same O- or N-alkylated or benzylated products, which displayed a similar 
behavior as for their natural prenyl donor DMAPP (Yu et al. 2015). 
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Molecular modeling guided site-directed mutagenesis as tools for creation of 
enzymes with new features 
 
The crystal structures of FgaPT2 (Metzger et al. 2009), FtmPT1 (Jost et al. 2010), 
CdpNPT (Schuller et al. 2012) and AnaPT (Yu et al. 2013) have been determined 
during the past six years and were used as a basis for understanding the prenyl transfer 
reactions (Jost et al. 2010; Luk and Tanner 2009; Metzger et al. 2009). The structure of 
FtmPT1 allowed us to identify a reaction chamber with modifiable specificity. 
FtmPT1_G115T obtained by mutation of G115 to threonine still accepted brevianamide 
F as substrate, but yielded mainly a reversely syn-cis C3-prenylated derivative instead 
of the regularly C2-prenylated (Jost et al. 2010). 
Another example of the usage of structure information for mutant design is shown with 
FgaPT2 (Table 1). Initial investigation demonstrated that FgaPT2 can convert L-
tyrosine to 3-dimethylallyl-L-tyrosine (Table 4), but with a very low activity. Molecular 
modeling-guided site-directed mutagenesis of FgaPT2 resulted in a mutant, 
FgaPT2_K174F, which showed much higher specificity toward L-tyrosine than L-
tryptophan. The catalytic efficiency of this mutant toward L-tyrosine was found to be 
4.9-fold of that of wild-type, while its activity toward L-tryptophan was less than 0.4 % 
of that of FgaPT2 (Fan et al. 2015). Therefore, we created the first specific tyrosine C3-
prenylating enzyme and altered the substrate preference of a PT by molecular 
modeling-guided site-directed mutagenesis. 
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Whole cell biocatalyst for the efficient prenylation of indole derivatives by 
Autodisplay of FgaPT2 
 
The tryptophan C4-PT FgaPT2 was displayed on the surface of Escherichia  coli cells 
by using Autodisplay technique for chemoenzymatic synthesis (Figure 4) (Kranen et al. 
2011). Indole-3-propionic acid and L-β-homotryptophan were tested with the FgaPT2 
whole cell biocatalyst and conversion yields of 30 and 13 % were obtained, respectively. 
Its catalytic efficiency was much higher than that of the purified FgaPT2 in 24 h assay 
toward indole-3-propionic acid, which could result from the enormously improved 
enzyme stability by immobilizing in the outer membrane of E. coli (Kranen et al. 2011). 
The whole cell biocatalyst endured a storage period of one month at 8 ℃ without any 
detectable loss in activity. Reusability was confirmed by recycling the biocatalyst by 
centrifugation. After three cycles of consecutive use, the whole cell biocatalyst retained 
a conversion rate of 46 % of indole-3-propionic acid and 23 % of L-β-homotryptophan 
(Kranen et al. 2011). Compared to the conventional whole cell catalysts, whose enzyme 
of interest within the cell cytoplasm, the Autodisplay strategy demonstrated many 
advantages. First of all, transport of substrates or products across membranes is not 
necessary; secondly, substrates and products can be easily separated from catalyst and 
catalyst can be recovered by centrifugation. At last, it is possible to avoid the formation 
of byproducts or metabolism of the substrate or product inside the cell (Kranen et al. 
2011). 
 
Targeted production of prenylated compounds by coexpression of non-ribosomal 
peptide synthase and prenyltransferase genes in Aspergillus 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
167
18 
 
The flexibility of the PTs toward aromatic substrates and high regio- and 
stereoselectivity regarding prenylation position at the indole ring as well as different 
prenylation patterns also make these enzymes interesting tools for production of natural 
or unnatural prenylated compounds by synthetic biological approach. As a proof of 
principle, the NRPS gene ftmPS was expressed alone or together with the PT gene 
ftmPT1, both from the biosynthetic gene cluster of verruculogen in A. fumigatus. 
Expression of ftmPS in A. fumigatus and A. nidulans resulted in the formation of 
brevianamide F (Figure 5) with product yields of 32 and 45 mg per liter culture, 
respectively (Maiya et al. 2006). Coexpression of ftmPS and ftmPT1 as one construct 
in A. nidulans resulted in the formation of tryprostatin B (Figure 5) with product yield 
of up to 260 mg per liter culture (Maiya et al. 2009). That is an up to 650-fold increase 
in comparison to that of A. fumigatus BM939 (Cui et al. 1995). These results led to test 
the potential for production of other prenylated compounds by combination of genes 
from different clusters. For this purpose, the orthologous NRPS gene ftmPS 
(NFIA_093690) from N. fischeri encoding a cyclic dipeptide-forming enzyme was 
cloned in one construct and three characterized PT genes in other constructs. These 
included one reverse cyclic dipeptide C2-PT gene cdpC2PT from N. fischeri and two 
reverse C3-prenyltransfersae genes, i.e., cdpC3PT from N. fischeri and cdpNPT from 
A. fumigatus (Mundt and Li 2013; Yin et al. 2010a; Yu et al. 2013). The genes are 
expressed under the control of the constitutive gpdA promoter and trpC terminator. 
Expression of ftmPS from N. fischeri alone in A. nidulans resulted in the formation of 
the expected cyclic dipeptide brevianamide F (Figure 5) with a yield of up to 37 mg per 
liter culture. Introducing cdpC2PT and cdpNPT into a ftmPS overproduction strain led 
to accumulation of reversely C2- and C3-prenylated derivatives, respectively. 
Coexpression of ftmPS with the reverse C3-PT gene cdpC3PT resulted in the formation 
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of N1-regularly, C2- and C3-reversely prenylated derivatives (Figure 5) (Wunsch et al. 
2015a). The prenyl transfer reactions catalyzed by CdpC2PT, CdpNPT and CdpC3PT 
in vivo correspond well to those detected with purified proteins (Mundt and Li 2013; 
Yin et al. 2010b; Yu et al. 2013). This proved that the data obtained from enzyme assays 
with PTs can be transferred directly for in vivo production of such compounds by 
synthetic biology.  
 
Conclusion and outlook 
 
In the past ten years, significant progress has been achieved on the PTs of the DMATS 
superfamily. More than forty members of this family have been characterized 
biochemically and four structures of them were solved, which provided us not only with 
more biocatalysts for production of prenylated products, but also useful information to 
understand these biocatalysts. Investigation on the substrate and catalytic promiscuity 
of the DMATS enzymes demonstrated their potential application in the 
chemoenzymatic synthesis and synthetic biology. More than 250 prenylated 
compounds have been produced by using PTs as biocatalysts and are summarized in 
this review. Availability of more structures will provide basis for creation of new 
desirable biocatalysts by site-directed mutagenesis, especially such enzymes with broad 
substrate specificity, high catalytic efficiency and high regio and stereoselectivity for 
unnatural substrates. 
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Legends to Figures 
 
Figure 1. Chemoenzymatic synthesis of prenylated flavonoids. 
Figure 2. Chemoenzymatic synthesis of prenylated indolocarbazoles. 
Figure 3. Prenylation of hydroxynaphthalenes catalyzed by BAE61387 in the presence 
of DMAPP, GPP and FPP. 
Figure 4. The Autodisplay procedure of FgaPT2 on the surface of E. coli. (modified 
according to (Kranen et al. 2011)) 
Figure 5. Coexpression of NRPS and PTs genes in Aspergillus to produce prenylated 
cyclic dipeptides. 
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Table 1 Product yields of prenylated simple indoles by tryptophan PTs.  
  
Substrate 
FgaPT2 
(C-4) 
5-DMATS 
(C-5) 
6-DMATSSa 
(C-6) 
7-DMATS 
(C-7) 
 
L-Trp 100 100 59.4 41.3 
D-Trp 9.7 n.t. 43.7 4.9 
1-methyl-L-Trp 0.4 46.9 1.3 14.8 
4-methyl-DL-Trp n.d. 56.6 57.3 36.9 
5-methyl-DL-Trp 8.1 1.7 52.2 30.9 
5-hydroxy-L-Trp 21.0 n.t. n.t. 11.0 
5-bromo-DL-Trp n.d. n.d. n.t. 3.0 
6-methyl-DL-Trp 15.2 53.2 42.9 8.2 
6-fluoro-DL-Trp n.d. 69.5 4.9 13.9 
7-methyl-DL-Trp 16.3 57.8 30.5 n.d. 
 
indole-3- 
propionic acid  
32.2 70.7 18.5 3.5 
L-β-homo-Trp 
 
51.5 48.8 57.7 11.6 
N-acetyl-DL-Trp 
 
n.d. 54.4 16.0 3.2 
L-abrine 
 
58.0 90.9 63.0 33.9 
11-methyl-DL-Trp 
 
1.6 n.t. n.t. 7.9 
DL-indole-3- 
lactic acid  
10.5 67.3 16.0 1.8 
trans-indole- 
3-acrylic acid  
n.t. 38.0 20.5 n.t. 
The data are adopted from publications for FgaPT2 after incubation with 0.18 µM protein 
for 1 h (Steffan et al. 2007); 5-DMATS (1 µM, 7 h) (Yu et al. 2012b); 6-DMATSSa (2.3 µM, 
16 h) (Winkelblech and Li 2014) and 7-DMATS (0.6 µM, 1 h) (Kremer and Li 2008).  
Prenylation positions are given in parenthesis under the enzyme names. n.d.: not 
detected; n.t.: not tested. 
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Table 2 Product yields of prenylated cyclic dipeptides by DMATS enzymes. 
 
Substrate 
FtmPT1 BrePT CdpC2PT CdpC7PT FgaPT2 
 
C-2 regular 
 
C-2 regular 
syn-cis 
 
C-3 regular 
syn-cis 
 
C-2 reverse C-7 regular C-4 regular 
cyclo-L-Trp-L-Pro 82.3 n.i.  78 n.i. n.i. 24 
cyclo-L-Trp-D-Pro 75.7 n.i.  72 n.i. n.i. n.t. 
cyclo-D-Trp-L-Pro 27.4  n.i. 13 n.i. n.i. n.t. 
cyclo-D-Trp-D-Pro 43.4  11.8 25 n.i. n.i. n.t. 
cyclo-L-Trp-L-Tyr 74.2 1.1  11 n.i. 28.2 35 
cyclo-L-Trp-L-Trp 67.0 n.i.  8 48 28.1 29 
cyclo-L-Trp-L-Leu 70.9 n.i.  46 37 29.2 23 
cyclo-L-Trp-Gly 5.07 18.6  39 n.i. n.i. 22 
cyclo-L-Trp-L-Phe 39.3 n.i.  31 17 13.6 n.i. 
cyclo-L-Trp-L-His 68.1 6.8  22 n.i. n.t. n.t. 
cyclo-L-Trp-L-Ala 53.5 12.7  35 8 19.5 n.t. 
cyclo-L-Trp-D-Ala 43.9 12.1  29 n.i. n.i. n.t. 
cyclo-D-Trp-L-Ala 46.4  11.6 22 n.i. n.i. n.t. 
cyclo-D-Trp-D-Ala 8.3  n.i. 13 n.i. n.i. n.t. 
cyclo-L-Trp-Ant n.t. 6 n.i. n.i. n.t. 
cyclo-D-Trp-Ant n.t. 8 85 45.6 n.t. 
The data are adopted from publications for FmPT1 (0.94 µM, 2 h) (Wollinsky et al. 2012); BrePT (3.0 µM, 16h) (Mundt 
and Li 2013) , CdpC2PT (4.0 µM, 16 h) (Mundt and Li 2013); CdpC7PT (9 µM, 16 h) (Wunsch et al. 2015b); FgaPT2 (1.8 
µM, 16 h) (Steffan and Li 2009). n.i.: not isolated; n.t.: not tested. 
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Table 3 Product yields of prenylated cyclic dipeptides by DMATS enzymes.  
 
substrate 
CdpC3PT AnaPT CdpNPT 
C3-IIA/Ca C3-IIB/C/Da C3-IIA/B/C/Da 
cyclo-L-Trp-L-Pro 58.3 (A) 15.2 (D) 4.8 (D)/75.1 (A) 
cyclo-L-Trp-D-Pro 69.6 (A) n.i. 62.5 (A) 
cyclo-D-Trp-L-Pro 3.7 (C) n.i. n.i./n.d. 
cyclo-D-Trp-D-Pro 2.7 (C) 3.2 (B) 94.1 (B)/n.i. 
cyclo-L-Trp-L-Tyr 30 (A) 25.7 (D) n.t. 
cyclo-L-Trp-L-Trp 12 (A) 37.0 (D) n.t. 
cyclo-L-Trp-L-Leu 31 (A) 63.6 (D) n.t. 
cyclo-L-Trp-Gly 37 (A) 12.3 (D) n.t. 
cyclo-L-Trp-L-Phe 6 (A) 31.4 (D) n.t. 
cyclo-L-Trp-L-His n.t. n.t. n.t. 
cyclo-L-Trp-L-Ala 39.5 (A) 39.7 (D) 38.4 (D)/22.0 (A) 
cyclo-L-Trp-D-Ala 32.0 (A) 29.1 (D) 34.3 (D)/51.9 (A) 
cyclo-D-Trp-L-Ala 17.8 (C) 21.7 (B) 26.1 (B)/36.2 (C) 
cyclo-D-Trp-D-Ala 11.0 (C) 10.8 (B) 72.7 (B)/n.i. 
cyclo-L-Trp-Ant n.t. 100 (C) 77.1 (B) 
cyclo-D-Trp-Ant n.t. 
80.8 (D) 
(two byproducts) 
99.4 (A) 
The data are adopted from publications for CdpC3PT (1.3 µM, 24 h) (Yin et al. 2010b); (8 
µM, 3 h) (Yu et al. 2013); AnaPT (0.54 µM, 24 h) (Yin et al. 2010a); (8 µM, 3 h) (Yu et al. 
2013); CdpNPT (0.38 µM, 24 h) (Yin et al. 2009a); (8 µM, 3 h) (Yu et al. 2013). 
The codes for the prenylated products are given in parenthesis after product yields. 
aC3-IIA/C refers to C3-IIA or C3-IIC, C3-IIB/C/D for C3-IIB, C3-IIC or C3-IID, and C3-
IIA/B/C/D for C3-IIA, C3-IIB, C3-IIC or C3-IID. n.d.: not detected; n.i.: not isolated; n.t.: 
not tested. 
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Table 4 Product yields of prenylated tyrosine derivatives by DMATS enzymes. 
substrate  SirD TyrPT 7-DMATS FgaPT2 
 
L-Tyr  63.4 64 36 18 
D-Tyr  n.i. n.i. n.d. n.d. 
3-fluoro-DL-Tyr  34.0 50 n.t. n.d. 
3-iodo-L-Tyr  17.3 100 97 n.d. 
3-amino-L-Tyr  68.5 n.t. n.t. n.t. 
4-amino-L-Phe  6.7 98 70 70 
3,4-dihydroxy-L-Phe  12.0 100 n.i. n.t. 
 
α-methyl-L-Tyr 
 
63.0 64 n.d. n.d. 
3-(3,4-dihydroxy-
phenyl)-DL-Ser 
 
11.4 n.t. n.t. n.t. 
The data are adopted from publications for SirD (0.58 µM, 16 h) (Zou et al. 2011), 
TyrPT (1.6 µM, 16 h) (Fan et al. 2014), 7-DMATS (0.58 µM, 16 h) (Fan and Li 
2014) and FgaPT2 (3.6 µM, 16 h) (Fan et al. 2015). n.d.: not detected; n.i.: not 
isolated; n.t.: not tested. 
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Table 5 Product yields of prenylated xanthones by XptB and AstPT. 
 
substrate 
XptB AstPT 
prenylated 
position 
conversion 
yield [%] 
prenylated 
position 
conversion 
yield [%] 
 
7-O 23 7-O 23.1 
 
7-O 25  n.d. 
 
7-O 31  n.d 
 
7-O 76  n.d. 
 
 n.d. 3-O and 6-O 11.0 
 
 n.d. 3-O and 7-O 6.1 
The data are adopted from publication for XptB (3.8 µM, 16 h) (Pockrandt et al. 
2012) and for AstPT (4.1 µM, 16 h) (Tarcz et al. 2014b). n.d.: not detected. 
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Table 6 Product yields of prenylated hydroxynaphthalenes by DMATS enzymes.  
 
substrate 
AnaPT CdpNPT CdpC3PT 7-DMATS 6-DMATSSa 
prenylated position (product yield, %) 
 
C-4 (91.5) C-4 (93.3) C-4 (14.1) C-4 (45.4) n.i. 
 
n.t. n.t. n.t. n.t. 
C-6/C-7 
(61.5) 
 
n.i. C-4 (24.7) n.i. C-4 (92.6)  n.i. 
 
C-4 (88.7) C-4 (46.7) C-4 (9.8) C-4 (88.5) C-4 (33.7) 
 
C-4 or C-2 
(25.7) 
n.d. n.d. C-4 (59.0) n.i. 
 
n.i. n.i. n.i. n.i. C-6 (43.8) 
 
C-1 (42.7) n.d. n.d. n.d n.d 
 
C-1 C-1 
n.d 
C-1 
n.i. five 
byproducts 
n.i. n.i. 
 
C-1 (+) 
byproducts 
C-1 (+), 
C-3 (+) 
byproducts 
n.d 
C-1 (+) 
byproducts 
n.i. 
The data are adopted from publications for AnaPT, CdpNPT, CdpC3PT and 7-DMATS (20 
µg, 7 h) (Yu et al. 2011); 6-DMATSSa (9.6 µM, 16 h) (Winkelblech and Li 2014). +: major 
product; n.i.: not isolated; n.d.: not detected; n.t.: not tested. 
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Table 7 Product yields of prenylated acylphloroglucinols by AnaPT. 
 
substrate 
prenylated 
position 
product 
yield [%] 
substrate 
prenylated 
position 
product 
yield [%] 
 
C-2 2.4 
 
C-6 4.6 
C-2 and C-4 8.4 
 
C-6 32.1 
 
C-4 9.3 
 
C-6 32.3 
 
C-4 6.3 
 
C-6 28.2 C-6 3.1 
The data are adopted from publication for AnaPT (10.1 µM, 6 h) (Zhou et al. 2015). 
 
 
Table 8 Product yields of geranylated cyclic dipeptides by AnaPT 
 
 prenylated 
position 
product 
yields [%] 
prenylated 
position 
product 
yields [%] 
cyclo-L-Trp-Ant C-6 88 n.d. n.d. 
cyclo-D-Trp-Ant C-6 31 C-7 60 
cyclo-L-Trp-L-Leu C-6 15 C-7 57 
cyclo-L-Trp-L-Trp C-6 15 C-7 35 
cyclo-L-Trp-L-Tyr C-6 9 C-7 24 
cyclo-D-Trp-L-Tyr C-6 32 C-7 13 
The data are adopted from publication for AnaPT (4.0 µM, 16 h) (Pockrandt and Li 2013). n.d.: 
not detected. 
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Table 9 Product yields of prenylated xanthones by AstPT. 
 
substrate 
prenylated 
position 
dimethylallyl (n=1) geranyl (n=2) farnesyl (n=3) 
product yield [%] product yield [%] product yield [%] 
 
7-O 23.1 26.1 18.8 
 
3-O 2.1 9.1 5.3 
6-O 8.9 2.1 0.87 
 
3-O n.d. 8.4 14.0 
The data are adopted from publication for AstPT (4.1 µM, 16 h) (Tarcz et al. 2014b). n.d.: not 
detected. 
 
 
Table 10 Product yields of prenylated L-tryptophan by DMATS enzymes with 
unnatural alkyl/benzyl donors. 
 
 MAPP 2-pen-PP benzyl-PP 
 prenylated position and product yield [%] 
FgaPT2 C-4 (19)a, C-5 (19) a C-5 (37) a C-5 (58) b 
5-DMATS C-5 (13.6), C-6 (45.3) C-6 (91) C-6 (22.9), C-5 (5.7) 
5-DMATSSc C-5 (2.3), C-6 (9.3), 
C-7 (9.3) 
C-5 (9.3), C-6 (27.9), 
C-7 (27.9) 
C-6 (5.3), 
byproducts 
6-DMATSSa C-6 (51.1) C-6 (91.2) C-6 (13.9) 
6-DMATSSv C-6 (37.6) C-6 (89.3) C-6 (8.2) 
TyrPT C-6 (5.9), C-7 (8.9), 
byproduct 
C-6 (21.5), C-7 (9.9), 
byproducts 
C-6 (5.7), 
byproducts 
a The data are adopted from publication for FgaPT2 (0.89 µM, 16 h) (Liebhold et al. 2012); b for 
FgaPT2 (1.8 µM, 16 h) (Liebhold and Li 2013); For the rest data: enzyme (7.5µM, 16 h) was adopted 
here (Winkelblech et al. 2015b). 
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Table 11 Product yields of prenylated cyclic dipeptides by DMATS enzymes with 
unnatural alkyl donors. 
  
Substrate with enzyme donor 
prenylated position and product yields [%] 
C2-alkylated C3-alkylated 
cyclo-L-Trp-Ant + AnaPT MAPP 65.2 C3-IIB-S (14.1) C3-IIB-R (19.4) 
2-pen-PP 26.8  C3-IIB-R (63.4) 
cyclo-D-Trp-Ant + 
CdpNPT 
MAPP 6.2 (3:1)a C3-IIA-R (15.1) C3-IIA-S (15.1) 
2-pen-PP 14.2 (5:1)a C3-IIA-R (31.7) C3-IIA-S (15.8) 
cyclo-L-Trp-L-Leu 
+ CdpC3PT 
MAPP 13.5 C3-IIA-R (7.5) C3-IIA-S (6.2) 
2-pen-PP 15.3 C3-IIA-R (8.0) C3-IIA-S (8.0) 
cyclo-L-Trp-L-Pro 
 + FtmPT1 
MAPP 74.7 (1.4:1)a C3-IIA-R (7.2) C3-IIA-S (14.5) 
2-pen-PP 52.5 (1:3.4)a C3-IIA-R (15.1) C3-IIA-S (30.1) 
cyclo-L-Trp-L-Pro 
 + BrePT 
MAPP 22.9 (1.1:1)a C3-IIA-R (0.4) C3-IIA-S (4.9) 
2-pen-PP 59.3 (5:1)a C3-IIA-R (3.9) C3-IIA-S (1.9) 
The data are adopted from publication for AnaPT (4.0 µM), CdpNPT (9.8 µM), CdpC3PT (10.5 µM), 
FtmPT1 (3.7 µM), BrePT (10.0 µM) and incubation time 16 h (Liebhold et al. 2013). 
a the ratio of two isomers. 
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Table 12 Product yields of prenylated tyrosine by tyrosine PTs with unnatural 
alkyl/benzyl donors. 
 
substrate 
DMAPP MAPP 2-pen-PP benzyl-PP 
TyrPT SirD TyrPT SirD TyrPT SirD TyrPT SirD 
product yield [%] 
L-Tyr 89.1 99.3 21.2 28.0 56.6 44.3 n.i. n.i. 
4-amino-L-Phe 78.1 66.1 57.7 34.8 46.4 42.6 67.2 54.6 
3-fluoro-DL-Tyr 50.1 66.5 13.1 8.9 43.9 20.5 n.i. n.i. 
3,4-dihydroxy-L-Phe 100 88.2 n.i. n.i. 30.2 14.3 n.i. n.i. 
8-methyl-L-Tyr 98.3 89.4 n.i. n.i. 10.3 33.5 n.i. n.i. 
The data are adopted from publication for TyrPT and SirD (3.7 or 3.9 µM, 16 h) (Yu 
et al. 2015). n.i.: not isolated 
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5. Conclusions and future prospects 
 
In this thesis, a new member of DMATS superfamily was characterized biochemically 
and the close relationship and complementary substrate promiscuity of tyrosine and 
tryptophan PTs were reported. Meanwhile, the potential usage of DMATS enzymes 
was further expand for chemoenzymatic synthesis of prenylated tryptophan, tyrosine 
and cyclic dipeptide derivatives, in some cases with enhanced catalytic activity by 
molecular modeling-guided mutagenesis. 
The results of this thesis brought the close relationship and complementary substrate 
promiscuity of tyrosine and tryptophan PTs into light (Figure 5-1). This topic started 
with the characterization of a new member of DMATS superfamily TyrPT from 
Aspergillus niger. TyrPT was found to catalyze the O-prenylation of tyrosine as well as 
C7-prenylation of tryptophan. It was further compared with the known tyrosine O-PT 
SirD and tryptophan C7-PT 7-DMATS toward tyrosine and tryptophan derivatives. 
TyrPT exhibited broader substrate spectrum and significantly higher catalytic activity 
for several substrates. This work provides a new enzyme for production of prenylated 
derivatives and enhances the relationship of tyrosine O- and tryptophan C7-PTs. 
Further study revealed that tryptophan C4- and C7-PTs FgaPT2 and 7-DMATS also 
accepted tyrosine and its derivatives as substrates and catalyzed a unique C3- and O-
prenylation, respectively. A mechanism of FgaPT2 reaction with tyrosine was proposed 
based on the molecular modeling results with the available crystal structure of FgaPT2. 
The catalytic efficiency of FgaPT2 toward tyrosine was then improved by molecular 
modeling-guided site-directed mutagenesis. One mutant FgaPT2_K174F showed 
practically no activity toward L-tryptophan, whereas the acceptance of L-tyrosine was 
improved significantly.  
Additionally, a tyrosine analog, L-o-tyrosine was also accepted by the tryptophan PTs 
FgaPT2, 5-DMATS, 6-DMATSSv and 7-DMATS as well as by the tyrosine PT TyrPT, 
but not by SirD. Another tyrosine analog L-m-tyrosine was only converted by FgaPT2 
and 7-DMATS. For both substrates, tryptophan PTs demonstrated higher activities than 
tyrosine PTs. C5-prenylated o-tyrosine as well as C4- and C6-prenylated m-tyrosine 
were identified as products of these enzymes.  
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Figure 5-1. Complementary substrate promiscuity of tryptophan and tyrosine PTs. 
Previous reports demonstrated that the tryptophan PTs accepted cyclic dipeptides only 
at high protein concentrations. Correspondingly, tryptophan was a very poor substrate 
for cyclic dipeptide PTs. In this thesis, an unnatural cyclic dipeptide cyclo-L-
homotryptophan-D-valine with one additional C-atom between the indole and 
diketopiperazine rings was synthesized and found to be well accepted by three 
tryptophan PTs FgaPT2, 5-DMATS and 7-DMATS as well as by five cyclic dipeptide 
PTs BrePT, FtmPT1, CdpC3PT, CdpNPT and AnaPT. Seven prenylated products with 
one prenyl moiety at each position of the indole nucleus and one diprenylated derivative 
were isolated from enzyme assays. 
Instead of modification of substrate, the acceptance of cyclic dipeptides by tryptophan 
C4-prenyltransferase FgaPT2 was significantly improved by saturation mutagenesis 
experiments on the key amino acid R244. Thirteen R244 mutants demonstrated 
differently increased enzyme activities for tryptophan-containing cyclic dipeptides, 
with up to 155-fold catalytic efficiency of that of FgaPT2. Furthermore, different 
preferences for cyclic dipeptides were observed for these mutants. Therefore, thirteen 
new biocatalysts were created from FgaPT2 for efficient production of C4-prenylated 
cyclic dipeptides. 
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In the future, the following works should be continued: 
 Further study on single or double mutations of FgaPT2, especially for the key 
amino acid Y191, L81 and I80, involved in the binding of tryptophan side chain, 
to expand its aromatic substrate spectrum. 
 Mutation study on E298 of 7-DMATS, which is corresponding to R244 of 
FgaPT2, to testify whether this amino acid residue is important for the 
acceptance of cyclic dipeptides. 
 Collect all available data of mutated DMATS enzymes and try to rational design 
PTs which could catalyze additional Friedel-Crafts reactions for production of 
desired products. 
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